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1. General Introduction 
1.1 ADHD in adults
Attention Deficit/ Hyperactivity Disorder (ADHD) is not only limited to young patients. 
It is increasingly diagnosed in adults. Although the estimated prevalence in Europe 
ranges between 2 and 3% (48), the knowledge about adult ADHD pathophysiology and 
its neurobiological basis developed only in the past two decades, primarily stimulated 
by the rapid developments in modern genetic and imaging techniques. ADHD in 
adulthood leads to an array of major psychosocial problems such as social maladaptation, 
academic underachieving, antisocial and aggressive behaviour, relation problems, high 
risk sexual behaviour and car accidents (11,12;55;67;66). These factors in total lead to a 
negative impact on social and economic well-being of the individual.
As can be inferred from Table 1, the key problem in the diagnosis of ADHD in adulthood 
is that the clinical diagnostic items are still based on childhood criteria. This raises the 
question whether the diagnostic standards in adults are up to date.
In 1995, Paul Wender and coworkers from the University of Utah stressed that the 
symptoms in adult ADHD are not just extrapolations from those in childhood and 
adolescence. This UTAH workgroup developed criteria for adult characteristics that 
differ significantly from those in childhood (117). The authors pointed out that, apart 
from the common features such as impulsivity, motor hyperactivity and attention deficit 
symptoms, affective lability, hot temper/ explosive short-lived outbursts, emotional 
overreactivity, and disorganization/ inability to complete tasks, are key symptoms of the 
adult ADHD syndrome. Wender et al. brought these aspects together in a structured 
interview, the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS,117). 
The authorized German version is called the Wender Reimherr Interview (WRI,97).
Despite the methodical shortcomings, it was decided to apply the international 
diagnostic standards and, therefore, the adult ADHD patients participating in the studies 
of this thesis were recruited fulfilling the combined type DSM IV criteria The WRI was 
used in the clinical studies to provide additional clinical data of the patients.
ADHD phenotypes in adulthood show a varying psychopathological picture over time. 
During lifetime, the ADHD core features may change, because impulsivity and 
hyperactivity become less prominent over time than the attention deficit symptoms 
(15). Moreover, it has to be stressed that some patients diagnosed with ADHD in 
childhood don`t display the full clinical symptom scale in adulthood any more, leading 
to a so-called non-persistent or subclinical form of ADHD. Information about this 
phenotype is, however, very limited. 
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Table 1   Diagnostic criteria for Attention-Deficit/Hyperactivity Disorder (DSM IV)
A. Either (1) or (2): 
(1) inattention: six (or more) of the following symptoms of inattention have persisted for 
at least 6 months to a degree that is maladaptive and inconsistent with developmental 
level: 
(a) often fails to give close attention to details or makes careless mistakes in 
schoolwork, work, or other activities 
(b) often has difficulty sustaining attention in tasks or play activities 
(c) often does not seem to listen when spoken to directly 
(d) often does not follow through on instructions and fails to finish school work, 
chores, or duties in the workplace (not due to oppositional behavior or failure to 
understand instructions) 
(e) often has difficulty organizing tasks and activities 
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sustained 
mental effort (such as schoolwork or homework) 
(g) often loses things necessary for tasks or activities (e.g., toys, school assignments, 
pencils, books, or tools) 
(h) is often easily distracted by extraneous stimuli 
(i) is often forgetful in daily activities 
(2) hyperactivity-impulsivity: six (or more) of the following symptoms of hyperactivity-
impulsivity have persisted for at least 6 months to a degree that is maladaptive and 
inconsistent with developmental level:
Hyperactivity 
(a) often fidgets with hands or feet or squirms in seat 
(b) often leaves seat in classroom or in other situations in which remaining seated is 
expected 
(c) often runs about or climbs excessively in situations in which it is inappropriate (in 
adolescents or adults, may be limited to subjective feelings of restlessness) 
(d) often has difficulty playing or engaging in leisure activities quietly 
(e) is often “on the go” or often acts as if “driven by a motor” 
(f ) often talks excessively
Impulsivity
(g) often blurts out answers before questions have been completed 
(h) often has difficulty awaiting turn 
(i) often interrupts or intrudes on others (e.g., butts into conversations or games) 
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Finally, with increasing age, adults with ADHD have a serious risk of developing various 
comorbid psychiatric disorders, in particular affective disorders and substance use 
disorders (119;60). Personality disorders often coincide with ADHD (69). This severely 
hampers an adequate description of the core ADHD phenotype or endophenotype in 
clinical research. It is, therefore, crucial in pathophysiological research to investigate 
ADHD patients without these kinds of comorbidities. The studies of this thesis aim to 
contribute to the clarification of the neurobiological basis of impaired attentional and 
executive networks, as well as of motor disturbances, in adult ADHD patients in whom 
further comorbidity and history of drug abuse are absent.
1.2 Syndromal views of ADHD in historical perspective
Since decades, ADHD is most frequently diagnosed in child and adolescence psychiatry. 
Therefore, the history of ADHD primarily means the history of ADHD in childhood. 
Although the discussion about the diversity of clinical concepts of ADHD is still going 
on, the historical perspective is important for a good understanding. The earliest 
mentioning of ADHD-like behaviour in adulthood may be deduced from the description 
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Table 1   Continued
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment 
were present before age 7 years. 
C. Some impairment from the symptoms is present in two or more settings (e.g., at 
school [or work] and at home). 
D.  There must be clear evidence of clinically significant impairment in social, 
academic, or occupational functioning. 
E.  The symptoms do not occur exclusively during the course of a Pervasive 
Developmental Disorder, Schizophrenia, or other Psychotic Disorder and are not 
better accounted for by another mental disorder (e.g., Mood Disorder, Anxiety 
Disorder, Dissociative Disorders, or a Personality Disorder). 
Code based on type: 
314.01  Attention-Deficit/Hyperactivity Disorder, Combined Type: if both Criteria A1 and A2 
are met for the past 6 months 
314.00  Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type: if 
Criterion A1 is met but Criterion A2 is not met for the past 6 months
314.01  Attention-Deficit/Hyperactivity Disorder, Predominantly Hyperactive-Impulsive 
Type: if Criterion A2 is met but Criterion A1 is not met for the past 6 months 
Coding note: For individuals (especially adolescents and adults) who currently have 
symptoms that no longer meet full criteria, “In Partial Remission” should be specified.
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by Hippocrates more than 2500 years ago. In his “Aphorisms” (2), he depicted a patient 
who had a “quickened response to sensory experience, but also less tenaciousness 
because the soul moves on quickly to the next impression”. His advice was to treat this 
“overbalance of fire over water” with changes in nutrition: “barley rather than wheat 
bread, fish rather than meat, drinking water rather than wine”, and he suggested 
“many natural and diverse physical activities”. Such a concept of an association between 
diet and behaviour was recently “rediscovered” by a Dutch/Belgian research group 
demonstrating the burden of food substances on the severity of ADHD symptoms in 
children (87).
In 1789, Sir Alexander Crichton described a “mental restlessness” in children which was 
associated with incapacity of attending (73). In his historical review, Eduard Seidler (99) 
described the development over time of the socio-medical interpretation of hyperkinetic 
behaviours in childhood. Such disinhibited motor signs were observed since the middle 
of the 19th century and interpreted as “naughtiness” (Hoffmann 1845), followed by 
“neurasthenia” (Beard 1869), “character weakness” (Strümpell 1890), “neuropathy” 
(Czerny 1908), “moral defect” (Still 1902), and in the 1950ies was labeled as “minimal 
brain damage” (see overview 73,99) in the context of ADHD-like clinical syndromatology 
of children who survived the Encephalitis lethargica and the influenca pandemy.
In 1845, the German general practitioner and later psychiatrist Heinrich Hoffmann 
described the famous “Zappelphillip“ and “Hans Guck in die Luft“, presenting the 
phenotypes of the combined hyperkinetic and the inattentive subtype of childhood 
ADHD, however, without interpreting those as disorders. He classified this child 
behaviour as naughtiness only (99). In the same year, Wilhelm Griesinger described 
children with a “nervous constitution“, who “cannot be quiet for a moment … don´t 
have any attention“ and, therefore, suffer from a “disturbed reaction function of the 
central organ to stimuli that work on it”. 
Still (105,106) was the first who systematically mentioned the hyperkinetic disorder in 
the Anglo-saxonian scientific literature. In his opinion, challenging behaviours in 
children originated from deficits in moral functioning.
The viewpoint that hyperkinetic disorders have to be seen as a syndromal entity started 
with Bradley in 1937 (18), who discovered that the stimulant drug Benzedrine ameliorated 
hyperactive behaviour in children and induced relaxation. Subsequently, methylphenidate 
was synthesized in the 1940ies for the treatment of the hyperkinetic syndrome as a form 
of “minimal brain damage syndrome”. Although in the 1950ies the concept of early birth 
brain damage was no longer considered to be valid, in the sixties the concept of minimal 
brain dysfunction in terms of hyperkinetic reaction of childhood was introduced with 
the DSM II (1968) in order to relativize the hypothesis of brain damage (73).
In the 1980 version of the DSM III, the attention deficit component of the hyperkinetic 
disorder was first introduced and modified during subsequent editions until the present. 
In the DSM-IIIR (1987), Attention Deficit Hyperactivity Disorder was differentiated from 
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Attention Deficit Disorder without hyperactivity and termed Undifferentiated Attention 
Deficit Disorder to accentuate a distinct concept of this entity. At present, hyperkinetic 
behaviours, attention deficits and their combination are classified apart from each other 
to underline possible different etiologies of a developmental disorder (DSM-IV-TR, 
2000). Further nosological shifts are to be awaited in future classification systems, that 
may eventually include endophenotypes based on the executive functioning or on 
attention/motor phenomena in separate genetic subphenotypes.
1.3 Brain mechanisms in ADHD: Attention and executive functions
To understand the differential pathophysiological mechanisms that are implied in adult 
ADHD syndromatology, it should be emphasized that lack of attention and impulsivity 
are the most prominent phenotypical features of ADHD in adulthood (100), which points 
towards the significance of attention deficits and executive dysfunctioning. Symptoms 
of motor disinhibition from childhood on show a decrease over time or may become 
more internalized (16). In the studies of this thesis, the first point of interest is the 
attention deficit syndrome in relation to the brain networks that are involved (see Figure 1).
GENERAL INTRODUCTION 1
Figure 1   Different levels of brain attention networks (adapted from (35))
FEF: Frontal Eye Field; PFC: Prefrontal cortex; ACC: Anterior cingulated cortex; PPC: Posterior parietal cortex; 
ARAS: Ascending reticular activating system.
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In the central nervous system, the attention networks comprise three major components 
(89;30;45). The first constitutes mainly subcortically located arousal and alerting neuronal 
circuits that comprise the ascending reticular activating system, which projects to 
brainstem and thalamus and, via the striatum, towards the limbic system with ultimately 
cortical projections. The main function of this subcortical neuronal network is the 
activation and synchronization of the cerebral cortex (Behavioural Activating System – 
BAS) (see for review:35) and is especially active with salient stimuli from external and 
internal environments. 
The second, so-called mixed cortical-subcortical circuits, detect novel stimuli (superior 
colliculi), filter irrelevant stimuli (pulvinar), or disengage attention focus (posterior parietal 
cortex). 
The third component comprises the selective or directed/cortical attentional network 
that is of special significance for the pathophysiology of ADHD. This neuronal system is 
responsible for the generation of volitional saccades (frontal eye fields), inducing motor 
intention (premotor cortex), is linked to the working memory (dorsolateral prefrontal 
cortex) and is modulated by the anterior cingulate cortex (ACC; target detection, 
response selection and inhibition, conflict monitoring, motivation) (23).
This circuit is also named the executive (conflict) system and has been shown to have a 
strong heritability component (46). Within this network, the dorsal part of ACC (dACC) is 
strongly connected with serotonergic and dopaminergic neuronal systems. 
Regions of the parietal cortex (tertiary visual brain regions) also play an important role 
in mediating sensory functions. The posterior parietal cortex disengages the attentional 
focus to a target (91) and the superior parietal lobule has the function of voluntary shifts 
of attention (29). Dominance of the right hemisphere is considered to be important for 
orienting as well as for selective attention (84;89). 
Executive functions include the targeted control of complex behaviours, where divergent 
cognitive aspects are coordinated. They converge in a wide spectrum of mental processes 
that lead to fluent processing of information and coordination of execution via central 
nervous system processes. The underlying mechanisms of executive functioning include 
problem solution, planning, action control, and control of motivation and emotions 
(102,86). Motivation and delay aversion play an intriguing role in executive functioning 
in ADHD (28,82).
Barkley (1997) postulated a concept of executive control for internally represented 
information in ADHD via four executive instances: working memory, self regulation of 
affect/motivation/arousal, internalization of speech, and reconstitution. Motor control is 
finally modulated via inhibiting task-irrelevant responses, executing goal-directed responses, 
execution of complex motor sequences associated with goal-directed persistence. This 
makes a sensitivity to response feedback necessary to control behaviour by internally 
represented information. Barkley (13) suggested the involvement of several mechanisms 
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in the behaviour inhibition in ADHD: inhibition of prepotent responses, stopping of 
ongoing responses, giving feedback on errors, and interference control. 
Motor coordination problems are key features of ADHD with an estimated prevalence of 
about 50 percent (90). Motor difficulties range from sensory-motor dys-coordination to 
a delay of motor milestones development. Dopaminergic and noradrenergic neuronal 
structures in fronto-subcortical systems play a crucial role in the pathophysiology of 
disturbed motor functioning in ADHD (47;88). 
Functional imaging techniques can disentangle how brain networks adapt to internal 
and external influencing factors in adult ADHD. As compared to radionuclid imaging 
techniques (Positron Emission Tomography (PET) and Single Photon Emission Computer 
Tomography (SPECT)), the functional Magnetic Resonance Technique (fMRI) is 
non-invasive and allows registration of attention and executive brain activity with a 
high spatial resolution. Since its time resolution is relatively low, research on the motor 
system of adult ADHD patients with its fast dynamic components can be investigated 
only difficultly by the fMRI technique. To analyze motor functions, the transcranial 
magnetic stimulation technique (TMS) was therefore chosen because of several 
advantages. This technique is also non-invasive, usually well tolerated and provides 
insights into the transmission processes involved in the motor system. Furthermore, 
specific pulse protocols of TMS can help to visualize pharmacological effects on the 
human motor system. In the following chapters the used neurophysiological techniques 
will be delineated in more detail.
1.4  Research techniques
1.4.1 Functional Magnetic Resonance Imaging (fMRI) 
The magnetic resonance imaging (MRI) technique was first used in 1977 to visualize 
human tissues (32). The basic principle of MRI is the changing of the spin of protons 
which are present in all tissues (see for review:56). In principle, the spin aligns parallels 
with an extern magnetic field comparable to the way a compass needle is directed by 
the earth’s magnetic field, but it may be also antiparallel to it. A high frequency electro-
magnetic coil within the scanner gives impulses with the resonance frequency of a 
tissue (Larmor frequency) to reach a synchronized spin deviation. This deviation takes 
place in a gyroscopic movement of the spin axis (precession) and gives a characteristic 
signal depending on the magnetic field strength and environment of the atomic nuclei, 
e.g. brain tissue. The time for the spins to reach the original alignment to the magnetic 
field or transversal to it, is called relaxation time, T
1
 and T
2
, respectively. Regional 
differences in susceptibility for magnetization within a tissue lead to imaging contrasts 
and variations in signal phases, the so-called gradient echo sequences that are depicted 
by T
2
* relaxation. The use of coils that can generate linear changes of magnetic fields for 
very short moments, and the complex registration of the local frequency changes due 
to this, forms the basis for functional magnetic resonance imaging (fMRI). 
GENERAL INTRODUCTION 1
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The cerebral perfusion of neuronal or metabolic active brain structures increases much 
higher than its consumption of oxygen. The paramagnetic desoxygenated hemoglobin 
has a low signal, whereas the diamagnetic oxyhemoglobine in metabolic active brain 
regions results in a contrasting strong signal. This blood oxygenation level dependent 
(BOLD) contrast or the effects from the magnetic characteristics of desoxygenated and 
oxygenated hemoglobine, are the basic signal principles for fMRI. This non-invasive 
technique enables to perform repeated measurements of local brain activity. The Echo-
Planar-Imaging (EPI) technique generates within a very short time (100ms) a two 
dimensional picture of brain slices. This is done by means of switching very fast between 
frequency gradients and different brain slices. As a consequence a whole brain 
activation picture within a short time frame can be achieved. The fMRI design of this 
thesis followed an event-related paradigm. This indicates that each event of interest was 
summarized and averaged in contrast to the block design which measures the same 
events repeatedly. The event related study design gives better contrasts of salient 
stimuli, here the NoGo events.
1.4.2  fMRI and ADHD 
A large number of neuroimaging studies is available of which the results support the 
neurobiological basis of ADHD from childhood to adolescence. Imaging data about 
adult ADHD are still sparse. Chapter 2 reviews the neurobiological aspects of ADHD in 
adulthood and the different attention networks that are involved in arousal, orienting 
and sustained focusing on external targets are discussed. 
However, only limited information is available about the underlying pathophysiological 
mechanisms. From imaging studies using stimulants, it has become obvious that 
dopaminergic dysbalances in forebrain and basal ganglia are involved in attention 
deficit and hyperactivity/impulsivity symptoms. Ventral and dorsolateral prefrontal 
cortex, anterior cingulate, insula, amygdala, hippocampus, and ventral striatum are 
suggested to be involved in ADHD pathology in children and adolescents (44;42,41;96; 
70;25;98). Only a few studies are available about the pathophysiology of ADHD in 
adulthood and its correlation with the clinical phenotype. By means of PET, Volkow et al 
(111,112) demonstrated depressed dopaminergic activity in caudate and limbic brain 
regions in adult ADHD patients. The improvement of dopaminergic dysfunctions by 
application of methylphenidate appeared to be associated with the normalization of 
the clinical phenotype.
In children with ADHD, Konrad et al. (71) used event related fMRI to investigate brain 
activations in the neuronal networks involved in attention processes in particular. In 
contrast to controls, the activation of the attentional networks followed a deviant 
pattern, in that there was less right-sided activation in the anterior cingulated gyrus 
during alerting, more fronto-striatal-insular activation during reorienting, and less fron-
to-striatal activation for executive control. The BOLD signals appeared to be dysregulated 
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in the putamen during reorienting and executive control, suggesting altered brain 
activation strategies in ADHD.
In medication naïve children and adolescents with ADHD, it was demonstrated that 
functional abnormalities are task-specific and encompass not only fronto-striatal but 
also parietal and temporal cortices (103). In drug naïve adult patients with ADHD, it 
appeared that abnormal brain functioning was not limited to complex executive 
functions, because abnormal processing of numeric stimuli was noticed during both 
simple and complex cognitive tasks. The data from fMRI measurements during complex 
tasks performed by the patients showed greater activation of left hemispheric linguistic 
processing areas and failed to activate the bilateral parietal regions important for 
complex executive processes (57). There is still a need to understand how the clinical 
phenotype of adult ADHD correlates with the deviant brain activation patterns and 
which factors are involved in it. This is the central question of the study in chapter 3, 
which deals with drug naive adult ADHD patients without axis I comorbidity. In addition, 
the level of attention networks (ascending reticular activation system/ARAS vs. 
subcortical vs. cortical – arousal vs. orienting vs. top down system) which are impaired 
in ADHD, was the focus of interest in this study with adult patients with ADHD. Since 
patients with subclinical ADHD can also be diagnosed, the question was also whether 
in these patients pathophysiological parallels may be found or that their compensatory 
network activations can be differentiated, both qualitatively and quantitatively, from 
those displaying the full phenotype.
1.4.3 Paired pulse Transcranial magnetic stimulation (ppTMS)
The transcranial magnetic stimulation technique has been shown to be useful for 
studying the complex central neuronal systems that are implicated in motor brain 
networks (123,72,85). Barker and colleagues were the first to use transcranial magnetic 
stimulation (TMS) techniques in men in 1985 (10). In contrast to the transcranial electric 
stimulation of the human cortex, the magnetic stimulation is non-invasive and painless. 
A further advantage of TMS is that the magnetic impulses penetrate skin, skull and brain 
tissues without Ohmic resistance or relevant energy loss. TMS results in an indirect 
transsynaptic activation of, in general, tangentially oriented interneurons, in contrast to 
the direct electrical stimulation of pyramid cell axons or the Ranvier nodes (92).
A magnetic stimulator consists of two main components, the generator which is a large 
capacitor and the coil with a certain inductance and resistance that transfers the energy 
to the tissue. The capacitor is charged to about 2 kV and, after discharge, a strong 
biphasic peak current of 5-8 kA is generated for 300 µsec. The current pulse induces a 
magnetic field which again results in an electric field perpendicular to it. Typically, the 
figure of eight coil used in these experiments generates a maximum magnetic field 
strength of about 2,5 Tesla. The use of a figure of eight coils has, as compared to with 
the standard round coils, the advantage of generating very focused electric fields 
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perpendicular to the coil currents. The strength of the magnetic field declines with the 
inverse third power of the distance (43) and, consequently, the electric field intrudes the 
brain to about 2 cm. When the magnetically induced current sufficiently flows parallel 
to the brain surface, depolarization of neuronal membranes occurs, and hence an 
action potential is generated. Interneuronal structures that are oriented horizontally to 
the surface of the brain (34) are activated.  
TMS is thought to activate predominantly the pyramidal cells transsynaptically through 
excitatory interneuronal elements (3;34;36;81). Thus, cortical and some subcortical white 
matter brain structures can easily be stimulated with this technique. 
As first step, the resting motor threshold (RMT) and the active motor threshold (AMT) 
have to be defined via electrodes placed on the target muscle (in our studies: the 
first dorsal interosseus [FDI] muscle). RMT and AMT are supposed to be markers of 
membrane stability of cortical neurons (123). In our studies, RMT and AMT were determined 
according to the protocol of Kujirai et al. (72). Briefly, RMT was the minimal stimulus 
intensity that was required to produce motor potentials of more than 50 µV peak to 
peak amplitude in 50% of the test pulses. AMT was determined in analogy to RMT, while 
the subject tonically distended a dynamometer with the FDI at 10–20% of the maximum 
power.
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Figure 2   TMS setup with magnetic coil in a typical position at the primary motor 
cortex and EMG recording of the first dorsal interosseal muscle (FDI); 
adapted from (74)
Magnetic coil
Synchronization
Magnetic stimulator
EMG - FDI
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While the magnetic coil is at the same place, the paired pulse TMS (ppTMS) technique 
induces two magnetic pulses: a conditioning pulse which is subthreshold in relation to 
the RMT and a test pulse which is suprathreshold in relation to the RMT. This technique 
was introduced by Kujirai et al. (1993) and enables to investigate primarily intracortical 
excitability (85). Between the subthreshold conditioning pulse (CP) and the suprathreshold 
test pulse (TP) there is a variable interstimulus interval (ISI) which modulates the 
magnetically evoked potential (MEP) amplitude of the target muscle. Inhibition is a 
cortical phenomenon which is considered to reflect the inhibitory activity of 
interneurons or connections between cortical output cells (115). Facilitation occurs at 
the level of the corticospinal neurons and upstream (123,125). ISI, and CP and TP 
amplitudes determine the brain circuits that are involved in the generation of the 
magnetically evoked motor potential (MEP). At an ISI of 1-5 msec, short intracortical 
motor inhibition (SICI) can be investigated, whereas at an ISI of 5-20 msec intracortical 
motor facilitation (ICF) can be studied.
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Figure 3   A typical set of MEPs elicited by the ppTMS technique. 1: MEP with a 
suprathreshold test pulse alone. 2: a paired pulse stimulus with a 
subthreshold conditioning pulse and a suprathreshold test pulse.  
The short interstimulus interval (ISI) leads to a amplitude reduction of  
the originally MEP elicited by the test pulse alone: short intracortical 
inhibition (SICI). 3: with a longer ISI the MEP size gets higher than with the 
test pulse alone. This leads to intracortical facilitation (ICF). 
1
2
3
Test pulse (tp) alone
Test pulse (tp)
ISI 3ms
ISI 11ms
(cp) (tp)
0,5mV
10ms
MEP
Conditioning pulse (cp)
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The cortical excitability as reflected by SICI and ICF is supposed to be modulated 
through complex neuronal transsynaptic systems (mainly GABA, dopamine, glutamate, 
serotonine). Several drugs influence the ppTMS motor inhibition as well as the facilitation 
(121). Dopaminergic and noradrenergic agonists have been shown to increase SICI, 
while dopamine antagonists have an inverse effect (121). The degree of SICI is also 
assumed to be increased by GABAergic action via cortical GABAergic interneurons, 
while ICF is decreased (65;118;122,74). Pharmacologic interactions with SICI and ICF may 
also vary dependently from e.g. health state, as it is known that paroxetine enhances ICF 
in healthy probands, but decreases ICF in schizophrenic patients (50). On the other 
hand, serotonine reuptake inhibitors can have opposite effects on SICI, dependent on 
the 5-HT transporter phenotype (40). In patients with Parkinson’s disease, it has been 
shown that dopamine deficiency is associated with reduced SICI (95;124). In addition, a 
shortening of silent period and reduction in SICI was observed in patients with Tourette 
disorder as compared to healthy controls. Cortical excitability was found to be 
asymmetric in treatment-refractory major depressive disorder compared to healthy 
controls (75). With the ppTMS technique, these investigators found that the left primary 
motor cortex showed significantly higher intracortical inhibition and facilitation whereas 
there was no significant hemispherical asymmetry in healthy controls.
Thus, both the endophenotype of an individual and the clinical diagnosis influence the 
response of SICI and ICF to pharmacological agents.
1.4.4  Principles of the Cortical Silent Period (CSP)
The TMS impulse at the motor cortex during maintained voluntary muscle contraction 
results in the so-called cortical silent period (CSP), which reflects multifactor inhibitory 
mechanisms (ref). Dependent upon the strength of the TMS impulse, the ongoing elec-
tromyographic activity is discontinued for a moment of several milliseconds. The CSP is 
defined by the time of salience until reappearance of the ongoing electromyographic 
activity. Although the neuronal mechanisms underlying the CSP are not fully understood 
as yet, GABAergic neurotransmission has been suggested to be involved (77). Lesion 
studies have led to the hypothesis that the CSP is generated in the primary motor cortex 
(114). Finally, it was shown that CSP and SICI have an inverse relationship and that SICI is 
suppressed while ICF is facilitated during CSP. The CSP can be considered as a measure 
of motor cortex excitability via influences from basal ganglia, ventrolateral thalamus and 
inhibitory interneurons (1) 
1.4.5  ppTMS and ADHD
The ppTMS technique has been shown to provide a reliable test-retest stability of SICI 
and ICF in adults (93,74). Compared to the data from children with ADHD (78,79,19,20,21), 
the number of studies with ppTMS in adult patients is rather limited (61,62,94) and their 
results are equivocal.
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Both reduced and enhanced as well as not significantly changed SICI amplitudes have 
been reported dependent on the use of psychostimulant agents in adult ADHD 
(51,52,62,68). A further methodical issue has to be considered in the studies that 
investigate SICI and ICF as well as the effects of Methylphenidate (Mph) in adults with 
Tourette disorder with comorbid ADHD symptomatology (51,52). This underlines the 
need to perform studies with ADHD patients without axis I comorbid disorder, when 
the primary target is to elucidate the neurobiological mechanisms underlying ADHD 
symptomatology. It has to be underlined that the interpretation of the effect of Mph on 
neurotransmitter functionality is complicated since the compound affects not only 
dopaminergic and noradrenergic transmission, but also a variety of other neurotrans-
mission systems related to serotonine and muscarinic acetylcholine transmission 
systems (113,76).
Conflicting results about the ppTMS effect of Mph on SICI and ICF can partly be 
explained by the limited number of studies that use TMS techniques in adult ADHD 
with Tourette syndrome as comorbid disorder (51,52). Moreover, pharmacokinetic and 
pharmacodynamic variations in the Mph preparations may be implicated (125,51,64). As 
presented in chapter 4, a study of this thesis comprising a group of appropriately 
diagnosed drug naive adult ADHD patients of both sexes without any comorbid axis I 
disorder and a sex and age matched group of healthy controls. This investigation also 
included the analysis of potential hemispherical effects on cortical motor excitability 
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Figure 4   A typical recording of electrical myographic activity during ongoing 
muscle contraction and after a suprathreshold magnetic test pulse.  
Note that after an initial magnetically evoked muscle potential the 
ongoing electromyographic activity shows a silent phase (csp) until  
the baseline EMG activity reappears. Adapted from (1) 
1 mV
50ms
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and the correlation of the neurophysiological parameters with the clinical ADHD 
phenotype. In the long acting Methylphenidate (LA-Mph) study with ppTMS, the main 
focus of interest is the investigation of the impact of the chronically applied stimulant 
drug methylphenidate on motor overexcitability in adult ADHD and its correlation with 
the objective clinical phenotype. 
2. Aims of this study 
Since little is known about the general pathophysiological mechanisms underlying the 
phenotypical presentation of ADHD in adults, the aim of this thesis is to elucidate 
impairments in brain networks involved in attention processing and executive 
functioning by means of functional imaging techniques. Secondly, motor system 
functionality in adult ADHD is studied using ppTMS, a non-invasive technique that is 
considered to be the most appropriate for depicting the intracortical excitability and its 
modulation by compounds such as LA-Mph. As the psychopathology of ADHD is 
supposed to originate from a dysequilibrium of dopaminergic transmission, it is of 
special interest to investigate psychiatric symptoms which are assumed to be related to 
dopaminergic dysfunctionality, e.q. attention deficits, executive dysfunctioning and 
psychomotor disturbances. The results from the studies that include patients with (first 
episode) schizophrenia, may provide a better understanding of the specific psychopa-
thology of adult ADHD. More specifically, the aims of these studies were
1. To analyse central nervous systems involved in attention and execution by means of 
functional magnetic resonance imaging, following a continuous performance test 
paradigm (Go/NoGo), in order to identify correlations between dysfunctions in 
these networks and the adult ADHD symptom profile.
2. To study cortical motor inhibition and facilitation with the paired pulse transcranial 
magnetic stimulation (ppTMS) technique in order to delineate relationships between 
overexcitability of the motor cortex and phenotypical presentation of adult ADHD.
3. To explore the effects of LA-Mph on cortical overexcitability in adults with ADHD by 
means of ppTMS.
4. To investigate the excitability of the motor neuronal system with ppTMS in another 
psychiatric disorder which is associated with dopamine driven cognitive and 
executive functioning deficits and disturbances of motor excitability, namely 
first-episode schizophrenia, and to compare the motor cortex excitability with 
ADHD patients in order to delineate putative overlapping pathophysiological 
mechanisms. 
CHAPTER 1
25
3. Outline of the thesis
Chapter 2 provides an overview of imaging data in adult ADHD.
Chapter 3 deals with a controlled fMRI study focused on attention networks and 
executive functions in adults with ADHD. 
Chapter 4 comprises a study with ppTMS in which this technique was used to investigate 
motor cortex excitability and executive functioning in adults with ADHD. In addition, 
the ppTMS parameters that reflect motor disinhibition were correlated with the 
symptom profile of adult patients with ADHD.
Chapter 5 constitutes a clinical study in which the ppTMS technique is used to correlate 
motor overexcitability with the symptom profile of adult ADHD patients before and 
during treatment with LA-Mph. 
Chapter 6 describes a ppTMS study on abnormalities in motoneural systems of adult 
patients with first-episode schizophrenia and chapter 7 describes a study with adult 
patients with ADHD or first episode schizophrenia, diseases that are both supposed to 
have a dopaminergic brain transmission dysbalance. The motor excitability networks 
and hemispheric balance is evaluated in both patient categories. 
Chapter 8 concerns a general review of the fMRI and ppTMS data obtained from the 
above listed studies, and discusses the clinical relevance of the findings as well as the 
limitations and strengths of the subsequent clinical investigations. Some outlines for 
future investigations and the conclusions are also presented. 
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Abstract
This review provides an overview about recent findings in attention-deficit hyperactivity 
disorder (ADHD) brain imaging. ADHD is understood as a developmental disorder and 
several studies have addressed brain development in children and adolescents. The 
hallmarks of impairment of cerebral processing in ADHD are executive dysfunctions 
(motor execution, inhibitory control, working memory), as well as deficient attention 
processing. In adulthood, imaging studies have revealed disturbances in the prefrontal 
cortex, and anterior cingulated cortex (dACC) which are involved in the regulation of 
selective attention, executive control and decision-making. Dysfunction of basal ganglia 
is also a consistent finding in ADHD from childhood to adulthood. These findings 
suggest a persistent dysregulation of frontostriatal circuitries. The cerebellum, and its 
role in affect and cognition, is also persistently implicated in the pathology of ADHD. 
The cerebello-(thalamo-)striato-cortical network includes different attention networks 
and executive control instances. It appears from brain-imaging data in adults that the 
pathophysiological principles of ADHD do not profoundly change from childhood and 
adolescence to adulthood, regardless of some changes in psychopathology. The 
hypothesis of a neurodevelopmental disorder seems to be reinforced on the basis of 
imaging data of the adults.
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Introduction
Attention-deficit hyperactivity disorder (ADHD) affects adults with a prevalence of 
about 3–4% [1]. Whereas key symptoms of the psychopathological core symptoms in 
childhood are inattention, hyperactivity and impulsivity, adults with ADHD tend to be 
predominantly impaired by attention deficits and disorganization, whereas hyperactivity 
and impulsivity tend to ameliorate [2, 3]. Emotional dysregulation, mood and anxiety 
disorders as well as substance abuse are commonly described features and comorbidities 
in adult patients [4]. As clinical patterns differ between ADHD children and adults, and 
given that more than half of the children with ADHD do not continue being clinically 
affected in adulthood, one could hypothesize that adult patients with ADHD represent 
a distinct subpopulation with distinct neurobiological or environmental background. 
Therefore, there is a substantial need for neuroanatomical and functional neuroimaging 
investigations in adults suffering from ADHD. Indeed, like in many areas in neuropsy-
chiatry, neuroimaging techniques have been intensively used also in ADHD research in 
the past few years.
It is a principle question whether impairment of brain networks compares to those that 
have been extensively described in ADHD children. Thus, a key question in adult ADHD 
research is whether there is also impairment of frontostriatal/frontosubcortical networks. 
These pathways are involved in executive and motor control, as well as in inhibition of 
behavior and voluntary decision-making. Frontosubcortical networks contain a large 
amount of noradrenergic, dopaminergic as well as serotonergic projections. Striatal 
structures, such as putamen, globus pallidum and caudate nucleus, form a frontostriatal 
network and are typically impaired in ADHD [5]. Areas of particular interest are also the 
prefrontal and dorsolateral prefrontal cortex (PFC). The anterior cingulated cortex (ACC) 
seems to play a pivotal role in ADHD psychopathology. This region has widespread 
connections to forebrain and limbic structures. Besides its function as a conflict 
monitoring center, the ACC has the role of integrating polymodal inputs from different 
brain regions in the control of executive and inhibitory functions [6]. Finally, increasing 
attention is being paid to the cerebellum, which exerts strong influences on affective 
and cognitive function via thalamic connections [7, 8].
Brain Structure in ADHD
Global Neuroanatomical Findings
Total cerebral volume reduction is well described in children and adolescents with 
ADHD [9–16], which is most prominent in the right hemisphere. The right hemisphere is 
hypothesized to play a dominate role in decision-making, inhibitory control and 
selective attention [17, 18]. It has been shown that damage of the right hemisphere can 
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lead to desynchronization of brain activity and neglect of sensory stimuli [19, 20]. Sowell 
et al. [21] showed that brain alterations in children with ADHD are focused on those 
brain regions which are relevance for attention, executive control and linguistic 
performance. More specifically, they could demonstrate that cortical abnormalities are 
mainly localized in inferior portions of dorsal PFC and bilateral anterior temporal cortex. 
Increased gray matter was seen in large portions of the posterior temporal and inferior 
parietal cortex bilaterally.
Recently, Seidman et al. [22] investigated 24 adults with DSM-IV ADHD and 18 healthy 
controls comparable on age, socioeconomic status, sex, handedness, education, IQ, and 
achievement test performance. Compared to controls, adults with ADHD had 
significantly diminished overall cortical gray matter, and smaller prefrontal and ACC 
volumes in particular. The authors concluded that adults with ADHD have volume 
differences in brain regions associated with attention and executive control. These data 
are largely consistent with studies of children with ADHD, supporting the hypothesis 
that ADHD is a valid disorder with persistent biological features through all stages of life.
Region-Specific Neuroanatomical Findings
Frontal Lobe
Several studies have confirmed volume reductions of PFC in ADHD children, namely of 
the dorsolateral part (DLPFC) [9, 10, 13–16, 23]. The DLPFC plays an important role in 
attention, working memory, planning and organization of a task [18], whereas the 
ventrolateral prefrontal cortex (VLPFC) is involved in the regulation inhibitory control 
[24, 25]. The orbitofrontal cortex regulates social behavior and balance of inhibition and 
desinhibition as well as emotional attribution to decisions.
Hesslinger et al. [26] found diminished left orbitofrontal brain volumes in adult ADHD 
patients. These regions are associated with social behavior and impulse control. Also in 
adults with ADHD, selective thinning of cerebral cortex in the networks that subserve 
attention and executive function was found by Makris et al. [27]. Significant cortical 
thinning in ADHD was seen especially in the right hemisphere involving the inferior 
parietal lobule, the dorsolateral prefrontal, and the anterior cingulated cortices. These 
neuroanatomical data give evidence to the frontal brain abnormalities also in ADHD 
adults, but the findings need further replication.
Anterior Cingulated Cortex
The dorsal part of the anterior cingulated cortex (dACC) is crucial for executive 
functioning, inhibitory control monitoring, target detection, error processing as well as 
reward-based learning. Volume reductions in the right posterior cingulated gyrus in 
ADHD children have been reported [28]. In adults, lower volumes of the ACC could be 
shown by in the anatomical study of Makris et al. [27].
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Temporal Lobe
Temporal lobes have polymodal sensory integration functions in language comprehension 
as well as object identification (‘what system’), emotional regulation and memory function. 
The right temporal convexity plays an important role for visuospatial functions, whereas 
the left temporal convexity contains a large auditory association area which contributes 
to language comprehension [29]. Sowell et al. [21] demonstrated by anatomical brain 
surface analysis that children with ADHD had reduced anterior temporal lobe volumes 
bilaterally. Temporal lobe volume reduction as part of a general brain volume reduction 
in children and adolescents with ADHD was described by Castellanos et al. [12]. However, 
there is no substantial information about the interplay between cognition and affect in 
sensory processing, and its modulation by temporal lobes in ADHD.
Basal Ganglia
The basal ganglia comprise of five nuclei: the caudate nucleus (‘cognitive associative’ 
striatum), putamen (sensorimotor striatum), nucleus accumbens (limbic striatum), globus 
pallidus and subthalamic nucleus. They are closely related to brainstem structures such as 
substantia nigra and the pedunculopontine nucleus. The striatum comprises the putamen 
and the pallidum, and displays a high density of dopaminergic neurons. Its main function 
is procedural learning and automatization of motor programs and behaviors and it serves 
to assemble complex response habits to strategically adapted environmental needs [30, 
31]. ADHD-associated symptoms are associated with striatal damage [32].
Basal ganglia volume reductions have been shown in several studies with ADHD 
children and adolescents. In most of them uni- or bilateral reduction of caudate volumes 
were found [9–12, 29, 33–36]. Schrimsher et al. [37] could predict the cumulative severity 
ratings of inattentive behaviors by measuring caudate volume asymmetry from serial 
sagittal magnetic resonance images from childhood to adolescence. Also unilateral 
volume reduction of the pallidum has been shown in several studies in children with 
ADHD [10–12, 28, 38].
Until now, no evidence for basal ganglia volume reduction in adult ADHD has been 
reported. A possible explanation is that differences between controls and ADHD almost 
disappear with increasing age before adulthood [12].
Corpus Callosum
The corpus callosum connects homonymous regions of the cerebral hemispheres. 
Injury of callosal structures can lead to problems in holding sustained attention [39], 
with associated deficits in learning and memory [40]. The neuropsychological deficits 
after injury of corpus callosum are often subtle or lacking.
Volume reduction of the corpus callosum is a common finding in studies with ADHD 
children and adolescents. Posterior regions of the corpus callosum are mostly affected 
[15, 41–45]. Data from adult ADHD are lacking so far.
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Parietal Lobe
Posner and Petersen [18] have described a posterior attention system located in the 
parietal lobe, which seems to be mainly modulated by noradrenergic transmission in 
contrast to the predominantly dopaminergic modulation of the frontal attention 
system. The posterior part of the parietal cortex is involved in orienting and selective 
attention networks [46]. It disengages the attentional focus from the contralateral target 
[47], and lesions of this region can lead to impaired attention [48, 49].
Only few studies have addressed to parietal lobe structure and function in ADHD. 
Castellanos et al. [12] have shown that posterior parietal volume is reduced, whereas 
conversely Sowell et al. [21] have demonstrated an increase in cortical volume in children 
with ADHD. Given its importance in visuospatial orienting and as a region for polymodal 
sensory integration, it was Makris et al. [27] who pointed out volume reductions in the 
right inferior parietal lobule in adults with ADHD.
Occipital Lobe
In line with the general findings of Castellanos’ work [12], pronounced reduction of left 
occipital brain volume in children with ADHD was also found by another study group 
[16]. No data are presently available regarding occipital lobe anatomy in adults with 
ADHD.
Cerebellum
The role of the cerebellum in cognitive and affective function has been described in 20 
patients with cerebellar lesions [50]. Aside from the well-known motor coordination 
problems, patients with cerebellar lesion display impairment of executive functions, 
visuospatial cognition deficits as well as blunting of affect and disinhibition of behavior. 
Cognitive cerebellar functions are located mainly in the posterior lobe (neocerebellum), 
whereas executive, visuospatial, and memory functions of neocerebellum are impaired 
when the lesions are located in the hemispheres and dentate nucleus [50, 51]. The vermis 
has been shown involved with affective disturbances [51]. The cerebellum projects via 
thalamus to areas in the PFC [52] and there are reciprocal projections from the PFC to 
cerebellum, thus forming a functional network that influences rather than generates 
motor control, inhibitory and executive functions. Moreover, several studies have shown 
that the cerebellum has modulatory effects on forebrain dopamine outflow [53–56].
Several studies in ADHD in childhood and adolescence have shown structural cerebellar 
impairment [10–12, 15, 16, 57–59]. Indeed, the most marked neuroanatomical anomaly 
in ADHD has been described in the cerebellum, with volume changes more marked 
than in the PFC [12]. In children, reductions in right cerebellar hemisphere and vermis 
volume have been reported [11, 15, 16, 57–59]. These volume reductions correlated with 
attentional problems and global clinician ADHD ratings [12]. At present there are no 
data on cerebellar volume in adult ADHD.
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Other Brain Regions
In children and adolescents with ADHD an increased volume of the hippocampus 
bilaterally, which is involved in attentional processes such as visuospatial working 
memory and executive functions, has been reported [60]. Moreover, some evidence for 
a reduced size of the basolateral amygdala was found in this study. Since affective 
symptoms and emotional instability are typical features of and affective disorders are 
highly prevalent in adult ADHD, altered amygdala and hippocampus volumes are of 
particular interest also for adults with ADHD. However, in a recent study with adults 
suffering from ADHD, no differences regarding hippocampus and amygdale volumes 
were found [61].
Brain Function in ADHD
Functional MRI (fMRI), MRI relaxometry and ligand-bound imaging techniques like 
SPECT or positron emission tomography (PET) have been used to study functional 
abnormalities of brain networks in ADHD. From a neurological viewpoint, attention 
networks can be basically distinguished into three components [18, 46, 62]:
•  The arousal and alerting networks are mainly subcortically located and constitute of 
the ascending reticular activating system. They project to the whole brainstem and 
thalamus and, through the striatum, up to the limbic system to form cortical 
projections. The main function of this component is the activation and synchroniza-
tion of the cerebral cortex during behavior and motivation, and has affinity to salient 
stimuli and memorization.
•  The mixed cortical-subcortical orienting networks are involved in detection of novel 
stimuli (superior colliculi), filtration of relevant stimuli (pulvinar) and disengagement 
of attention focus (posterior parietal cortex).
•  The selective (or directed/cortical) attentional network is of particular interest for 
ADHD pathophysiology. It involves frontal brain structures for generation of volitional 
saccades (frontal eye fields), induces motor intention (premotor cortex), is linked to 
the working memory (DLPFC) and is modulated by the ACC (target detection, 
response selection and inhibition, conflict monitoring, motivation) [63]. This network 
is also called executive (conflict) network and has been shown highly heritable [64]. 
Within this network, the dACC has strong connectivity to frontal brain structures with 
dense serotonergic and dopaminergic components. Regions of the parietal cortex 
also play an important role in mediating sensory functions. Th e posterior parietal 
cortex disengages the attentional focus to a target [47] and the superior parietal 
lobule has the function of voluntary shift s of attention [29]. Right hemisphere 
dominance could be found for the orienting as well as selective attention [17, 18].
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Konrad et al. [65] have used event-related fMRI to investigate brain activations related to 
these three particular aspects of attention. It could be shown that children with ADHD 
recruited deviant brain regions for all three above-mentioned attentional networks. 
ADHD children had less right-sided activation in the anterior cingulated gyrus during 
alerting, more frontostriatal-insular activation during reorienting, and less frontostriatal 
activation for executive control. Dysregulation of blood oxygenation level-dependent 
signals was described in the putamen during reorienting and executive control, 
suggesting altered strategies in children with ADHD. In medication-naïve children and 
adolescents with ADHD, task-specific functional abnormalities in frontostriatal but also 
to parietal and temporal areas were found [66]. Hale et al. [67] concluded from their data 
that abnormal brain function among adult ADHD participants was not limited to 
complex executive functions. Abnormal processing of numeric stimuli was indicated 
during both simple and complex cognitive operations. For example, during the difficult 
tasks, they exhibited greater activation of left hemispheric linguistic-processing areas 
and failed to activate bilateral parietal regions important for the complex executive 
operations.
Anterior Cingulated Cortex
Hypoactivation of the dACC has been consistently described in children and adolescents 
with ADHD using continuous performance paradigms, with results being similar using 
fMRI of PET-imaging techniques [25, 68–71]. These findings have led to the hypothesis 
that dACC plays a significant role in ADHD pathophysiology.
Zametkin et al. [71] were the first to describe hypoactivity of dACC with PET in adult 
ADHD patients. According to the hypothesis of impairment of selective attention, 
several studies in adult ADHD have also shown hypofunctionality of the ACC [68, 70]. 
Following the executive attention hypothesis, the earliest fMRI study in adult ADHD was 
performed by Bush et al. [70], using a specially designed counting Stroop paradigm. This 
study demonstrated that the ‘cognitive division’ of the dACC was not activated in adult 
ADHD patients during interference conditions. As a compensatory mechanism, ADHD 
patients activated an alternative frontostriatal network by using different regions of 
lateral PFC, insular cortex, as well as unilateral activation of caudate, putamen, thalamus 
and pulvinar. These results may be interpreted as impairment of dACC function in ADHD 
subjects under conditions where interferences occur, while under conditions where 
subjects could focus on salient stimuli, there was no difference in dACC activation. This 
‘normal attention but abnormal stimulus alerting and conflict effect’ has also been 
reported from a neuropsychological point by Oberlin et al. [72]. Only ADHD subjects 
with the combined type were impaired in their reactions to abrupt visual cues or those 
that contain conflicting spatial cues. These features were not found in adults with the 
ADHD-inattentive type.
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Besides the role of dACC in selective attentional processing, response selection and 
inhibition and performance monitoring [73], dACC is also thought to influence 
reward-based decision-making [74]. The larger the gain, the higher the activity in the 
pregenual ACC during the decision phase [75]. Ernst et al. [73] found differences in 
motivational behaviors in ADHD, especially when the patients had to weigh long-term 
versus short-term rewards. The patients used more parts of the right ACC than healthy 
controls.
Memory performance was associated with activation of the ACC in healthy adolescents 
but with activation of the superior parietal lobe (SPL) and precuneus in adolescent 
ADHD patients [76]. The authors suggested that increased SPL activation in ADHD 
reflected attentional compensation for low ACC activation during the encoding and 
that the higher salience of emotional stimuli, in contrast, regulated the interplay 
between ACC and SPL in conjunction with improving memory to the level of healthy 
adolescents.
Using a working memory paradigm, Wolf et al. [77] could recently demonstrate lower 
connectivity in ACC and higher connectivity in dorsal cingulate cortex in adults with 
ADHD and healthy controls. Another fMRI study found evidence for decreased functional 
connectivity between ACC and posterior cingulated regions including the precuneus 
[78].
Motor System
The execution of simple motor tasks reveals distinct cerebral activation pathways. Using 
a simple finger-tapping task, Mostofsky et al. [79] reported that children with ADHD had 
decreased contralateral motor cortex and right parietal cortex activation during right- 
and left-handed finger sequencing. These findings could be interpreted as anomalous 
development of cortical systems necessary for execution of patterned movements.
In a study with PET, a correlation between motor hyperactivity with lower binding 
potential values for dopamine transporter (DAT) in the midbrain was shown in 
adolescents with ADHD [80]. Thus, altered dopamine signaling might have a causal 
relationship to hyperactivity. Studies with adult ADHD patients are not available so far.
Frontal Cortex
The most consistent findings in the neuroimaging literature of ADHD are deficits in 
neural activity within frontostriatal and frontoparietal circuits. However, the results vary 
across subregions of the frontal cortex, suggesting that ADHD is not associated with 
dysfunction of any particular part of frontal cortex.
The PFC is critical for the regulation of behavior, attention, and affect by use of represen-
tational knowledge. The PFC is important for sustaining attention over a delay, inhibiting 
distraction, and dividing attention, while more posterior cortical areas are essential for 
perception and the allocation of attentional resources. The PFC in the right hemisphere 
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is particularly important for behavioral inhibition. Lesions to the PFC produce a profile 
of distractibility, forgetfulness, impulsivity, poor planning, and locomotor hyperactivity.
Variable findings have been described for VLPFC and DLPFC. These brain regions also 
monitor attention, planning, working memory and executive control, especially with 
regard to inhibitory control [18, 81]. Rubia et al. [25] found hypoactivation in the right 
VLPFC and left caudatus of adolescents with ADHD, whilst Durston et al. [82] reported 
different activation of frontostriatal regions. Children with ADHD displayed more diffuse 
network activations including more posterior and dorsolateral prefrontal regions. Rubia 
et al. [83] reported that medication-naïve adolescent patients with ADHD showed 
significantly reduced brain activation in the right inferior PFC during successful motor 
response inhibition and in the precuneus and posterior cingulate gyrus during inhibition 
failure. These deficits correlated with behavioral scores of ADHD and persisted when 
corrected for medication history and performance discrepancies. Conversely, Ernst et al. 
[73] showed using PET that adult ADHD patients, as well as healthy controls, activated 
VLPFC and DLPFC including insula during a decision-making task. However, the 
activation of the dACC and hippocampus, subserving emotional and memory processes, 
was less extended in the ADHD group, who instead recruited the caudal part of the 
right ACC. These results were interpreted as a basis for problems of motivated behavior 
in ADHD.
Evidence for significant frontal hypoactivity, including anterior cingulate, dorsolateral 
prefrontal and inferior prefrontal cortices comes from a meta-analysis of studies with 
fMRI in children and adolescents with ADHD [84]. Analyses of studies which used other 
than response inhibition paradigms revealed a more extensive pattern of hypofunction 
in patients with ADHD than those of response inhibition (thalamus, basal ganglia and 
parietal cortex). Studies of response inhibition displayed more limited group differences 
regarding activation of inferior PFC, medial wall regions, and the precentral gyrus.
In adult ADHD patients, less activation and lower functional connectivity was observed 
during a working memory task in the left VLPC, while connectivity of the right PFC was 
increased when compared to control subjects together with functional changes in 
other brain regions [77]. Moreover, a correlation between activation of frontal cortical 
areas of adult ADHD subjects and inattention scores has been reported, suggesting a 
functional deficit within this network that depends on the degree of attention deficits 
[85]. On the other hand, increased activation of orbitofrontal cortex was found in 
response to gain outcomes during a monetary incentive delay task, suggesting that this 
part of frontal cortex is involved in abnormal reward processing in adult ADHD [86].
Cerebellum
Due to its involvement in cognitive, emotional processing and behavioral control, the 
cerebellum seems to be an important region of interest in ADHD research [50]. Anderson 
et al. [7] reported abnormalities of the vermis in children and adolescents in a MRI 
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relaxometry study that could be influenced by methylphenidate, suggesting an 
influence of cerebellar function in ADHD. The effects of methylphenidate on cerebellum 
depended on pretreatment activity level. With fMRI, Schulz et al. [87] described a higher 
activity of the cerebellum in adolescents with ADHD. In contrast, Valera et al. [88] found 
significantly decreased activity in cerebellum and also occipital lobe of adult patient 
with ADHD, even though working memory performance did not differ significantly 
between ADHD and controls. Kim et al. [89] examined ADHD children with PET and 
found decreased bilateral cerebellar blood flow in ADHD compared to controls. Volkow 
et al. [90, 91] reported that methylphenidate could increase metabolic activity of the 
cerebellum in normal adults, dependent of dopamine receptor activity.
Preliminary results from a study with ADHD children [92] hinted to a relation between 
cerebellum and forebrain dysfunction and ADHD symptomatology. The authors found 
with an ADHD diffusion tensor-imaging technique (DTI) prominent white matter 
abnormalities in the right premotor, right striatal, right cerebral peduncule, left cerebellar 
peduncule, left cerebellum and left parieto-occipital areas. In adults with ADHD, less 
activation during a working memory task and changes of functional connectivity of the 
cerebellum and cortical brain regions was described [77]. These results give additional 
evidence for corticopontocerebellar circuit deficits in ADHD.
Parietal Cortex
The parietal cortex belongs to an attentional system that includes frontoparietal 
network structures [18, 93]. For example, orienting networks include the SPL, as well as 
the temporal parietal junction and frontal eye field [94]. Krauel et al. [76] suggested 
increased activation in some parietal regions as an attentional compensation for low 
ACC activation in healthy adolescents. Together with frontal brain areas, the alerting 
attentional network activates parietal and thalamic areas that are potentially susceptible 
to the actions of norepinephrine [95–97].
Superior parietal and middle frontal areas are involved in visuospatial processing [98]. 
Silk et al. [99] have shown in an fMRI study with a mental rotational task, that ADHD 
children with combined subtype have lower activation of the action attentional system 
including superior parietal cortex as well as middle frontal areas. Patients had also 
increased activation of the posterior midline attentional system. This indicates that 
ADHD patients might also have parietal dysfunction as well as dysfunctions of the 
widespread frontal and striatal systems. As is the case with many of the networks 
discussed so far, these findings in children have yet to be extended to adults with ADHD. 
A first step towards this direction has been performed by Tamm et al. [100], who showed 
that adolescents with ADHD had significant impairments in their ability to direct and 
allocate attentional resources. This was associated with bilateral aberrations in the 
parietal attentional system.
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Basal Ganglia
In line with PET findings showing reduced basal ganglia perfusion in patients with 
ADHD [101], subsequent fMRI studies have reported abnormal activation of the striatum 
[25, 102–104].
Although the main focus of the study of Bush et al. [70] was not the basal ganglia, they 
observed increased activation of the right putamen in adults with ADHD while 
performing a Stroop task. Recently, Plichta et al. [105] could show hyporesponsiveness 
of the ventral-striatal reward system in adults with ADHD, who were examined during a 
series of choices between two monetary reward options. In addition, they reported 
increased activation of the dorsal caudate nucleus and amygdala associated with 
delayed reward. Similarly, decreased activation in the ventral striatum during the 
anticipation of gain in a monetary incentive delay task was described in another recent 
study [86]. Moreover, the authors described in this study a negative correlation of ventral 
striatal activation with self-reported impulsivity and hyperactivity. Similar findings have 
been reported in a previous fMRI study of brain activation during a reward-anticipation 
task in adolescents with ADHD [104]. The negative correlation between impulsivity and 
striatal activation, which was found in both studies, has also been shown by Schneider 
et al. [85], who used an impulse-control paradigm. Taken together, these results suggest 
that striatal activation is involved in the processing of reward and the regulation of im-
pulsive-hyperactive traits in adults with ADHD.
ADHD and Comorbid Disorders
Studies with patients who have comorbid disorders or brain lesions are of interest 
because they may help to validate the specificity of the hypothesized frontostriatal(-
cerebellar) dysfunctions and compensatory mechanisms in ADHD.
Bussing et al. [58] have suggested that no differences in cerebellar morphology could 
be found between ADHD children with and without comorbid conduct disorder. Also, 
in this study no differences were reported in volume measurements of frontostriatal 
structures. On the other hand, electrophysiological studies with event related potentials 
showed abnormalities in prefrontal lobe activation in teenagers with conduct disorder 
[106].
Tourette’s syndrome (TS) is frequently comorbid with ADHD [107, 108]. In TS, basal 
ganglia volume reduction and loss of left > right side asymmetry of the globus pallidus 
is described in some but not all studies [108–110]. Some studies could not differentiate 
between TS and comorbid ADHD in terms of brain structure alterations, whereas some 
could find that patients with comorbid ADHD tended to have larger volumes across all 
cortical portions of those circuits to dorsal prefrontal and parietooccipital regions and 
smaller caudate nucleus volumes [111].
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Adler et al. [112] have used a simple attention task in adolescents with bipolar disorder 
and showed that comorbidity with ADHD was associated with less activation of the 
VLPFC, ACC and higher activation in posterior parietal cortex as well as middle temporal 
gyrus. Thus, comorbidity with ADHD might result in less activation of prefrontal regions 
while posterior parietal and temporal cortical areas are used as alternative pathways. 
Facial recognition is also impaired in ADHD in a similar way when compared with 
patients with schizophrenia [113]. Both groups display reduced activity in the medial 
prefrontal and amygdala brain regions required to process emotional faces.
Autism may occur with ADHD and impairment of attention has been consistently 
reported in autism [114]. In anatomical studies, patients with autism displayed larger 
total brain and white matter volumes in caudate, globus pallidum, most cortical brain 
regions and in the cerebellum as compared to ADHD subjects [115]. Reduced fMRI 
activation was found primarily in amygdala of autistic patients during social tasks [116], 
but autistic spectrum disorders also display dysfunctional cerebellofrontal spatial 
attention system [117, 118] similar to ADHD.
Conclusions
In contrast to neuroimaging investigations in children and adolescents with ADHD, the 
number of studies in adult patients is still limited. Imaging data in general are often 
confounded by small sample sizes, non-replicated and sometimes even contradictory 
results. However, recent findings have shown similarities between abnormalities in 
adult ADHD patients and children with ADHD suggesting impairment of frontostriatal(-
cerebellar) networks. Consistent findings have been reported regarding dysfunction of 
the striatum and the ACC. Prefrontal cortical structures also seem to play a pivotal role 
in ADHD psychopathology, although these findings are not specific to ADHD. As in 
children, the cerebellum is also dysfunctional in adults with ADHD. Moreover, there is 
increasing evidence that also parts of the posterior attention networks are less active in 
both childhood and adult ADHD. Functional abnormalities comprise frontostriatal, 
parietal and also temporal cortical areas in a task-specific manner. Attention orienting is 
less affected than salient stimulus or conflict alerting. Also, several ‘vertical’ levels of 
attention networks – beginning from the arousal to the orienting up to the selective 
attention network – are affected in ADHD.
Data on ADHD patients with comorbid psychiatric disorders are not consistent so far 
and their contribution to our understanding of ADHD pathophysiology is limited. 
However, it seems that ADHD symptoms combined with other disorders are associated 
with frontostriatal dysfunction.
Structural and functional brain-imaging investigations are an important source for our 
growing knowledge of ADHD pathophysiology. However, due to the lack of sensitivity 
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and specificity of the findings, neuroimaging techniques are not ready to be used as a 
diagnostic tool. It seems possible that with the progress in understanding the pathogenesis 
of ADHD together with the technical progress in brain-imaging techniques, we might 
overcome this shortcoming in future.
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Abstract
Attention deficit hyperactivity disorder (ADHD) is a common, genetically transmitted 
childhood onset disorder with a high rate of persistence in adulthood. Although many 
studies have shown anatomical and functional abnormalities in children and adolescents, 
studies with adult patients are rare. 19 adults with ADHD (11 ADHD, combined type; 8 
ADHD, partially remitted) and 17 controls were included in this functional magnetic 
imaging (fMRI) study. Brain activation was investigated with a continuous performance 
test (CPT). Impaired activation of a fronto-striatal and a parietal attentional network was 
observed during the NoGo condition in ADHD subjects. Correlations of reduced activity 
of caudate nuclei, anterior cingulate cortex as well as parietal cortical structures and 
increased activity of insular cortex with inattention and impulsivity symptom scores 
were found. The activation patterns were similar to those known from children and 
adolescents with ADHD. In conclusion we found not only a widespread dysfunction of 
brain regions that are involved in cognitive processing in adults with ADHD compared 
to controls, but also correlations between symptom severity and dysfunction of 
neuronal systems across adult subjects without ADHD, childhood but not persistent 
and persistent ADHD.
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1. Introduction
Attention deficit hyperactivity disorder (ADHD) is a common, genetically transmitted 
childhood onset disorder characterized by inattention, hyperactivity and impulsivity 
(Wender, 1995). According to the dimensional character of ADHD psychopathology, this 
condition has been suggested rather the extreme variant of a psychopathological 
continuum than a distinct disorder. Follow-up studies show that up to 60% of patients 
suffering from this disorder still show some or all of the ADHD characteristics as adults 
(Barkley, 2002). A cross-national prevalence of 3.4% for adult ADHD has been reported 
(Fayyad et al., 2007). Regarding the negative impact of ADHD concerning functional 
impairment and social outcome, and the need for optimizing diagnosis and treatment 
in adulthood, there is high interest in understanding the pathophysiological mechanisms 
in ADHD across the lifespan.
Structural and functional imaging data are mainly based on studies with ADHD children 
(Sowell et al., 2003; Pliszka et al., 2006). Studies with functional neuroimaging techniques 
performed with ADHD children suggest dysfunction of the ventral and dorsolateral 
prefrontal cortex, the anterior cingulate, insula, amygdala, hippocampus, and ventral 
striatum (Ernst et al., 2002; Elliot et al., 1999; Rogers et al., 1999; Elliot et al., 2000; Knutson 
et al., 2001; Bussey et al., 1997; Schultz, 1999). In addition, it has been reported that meth-
ylphenidate, which is highly effective in the treatment of ADHD and which exerts its 
effects via dopaminergic pathways, was able to normalize striatal circuitry function and 
could improve frontal activation in children and adolescents with ADHD (Vaidya et al., 
1998; Shafritz et al., 2004). 
In detail, imaging data seem to be somewhat divergent and suggest that many brain 
regions are involved in the pathophysiology of ADHD, which might be at least partially 
due to small samples investigated and different neuropsychological paradigms 
applicated. However, there is converging evidence from these studies that behavioural 
and cognitive problems associated with ADHD are mainly associated with dysfunction 
of fronto-striatal regions or mainly in the forebrain located regions that influence 
inhibitory control mechanisms (Durston et al., 2002). 
In adults with ADHD marked reduction of global metabolism in both hemispheres 
(Zametkin et al., 1990) and also diminished dopaminergic uptake in the left and medial 
prefrontal cortex have been reported (Ernst et al., 1998). Similarly to childhood ADHD it 
has been shown that prefrontal cortex, anterior cingulate cortex and basal ganglia are 
also involved in adult ADHD (Bush et al., 1999; Ernst et al., 2003; Zametkin et al., 1990). In 
a functional magnetic resonance imaging (fMRI) study Bush and colleagues (1999) 
showed that specific regions of Anterior Cingulate Cortex (ACC), which have been 
shown to be involved in attention focusing and mediation of response selection, were 
disturbed in patients with ADHD, but a frontostriatal-insular network was activated 
instead. 
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Literature gives evidence for negative correlation of ventro-striatal activity with impulsivity 
and hyperactivity in adolescents and adults with ADHD (Scheres et al., 2007, Ströhle et 
al., 2008). ADHD patients can also overreact with defined cerebral regions in response to 
reward outcomes (Ströhle et al., 2008). Thus, recent imaging data underline the central 
role of fronto-striatal circuits in ADHD including the orbitofrontal, mesial and lateral 
prefrontal brain regions (Ernst et al., 2003; Durston et al., 2003; Rubia et al., 1999). Bush et 
al. (2008) pointed out the importance of the dorsal anterior midcingulate cortex that 
plays a key role in cognition, attention, target detection, motor control, error detection 
and feedback-based decision making and could show with fMRI technique in adult 
ADHD that methylphenidate could normalize hypofunction in this area. 
Due to the still limited number of studies with adults with ADHD and the lack of 
follow-up investigations of ADHD children, it remains unclear whether disturbed 
network activation differs between ADHD children and adults and whether clinical 
remission of ADHD psychopathology runs parallel to normalization of brain function. It 
should be considered that adults with ADHD might use at least partially compensatory 
mechanisms which are not yet present in ADHD children.
In this study we aimed to investigate activation patterns of attentional networks in 
adults with ADHD. Due to the dimensional character of the disorder and the decline of 
symptoms in a considerable proportion of patients with age, we hypothezised that 
compared to controls there might be not only different activation patterns in ventro-
striatal and parietal cortex, but also correlations between symptom severity and brain 
dysfunction across adult subjects without ADHD, childhood but not persistent and 
persistent ADHD.
2. Methods
2.1. Subjects 
Adult patients were recruited from a specialized ADHD outpatient unit of the Neuro- 
center located at the Saarland University Hospital. ADHD was diagnosed according to 
DSM-IV criteria after careful clinical investigation. None of the participants of the study 
had received any kind of stimulant medication before. They were diagnosed for the first 
time with ADHD. All participants of the study were right handed and without any 
medication. Subjects had no other psychiatric axis I disorder beside ADHD and no 
history of any CNS-affection in the 6 months before entering the study. SKID I interviews 
(Wittchen et al., 1997) were used to exclude relevant actual psychiatric and neurological 
disorders. IQ was assessed by use of the multiple-choice vocabulary test (MWT-B), which 
is a verbal test with German norms (Lehrl, 1995).
Only ADHD patients with a total score of 30 or more on the German validated form of 
the Wender-Utah-Rating-Scale (WURS-k; Retz-Junginger et al., 2003) participated in this 
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study, in order to ensure for childhood onset of ADHD symptoms. According to former 
validation studies, scores above this cut-off are highly indicative for childhood ADHD. 
Quantification of current ADHD symptoms according to DSM-IV was performed using a 
standardized and validated self-rating scale for adults (ADHD-SR; Rösler et al., 2004, 
2008). The ADHD-SR consists of 18 items according to DSM-IV ADHD symptoms, which 
are rated on a 0 – 3 Likert scale. The maximum total score is 54 points, those of the 
inattention subscale 27 (9 items), of the impulsivity subscale 12 (4 items) and for the 
hyperactivity subscale 15 (5 items), respectively. ADHD-SR total and subscores were 
used for further correlation analyses of brain activations in the functional magnetic 
resonance imaging procedures.
The term “not persistent ADHD” was used for patients with childhood ADHD who were 
partially remitted on the syndromatical level as discussed by Biederman and colleagues 
(2000). These patients have lost the full diagnostic status according to DSM-IV but still 
showed symptoms of ADHD and functional functional impairment.
2.2. Continuous Performance Test (CPT)
According to Barkley (1997) the fundamental deficit in individuals with ADHD is one of 
self-regulation and the control over behavioral inhibition. It has been argued that this 
results primarily from frontal lobe dysfunction and not because of adverse environmental 
conditions. According to this concept, executive dysfunction including working memory, 
internalization of speech, sense of time and goal directed behavior are secondary 
psychological and functional problems of impulse control deficit and frontal brain plays 
a crucial role in its regulation. Therefore, the CPT NoGo condition was chosen as the 
primary target stimulus in statistical analyses.
We used the continuous performance test (CPT), which is conceptualized for investigating 
sustained attention, vigilance and inhibitory control (Rosvold et al., 1956; Fallgatter and 
Strik, 1997). Briefly, a pseudorandom sequence of letters was presented 420ms each. 
Subjects were instructed to push a button of a MRI compatible optical fiber pad, if the 
letter ‘O’ (predatory condition) was immediately followed by the letter ‘X’ (Go condition), 
but not when another letter than ‘X’ followed the ‘O’ (NoGo condition). In neurophysi-
ological studies a robust physiological frontalization of the brain electrical field during 
the NoGo condition and reduced frontal brain activity in ADHD children and adults has 
been shown (Fallgatter et al., 1997, 2004, 2005). CPTs with low rates of signal probability 
would likely demonstrate different relationships with ADHD symptoms and symptom 
domains (Conners 1994). But there is a controversial discussion over which CPT gives the 
best correlates with the ADHD symptoms (Corkum et al., 1993, 1995; Koelega, 1995). In a 
study examining performance on measures over time, increased mean hit reaction time 
and standard errors over time was highly associated with most ADHD symptoms 
(Epstein et al., 2003). In summary there is no “goldstandard” which CPT best fits with 
ADHD symptoms or subtypes.
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The projection of the letters was performed by a computer-guided beamer on a screen 
while participants watched the screen through a mirror on the head coil positioned 
above their eyes. The speed of presentation for each letter in the CPT was set near the 
limit of overall cognitive attention and reaction time capacity. Thus, drifting away of the 
attention from the task presentation was minimized. 
Given the fact that eye fields were limited through a mirror system and the narrowed 
projection into a relative dark environment there were few possibilities to lose the 
optical focus. An automatic eye tracking system was not used.
During fMRI recordings 30 Go events and 30 NoGo events were presented in a pseudor-
andomized manner. A total of 285 sequences were recorded.
2.3. Magnetic Resonance Imaging
2.3.1. Anatomical sequences
Imaging was performed with a 1.5T Siemens Magnetom Vision whole body scanner 
system. A standard head coil was used. Head position was stabilized with vacuum 
cushion and fixed with adhesion bands to minimize head movements.
For each subject T2-weighted anatomic sequences (data matrix 256 x 256 voxel, 0.93752 
mm2 pixel size, 5 mm slice thickness, TR 4.6s, TE 99ms) in plane with the echo planar 
images were performed. Thus, functional images could be aligned with the three 
dimensional images. Anatomical abnormalities or symptomatic causes for attention 
deficit syndromes like liquor circulation disturbances, inflammatory syndromes or 
stroke could be excluded from the study.
2.3.2. Event related functional MRI
Gradient-echo EPI sequences with a TE of 60ms, flip angle of 90° and TR of 2.69 sec were 
recorded. The matrix of 64 x 64 had a field of view of 240mm, resulting in a planar 
resolution of 3.75 x 3.75 mm. The total number of slices was 24, the slice thickness was 
5mm, the interslice gap was 0.5mm.
Four volumes were discarded to allow stabilization of magnetization before starting of 
recording. A total of 285 volumes were recorded, containing 30 Go and 30 NoGo events, 
each. The runs were completed after 12 minutes.
2.4. Data Processing and Analysis
Offline reconstruction and realignment of functional images were performed using the 
procedure of Friston et al. (1995) using Statistical Parametric Mapping (SPM 99, The 
Wellcome Department of Cognitive Neurology, University College London, UK). Prior to 
data analysis motion artifacts were screened. All subjects with a translational artifact of 
more than 2.5mm and rotational head movement of more than 2.5° were excluded. In a 
second step, recordings were corrected for these movement artifacts and then filtered 
for low frequency signal fluctuations (high pass cut off frequency: 1/123 s-1; low pass cut 
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off period: HRF waveform). Each mean image volume was then spatially normalized into 
the modified Talairach space employed in SPM 99 to a resulting resolution of 2x2x2mm 
using both affine and non-linear components. Finally, with a Gaussian kernel of two 
voxels/ 8x8x8mm spatial smoothing was performed in respect to the Gaussian random 
field theory.
Group comparisons of mean functional images were done by independent two samples 
t-test for the conditions Go and NoGo, respectively. Correlation analysis of mean 
functional images with ADHD-self rating scores was done with linear regression analysis 
(SPM99). If not otherwise mentioned standard p threshold was set at 0.001 (uncorrected). 
Voxel extension was set at k=5.
Correlation analyses were calculated by linear regression implemented in SPM with the 
activation - t values as the dependent and the explanatory variable of interest as the 
independent variable. In addition, t values at the respective correlated region of interest 
(ROI; see below) were extracted from SPM and Spearman correlations with the respective 
variable of interest were calculated.
3. Results
3.1. Patients characteristics
19 subjects with lifetime ADHD (ADHD - 6 male/ 5 female; age 32.6 ± 9.4 years (mean ± 
SD), range 19-48 years; ADHD partially remitted - 7 male/ 1 female; age 32.4 ± 8.3 years 
(mean ± SD), range 18 – 45 years) and 17 controls (10 male/ 7 female; age 29.4 ± 8.6 years; 
range 18-45 years) entered the study. 11 subjects of the ADHD group fulfilled the 
diagnostic criteria for ADHD, combined type, 8 patients were diagnosed with ADHD, 
partially remitted according to DSM-IV. Mean IQ of ADHD subjects (106 ± 13 (mean ± 
SD), range 88-124; ADHD partially remitted 115 ± 18 (mean ± SD), range 95-145) was 
somewhat lower than mean IQ of the control group (126 ± 12 (mean ± SD), range 
100-143), t-test, T=3.3, df(27) p=.003), but all IQs were within normal range. Ratings on the 
WURS-k and ADHD-SR of ADHD subjects and controls are given in table 1. There was no 
significant difference of the WURS-k scores between subjects with persisting ADHD and 
those with ADHD, partially remitted (Mann-Whitney test, Z=-.58, p=.60) whereas the 
current ADHD symptom scores (ADHD-SR) were significantly higher in the persistent 
ADHD group compared to subjects with ADHD, partially remitted and controls (Mann 
Whitney test, Z=-3.4 and -4.4, respectively, p=.000).
3.2. Continuous performance test
Concerning results of the CPT, patients with ADHD, combined type made significantly 
more omission errors and had longer reaction times at the Go condition than controls. 
There was a non significant trend that patients with persisting ADHD made more 
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commission errors than controls. No significant difference between the ADHD, combined 
type group and controls could be seen regarding the reaction time during the NoGo 
condition (table 1).
There was a significant correlation between accuracy of CPT Go-responses and reaction 
time within the entire study population (r=.489, p=.002) but not regarding NoGo- 
responses (r=.026, n.s.). Within the study subgroups, no correlations between CPT 
responses and reaction time were found (ADHD probands:r= .289, n.s.(Go), r=.716, n.s. 
(NoGo); ADHD partially remitted: r=.31, n.s. (Go), r=-.622, n.s. (NoGo); controls: r=.424; n.s. 
(p=.09) (Go), for NoGo-response not calculated due to lack of variance).
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Table 1   Clinical ratings and neurophysiological data from Continuous 
Performance Test (CPT) of adults with ADHD and controls
ADHD Group (N=19) Controls 
(N=17)
Statistic
Kruskal-
Wallis-Test 
*
ANOVA**
ADHD, 
combined type 
(N=11)
ADHD, partially 
remitted 
(N=8)
WURS-k Score 43.0 ± 11.6 38.4 ± 7.0 6.6 ± 4.5 *c2=25.5
p=.000
ADHD-SR 
Total Score
40.6 ± 4.8 26.8 ± 7.9 6.1± 6.0 *c2=28.8
p=.000
ADHD-SR 
Inattention Subscore 
20.6 ± 2.9 15.3 ± 6.0 2.4 ± 3.3 *c2=26.7
p=.000
ADHD-SR
Hyperactivity 
Subscore
11.4 ± 2.3 6.6 ± 4.1 1.1 ± 1.5 *c2=26.0
p=.000
ADHD-SR
Impulsivity Subscore 
8.6 ± 2.3 4.9 ± 2.4 1.4 ± 1.6 *c2=25.3
p=.000
Omission errors
(CPT Go condition) 
3.91 ± 1.70 4.75 ± 2.55 1.24 ± 1.44 **F=13.1
p=.000
Reaction time (ms)
(CPT Go condition)
478 ± 78 459 ± 43 414 ± 48 **F=4.42
p=.020
Comission errors
(CPT NoGo condition)
0.64 ± 0.81 1.13 ± 1.46 0.24 ± 0.44 **F=2.97
p=.065
Reaction time (ms)
(CPT NoGo condition) 
330 ± 259 185 ± 93 202 ± 122 **F=0.86
p=.454
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3.3. fMRI activation patterns of CPT paradigm
Figure 1 shows general activation patterns of healthy participants of the CPT in the 
NoGo condition. Besides the involvement of brainstem and thalamic regions, CPT 
performance lead to bilateral activation of parts of forebrain, namely the prefrontal 
cortex as well as parietal and occipital brain regions. These regions have been shown to 
be part of an orienting and selective activation network (Fan et al., 2002). The activation 
pattern also comprises the essential elements of a cerebello-thalamico-subcortico- 
cortical attention network seen in tasks that modulate different levels of attention. 
Important brain structures activated here were the bilateral cerebellum, thalamus, 
nucleus ruber, putamen, insula, inferior, middle and superior frontal gyri, cingulate gyri, 
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Figure 1   Brain activation patterns of CPT paradigm in healthy controls  
(Significance level set at p<.001; voxel extension k=5);  
a) BOLD signals in the NoGo condition; aspects from the right hemisphere. 
b) BOLD signals in the NoGo condition; aspects from the left hemisphere. 
c) BOLD signals in the NoGo condition; aspects from the midsagittal view.
a
c
b
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middle temporal gyri, respectively. In the parieto-occipital cortex, a posterior attention 
network activation was seen in the bilateral postcentral gyri, fusiform gyri, middle 
occipital gyri, and inferior parietal lobules, respectively.
3.4. Group comparison analysis
Analysis of group differences revealed lower NoGo activation in several brain regions of 
ADHD subjects (figure 2). While the right frontal and parietal lobes were generally less 
activated in ADHD patients compared to the healthy controls, bilateral parts of the 
occipital cortex displayed higher activation during CPT paradigm. In group comparison 
with healthy controls, ADHD patients revealed less activation also in parts of the right 
fronto-striatal network (Brodman area [BA] 8) and right caudate nucleus as well as right 
temporal lobe. In the parietal cortex there was less activation in left and right polymodal 
sensory integration areas (left parietal lobule and right supramarginal gyrus). Detailed 
information about significant results (p<.001) are given in table 2 a) and b). These 
activation differences were also evident but less significant with statistical correction 
with IQ. Lowered temporal brain activity from ADHD patients was then not any more 
significant.
Group comparison between patients with ADHD combined type and ADHD partially 
remitted revealed significantly higher activities in the ADHD pr group in the left 
premotor and prefrontal cortex but no differences in the striatal or parietal cortex 
activation. Patients with ADHD combined type tended to show higher activation of the 
right temporal lobe (middle and inferior temporal Gyrus), bilateral cerebellar hemispheres 
and bilateral paramedial thalamus and finally dorsal pontine brainstem (data not 
shown). Facing the small number and clinical/ symptomatical similarity from subjects of 
these groups one can mainly argue from these data that with regard to fronto-striatal 
and parietal activation patterns there are only few significant differences between the 
ADHD combined type and the ADHD partially remitted group. Further studies with 
bigger test populations are needed to analysis these aspects more in detail.
3.5. Correlations of activation patterns with ADHD-SR scores
Cerebral activation provoked by the CPT NoGo condition was correlated and 
anticorrelated with ADHD-SR subscores in several brain regions. The data analysis was 
focused on neural regions that are involved in attention processes and inhibitory 
control, i.e. fronto-striatal as well as parietal brain. Brain regions with a significant 
increase or decrease of activation are listed in tables 3a) to f) in detail. The level of 
significance was set at p<.001, no correction for multiple tests was performed.
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Figure 2   Group contrast of fMRI activation (NoGo condition);  
a) Grey dots indicate brain regions where controls activate more than 
ADHD patients. Activity is reported for clusters with a contiguity threshold 
of k=5 voxels. Brightest gray reflects the threshold of p=.001, whereas 
black reflects the maximum p level that was found in the whole brain 
analysis (p=.00001). b) anatomical sections from this group contrast 
showing left superior parietal lobule and right caudate nucleus: regions 
were controls activate more than ADHD patients (Significance level set at 
p<.001; voxel extension k=5)
b
a
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Table 2   a) Group comparison showing brain regions where ADHD patients 
revealed lower activation compared to healthy controls (NoGo condition; 
p<0.001 (uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Right superior 
frontal gyrus
38,21,50
4,40,48
8
8
17
29
3.61
3.76
n.s. 
3.39
Left superior 
frontal gyrus
-16,-4,54 6 9 3.20 n.s.
Right caudate 
nucleus (head)
13,15,2 35 3.81 3.22
Right superior 
temporal gyrus
57,-30,9 42 17 3.49 n.s.
Right middle 
temporal gyrus
51,-66,18 39 23 3.34 n.s.
Right 
supramarginal 
gyrus
54,-51,35 40 38 3.60 3.51
Left superior 
parietal lobule 
-26,-62,51 7 87 3.61 3.25
  b) Group comparison showing brain regions where ADHD patients 
revealed higher activation compared to healthy controls (NoGo condition; 
p<0.001 (uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Left fusiform gyrus -20,-82,-9 19 42 4.65 3.56
Right lingual gyrus 2,-87,0
12,-90,-2
20,-92,-2
17,18 42 3.67 n.s. 
Left lingual gyrus -24,-93,1 18 16 3.59 n.s. 
Fusiform gyrus -48,-59,-9 37 5 3.27 n.s. 
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Table 3   a) Brain regions with decreasing activation correlating with higher scores 
in inattention; NoGo condition; p<0.001(uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Right and left 
superior frontal 
gyrus
16,27,53
5,42,47
-3,36,48
6
8
8
33
163
3.42
3.91
3.94
3.97
4.21
4.51
Right middle 
frontal gyrus
41,32,42 8 12 3.44 n.s. 
Left middle  
frontal gyrus
-28,15,56 6 6 3.33 3.65
Right caudate 
nucleus 
11,13,4
15,5,10
159 3.86
3.77
3.72
4.01
Left caudate 
nucleus
-9,6,11 16 3.47 3.56
Left praecentral 
gyrus
-28,-14,59 6 5 3.32 n.s. 
Right inferior 
parietal lobule
56,-51,36 40 27 3.74 3.55
Left superior 
parietal lobule
-26,-62, 51
-38,-60,49
7 86 3.75
3.38
n.s.
3.73
Left supramarginal 
gyrus
-55,-48,33 40 10 3.25 n.s. 
  b) Brain regions with increasing activation correlating with higher scores 
in inattention; NoGo condition; p<0.001(uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Right lingual gyrus 12,-89,1 17 6 3.46  n.s. 
Left middle 
occipital gyrus
-22,-84,9 18 5 3.44 3.58 
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3.5.1. Correlation with Inattentiveness
Lower activation associated with higher inattention scores were mainly found in brain 
areas that belong to a fronto-striatal network, suggesting a functional deficit within this 
network that depends on the degree of attention deficits according to ADHD DSM-IV 
(table 3a, figure 3a). Also activation of brain regions which belong to the parietal 
network was weaker when attention deficit scores increased. When we controlled data 
analysis for IQ, the same activation patterns were seen, even on a higher level of 
statistical significance (see table 3b).
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Table 3   c) Brain regions with hypoactivation correlating with higher scores in 
impulsivity; NoGo condition; p<0.001(uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Right superior 
frontal gyrus
18,24,53
6,38,47
8
8
57
9
4.13
3.24
4.42
3.3
Right middle 
frontal gyrus
34,24,40
42,28,44
8
8
6
6
3.23
3.15
3.57
n.s.
Left middle  
frontal gyrus
-37,36,35
-32,3,56
9
6
16
8
3.31
3.24
n.s.
n.s.
Right gyrus cinguli 2,19,38 32 37 3.66 4.13
Left precentral 
gyrus
-28,-14,58 6 43 3.42 3.34
Right inferior 
parietal lobule
60,-47,40
62,-25,26
52,-44,30
40
40
40
56
14
27
4.15
3.37
3.80
4.11
n.s.
3.54
Left superior 
parietal lobule
-30,-62,51 7 69 3.95 3.49
  d) Brain regions with increasing activation correlating with higher scores 
in impulsivity; NoGo condition; p<0.001(uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Left anterior Insula -37,12,1 13 188 3.81 3.72
Left lingual gyrus -1,-89,0 18 6 3.49 n.s.
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Increased brain activation was seen in secondary visual areas in lingual gyri (BA 18), 
arising the hypothesis that with increasing lack of attention there might be more effort 
in visual polymodal brain areas to try to compensate this lack of attention (table 3b). 
Non-parametric statistic revealed a significant negative correlation with medium correlation 
coefficient between left and right caudate nuclei activation and ADHD-SR inattention 
score (r
left
=-.51, p=.002; r
right
=-.60, p=.0001; figure). This result is shown in figure 3b. 
3.5.2. Correlation with Impulsivity
When brain activity was correlated with ADHD-SR impulsivity subscores, also a fronto-
parietal network appeared to be impaired with increasing psychopathology (table 3c). 
Frontal hypofunction comprised parts of the cingular cortex (BA 32) as an important 
region for integrating decisions and controlling motor execution (figure 4a). In this region 
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Table 3   e) Brain regions with decreasing activation correlating with higher scores 
in hyperactivity; NoGo condition; p<0.001(uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Right superior 
frontal gyrus
25,50,3 10 13 3.42 3.98
Left middle  
frontal gyrus
Left precentral 
gyrus
-12,1,58
-20,-6,58
-28,0,59
-28,-14,59
6
6
6
58
3.16
3.18
3.21
3.67
n.s. 
3.31
3.45
3.23
Left superior 
parietal lobule
-34,-60,51 7 41 3.76 3.27
  f) Brain regions with increasing activation correlating with higher scores in 
hyperactivity; NoGo condition; p<0.001(uncorrected)
Region Talairach 
coordinates 
x,y,z (mm)
Brodman 
area
Number of 
voxels
z-score z-score 
corrected 
for IQ
Left anterior Insula -42,-8,5 13 73 3.75 n.s. 
Right inferior 
temporal gyrus
45,-9,-20 20 8 3.30 3.70
Left lingual gyrus -1,-87,0 18 6 3.45 n.s. 
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Figure 3   a) Caudate Nuclei. Picture displays anticorrelation of brain activation 
with increasing ADHD-SR inattention subscore Significance level set at 
p<.001; voxel extension k=5. b) Scatter plot depicting the anticorrelation 
between activation in the right caudate and ADHD-SR inattention 
subscore in adults with ADHD combined type (black triangles), ADHD, 
partially remitted (open triangles) and normal controls (circles);r=-.60; 
p=.000.
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Figure 4   a) Anterior Cingulate Cortex (ACC/BA 32). Picture displays anticorrelation 
of brain activity with increasing ADHD-SR impulsivity subscore.  
b) Scatter plot depicting the anticorrelation between activation in  
the anterior cingulate cortex (BA 32) and ADHD-SR impulsivity  
subscore in adults with ADHD combined type (black triangles), ADHD, 
partially remitted (open triangles) and normal controls (circles); r=-.41; 
p=.014.
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Figure 5   a) Left Insular Cortex. Picture displays correlation of brain activity with 
increasing ADHD-SR impulsivity subscore;. b) Scatter plot depicting  
the correlation between activation in the left insula and ADHD-SR 
impulsivity subscore in adults with ADHD combined type (black triangles), 
ADHD, partially remitted (open triangles) and normal controls 
(circles);r=.52; p=.001.
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of interest, non-parametric analysis revealed a medium correlation coefficient and a 
significant negative correlation between ADHD-SR impulsivity subscore and impaired 
activation (r=-.41, p=0.014), which is shown in figure 4b. Statistical control for IQ resulted 
in higher significance concerning the lowered activity from the right cingulated gyrus, 
but  the lowered activity in the left middle frontal gyrus with increasing impulsivity was 
not any longer statistically significant. 
Increasing activation of left insula and secondary visual fields was detected with 
increasing impulsivity (figure 5a) also when corrected for IQ. For this region a medium 
correlation coefficient was found (r=.52, p=.001) (figure 5b).  
3.5.3. Correlation with Hyperactivity
Concerning correlation of ADHD-SR hyperactivity subscore with activation of brain 
regions displayed a pattern similar to that found for inattention measures (tables 3e and 
3f). Decreased activation of predominantly left frontal and parietal brain areas and an 
increased activation of insular cortex and gyrus lingualis were correlated with hyper -
activity scores. When controlled for IQ, no correlation with left anterior insula and left 
lingual gyrus activation was found.
4. Discussion
According to our hypothesis of altered activation patterns in adults with ADHD, we 
found in this fMRI study correlates of decreased function within fronto-striatal and 
parietal brain networks associated with ADHD psychopathology. These findings 
corroborate functional imaging evidence of disturbed fronto-parietal networks, which 
has been described in adolescents with ADHD (Silk et al., 2005). In agreement with the 
literature concerning anatomical and functional changes within the brain of children, 
adolescents and adults with ADHD, the brain regions suggested to be involved in ADHD 
pathophysiology were found to be affected also in our study. These regions of interest 
are the anterior cingulate cortex (ACC), the prefrontal cortex, striatum, insula, the parietal 
cortex and cerebellum (Makris et al., 2007; Schneider et al., 2006). 
Makris et al. (2007) reported thinning of prefrontal and parietal cortical regions belonging 
to attention and executive networks in adult ADHD and of the ACC in particular. Also 
Seidman and colleagues (2006) could show in adult ADHD patients morphological 
alterations of the ACC and prefrontal cortex. The ACC is the largest component of the 
limbic system. It plays a crucial role in the coordination of complex cognitive functions 
and in motor control. Two functional subdivisions of the ACC are specialized in 
“cognitive/attentional” and “affective emotional” information processing (Bush et al., 
1998, 1999). Bush et al. (1999) found that ACC activation in adult ADHD patients was 
specifically impaired during the interference condition of a counting stroop task. They 
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could also show improvement of ACC activity after 6 weeks of methylphenidate therapy 
(Bush et al., 2008). ACC dysfunction has been reported also in ADHD children (Rubia et 
al., 1999; Durston et al., 2003). In adult patients with ADHD dysfunction of ACC has been 
demonstrated also with positron emission tomography (Ernst et al., 2003) and neuro-
physiological techniques (Fallgatter et al., 2005).
Alike, also striatal structures have been suggested to play a crucial role in ADHD patho-
physiology. An elevated dopamine transporter density in the basal ganglia compared to 
healthy controls has been reported in ADHD adults (Krause et al., 2000, 2005; Dougherty 
et al., 1999). Using positron emission tomography (PET) Zametkin and colleagues (1990) 
demonstrated decreased metabolism of caudate nuclei during cognitive tasks in adults 
with ADHD. In functional imaging studies decreased activation of the striatum in ADHD 
has been described (Lou et al., 1984, 1989; Vaidya et al., 1998; Durston et al., 2003). Ströhle 
and colleagues (2008) described decreased ventral striatal activation during a reward 
task in ADHD, underlining the pathophysiological importance of fronto-striatal 
structures in ADHD also in the frame of reward paradigms. The diminished bilateral 
activation of caudate nuclei found in this study is in line with these findings and support 
the notion of disturbed dopaminergic transmission in adult ADHD patients. 
A robust finding in our study was a dysfunction of the parietal cortex in adults with 
ADHD compared to controls. Diminished activation of the parietal lobule with increasing 
psychopathology was found throughout all ADHD-SR subscores. Only a handful of 
studies have addressed to parietal lobe structure and function in ADHD so far (Tamm et 
al., 2006; Smith et al., 2006), although this brain area plays an important role in orienting 
and selective attention networks (Fan et al., 2005). Posner et al. (1990) have described a 
posterior attention system located in the parietal lobe, which seems to be mainly 
modulated by noradrenergic transmission in contrast to the predominantly 
dopaminergic modulation of the frontal attention system. The posterior parietal cortex 
disengages the attentional focus from the contralateral target (Rafal et al., 1995), and 
lesions at this region can lead to impaired attention (Posner et al., 1995; Ro et al., 2001). 
Given its importance in visuo-spatial orienting and as a region for polymodal sensory 
integration, the parietal brain seems to be generally underestimated in context with 
attention deficits in ADHD.
A lower metabolism and smaller volume in parietal regions has been shown in ADHD 
children (Castellanos et al., 2002, Filipek et al., 1997, Ernst et al., 1997). Konrad et al. (2006) 
have used fMRI to investigate brain activations related to these particular aspects of 
attention. In that study parietal brain regions were less recruited by ADHD compared to 
control children. Task-specific abnormalities of parietal and temporal cortices in children 
and adolescents with ADHD were also demonstrated by Smith and colleagues (2006). 
Booth and coworkers (2005) could show in children with ADHD that a small region of 
the superior parietal lobule displayed a weaker activation during a selective attentional 
task. The findings of our study compare to these reports and underline the role of 
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parietal cortical dysfunction even in adult ADHD. Moreover, these findings lead to the 
hypothesis that in addition to the well described frontal brain regions also polymodal 
integrative cortical functions of the parietal cortex are impaired in ADHD pathology. 
The dysfunction in this brain area might lead to difficulties in integrating different 
inputs to an executive program and its inhibition. 
Interestingly, we did not only find decreased activation of fronto-striatal and parietal 
attention systems in ADHD subjects, but also an increase of activation of some brain 
regions. Activation of the insular cortex in adult ADHD has been found in a prior fMRI 
study in which a counting Stroop paradigma was used (Bush et al., 1999). It has been 
speculated that the “insular pathway” might present an alternative to the activation of 
ACC and the prefrontal network during attention tasks (Bush et al., 1999). Thus, adults 
with ADHD might rather activate a different neuronal network than just use a given 
brain network that works insufficiently. Another hypothesis might be the higher 
anticipatory fear during task performance because of cognitive and inhibitory 
impairments (Chua et al., 1999). Wager and Barrett (2008) could demonstrate that 
shifting attention and executive working memory activate anterior insulae. This could 
be enhanced with emotional  tasks. The authors found that recall generated emotion 
activated especially the left insula. Thus, it should be also considered that ADHD patients 
might tend to subvocalize during their task, which might be an attempt to compensate 
inhibitory dyscontrol resulting from hyperactivity and impulsivity (Morris et al., 1999). 
Fear and subvocalization have been post-hoc reported from some individuals in our 
study, but this was not systematically documented.
The results of this study indicate that ADHD associated dysfunction of attention 
networks might persist across the lifespan. Even in those individuals with a history of 
childhood but partially remitted ADHD in adulthood displayed abnormalities similar to 
those of subjects with persisting ADHD, combined type. Assuming that remission of 
ADHD psychopathology in these subjects is not a diagnostic artefact due to 
inappropriate diagnostic criteria for adult ADHD, it might be concluded that clinical 
remission depends on the individual’s capability to compensate persisting dysfunction 
of attentional networks via activation of alternative pathways.
In this study we did not only compare brain activation patterns of adults suffering from 
ADHD with healthy controls during a cognitive task, but also looked for correlations 
between regional brain dysfunction and the degree of psychopathological 
abnormalities across the ADHD symptom domains. By doing this, we found that 
decrease of activation of frontal and parietal cortical areas was associated with an 
increase throughout the psychopathological domains of ADHD, inattention, 
hyperactivity and impulsivity. However, also differential effects were observed regarding 
the correlations between ACC dysfunction and impulsivity and between basal ganglia 
activation and inattention, supporting the concept of syndromatical ADHD subtypes 
(Biederman et al., 2000) and the hypothesis of independent changes of inattention and 
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hyperactivity-impulsivity symptom domains with age on a neuronal basis. However, it 
appears to be important to note that the correlations found in this study reflect a direct 
association between the severity of the clinical syndrome and the neuronal substrate of 
ADHD and underline the dimensional character of this disorder also in terms of their 
neuronal pathology. Several lines of evidence support the concept of ADHD as a 
dimensional disorder. For example, subthreshold ADHD cases showed fewer deviations 
regarding personality traits compared to full ADHD subjects, suggesting to present a 
milder form of ADHD that is consistent with dimensional views of this disorder (Faraone 
et al., 2009). Likewise, latent class analyses show that ADHD is best modeled as a 
continuum that is not caused by discrete dysfunction (Haslam et al., 2006). Further 
support comes from genetic studies, which have demonstrated the appropriateness of 
quantitative loci approaches in ADHD research, indicating no threshold effects on the 
risk for ADHD (Chen et al., 2008). 
DSM-IV refers to the dimensional character of the disorder by requiring at least 6 of 9 
typical criteria of inattention and/or 6 of 9 of hyperactive-impulsive features. If less than 
at least 6 criteria of either inattention or hyperactive-impulsive behavior are observed, 
no diagnosis of ADHD can be made, even if some characteristics of the disorder are 
present. According to DSM-IV, adults who suffered from ADHD in childhood but do not 
longer fulfill at least 6 items of either syndrome domain are diagnosed with ADHD, 
partially remitted. Thus, the diagnoses of ADHD, partially remitted directly refers to the 
dimensional character of this disorder and reflects the well known decline of the 
disorder with age, at least on a diagnostic and to lesser extend to a syndromatic level 
(Biederman et al., 2000). Concerning the dimensional character of attention, motor 
activity and impulsive behavior in general, and the lack of specific psychopathological 
ADHD features, a syndromatic continuum from healthy persons to those with sub-syn-
dromatic and full ADHD can be assumed. 
A limitation of this study is the recruitment of the patients from a specialized ambulance 
for ADHD and the high degree of preselection regarding psychiatric comorbidity and 
premedication. Therefore, the ADHD patients in this study might be not representative 
for typical adults with ADHD. However, the relatively low treatment prevalence of ADHD 
children in the past and the still lacking licence for any ADHD medication for ADHD 
adults in Germany allowed to include a quite homogeneous group of never medicated, 
but even moderately to severely affected ADHD patients in this study. 
Moreover, the limited number of ADHD patients in this study did not allow differentiat-
ing gender effects on ADHD neurophysiology. Also, no individuals with ADHD, 
inattentive or hyperactive-impulsive type underwent imaging procedures. The effects 
of these ADHD subtypes on attention network activation could thus not be worked out. 
Further studies with specific design will be necessary to investigate these aspects. 
Hyperactivity of some ADHD patients led to the problem that movement artefacts 
prohibited from fMRI data analyzing procedures. Especially the severely hypermotoric 
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ADHD patients had to be excluded from the study which could lead to a systematic 
bias. Finally, lacking structural data in this population, functional impairments might be 
confounded with structural differences between ADHD patients and controls, as they 
also concern the typical neural networks affected in attention processing (Makris et al., 
2007).
In conclusion the results of this study give evidence to the hypothesis of dysfunction of 
fronto-striatal as well as parietal attention networks in adult ADHD. Moreover, the results 
underline the notion that ADHD is a dimensional disorder and that the severity of 
symptoms correlates with the degree of dysfunction of these networks. The mechanisms 
underlying ADHD in adulthood seem to be very similar to those in childhood and 
adolescence, suggesting that there might not be a qualitative difference between 
childhood and adulthood regarding ADHD pathophysiology. In addition, adults 
diagnosed with ADHD, partially remitted according to DSM-IV displayed activation 
patterns that resembled those of the persistent ADHD subjects and therefore seem to 
close the pathophysiological gap between healthy adults and adults with persisting 
ADHD, combined type.
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Abstract
The aim of this study was to analyze motor inhibition and facilitation of adult ADHD 
patients using double pulse transcranial magnetic stimulation (TMS). Twenty-six right 
handed adult ADHD patients according to DSM-IV were investigated and compared to 
26 age and sex-matched controls. In the left hemisphere, mean motor inhibition was 
0.53 ± 0.33 (mean ± SD) in ADHD patients and 0.34 ± 0.16 (mean ± SD) in controls 
(p=0.012). There were no significant differences in motor excitability concerning 
facilitation or in the right hemisphere. Decreased motor inhibition correlated with a 
higher symptom score derived from the Wender Reimherr Interview (WRI) (rho=0.28; 
p=0.04) and also with self rated hyperactivity/impulsivity symptoms (rho=0.30; p = 
0.03).
In conclusion, decreased motor inhibition in adult ADHD corroborate similar findings in 
children with ADHD (Moll et al. 2000) and reflect disturbed impulsivity and hyperactivity 
on a neurophysiological level.
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Introduction
The Attention Deficit-/ Hyperactivity Disorder (ADHD) is one of the most frequent 
disorders not only in child and adolescent psychiatry but also in general psychiatry. The 
prevalence in adulthood has been determined as 4% (Kessler et al. 2006). According to 
DSM-IV the core psychopathology in all ages comprises hyperactivity, impulsivity and 
attention deficits. These symptoms are significantly correlated with deficits in social 
functioning (Barkley et al. 2006). In comparison with healthy controls individuals with 
ADHD have lower levels of school and vocational education, more job changes, higher 
rates of divorces (Biederman et al. 2006) and are at increased risk of severe accidental 
injuries (Grützmacher 2001). Persons with ADHD commit significantly more traffic 
violations compared with controls (Jerome et al. 2006). The prevalence of ADHD in 
forensic populations is remarkably high (Vermeiren 2003), particularly in young male 
offender populations (Rösler et al. 2004a). 
In this respect it is useful to question which abnormalities of the cerebral structures and 
functions may contribute to the emergence of psychopathology and social dysfunction. 
There is an overwhelming amount of evidence that ADHD is a disease with a profound 
genetic component (Faraone 2004). From twin studies, heritability estimates of 0.7 and 
higher were derived. These are among the highest heritability estimates in psychiatric 
disorders besides autism spectrum disorders. In molecular genetic studies associations 
were found predominately with genes controlling for the dopaminergic and 
serotonergic transmitter system (Heiser et al. 2004). Both transmitter systems are 
involved in the function of the prefrontal cortex. Dopamine plays a significant role in 
the anterior attention system (Pliszka 2005) and serotonin is a major component of the 
anterior cingulate cortex (Mantere et al. 2002), which seems to be affected in ADHD 
(Fallgatter et al. 2004, Seidman et al. 2006). In structural and functional imaging studies 
abnormalities of the prefrontal cortex are widely accepted findings, in addition to 
changes in the striatum and the cerebellum (Schneider et al. 2006). 
Transcranial magnetic stimulation (TMS) is a non-invasive method to examine cortical 
function and to study the activation of brain regions based on the ability of a magnetic 
field to penetrate skull and brain meninges, subsequently inducing neuronal depolarization 
and the generation of action potentials (Bailey et al. 2001). Single or paired pulse TMS 
and repetitive TMS (rTMS) is differentiated on the basis of stimulation type. The effects 
of single or paired pulse TMS do not outlast the period of stimulation, whereas rTMS can 
produce effects which outlast the stimulation period depending on the stimulation 
parameters (Ziemann 2004). TMS is presently under investigation as a treatment for 
different psychiatric disorders, mainly affective disorders (Simons and Dierick, 2005). In 
addition to therapeutic approaches, TMS can also be used to examine cortical function 
in different brain areas. One of the main areas of TMS application is the investigation of 
cortical excitability, which is mediated by neurochemical and synaptic processes in 
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neurons, which are affected by TMS. Strafella et al. (2003) demonstrated that rTMS of the 
prefrontal cortex induced focal dopamine release in the ipsilateral caudate nucleus and 
increased extracellular dopamine concentrations. TMS studies subsequently reported 
that excitability of the motor cortex was changed by stimulation of contralateral cortical 
areas (Baumer et al. 2006; Porro et al. 2007). 
Only a limited number of TMS investigations have been performed in individuals with 
ADHD. In ADHD children, Moll et al. (2000) reported reduced intracortical inhibition (ICI) 
associated with normal intracortical facilitation (ICF). After application of 10mg methyl-
phenidate (MPH) ICI was enhanced in these children. Gilbert et al (2005) reported that 
ADHD scores in a sample of children and adults with Tourette syndrome were inversely 
correlated with ICI measured with TMS. In their study, hyperactivity scores, but not 
inattention, accounted for this finding. Moreover, disturbed transcallosally mediated 
contralateral motor inhibition in children with ADHD (Buchmann et al. 2003, Garvey et 
al. 2005) and modulation of cortical excitability by MPH and atomoxetine have been 
described (Buchmann et al. 2006, Gilbert et al. 2006) in TMS studies .
In this study we hypothesized that impaired cortical inhibition found in children (Moll et 
al. 2000) is also present in adults with ADHD. We also hypothesized that reduced motor 
inhibition or increased facilitation is correlated with the severity of ADHD. 
Methods
Subjects and Instruments
The study was performed on 26 right-handed subjects with ADHD recruited from a 
specialized ambulance for ADHD-associated disorders. Each group consisted of 13 
female and male subjects, respectively. All patients were without any DSM-IV axis 1 
diagnosis, and were completely drug naïve. Further exclusion criteria were any history of 
neurological events, such as brain injury or any kind of vascular, inflammatory or 
degenerative brain disturbance (e.g. meningitis, encephalitis in childhood, 
developmental or degenerative disorder). Patients with low intelligence (IQ<85) were 
not included in the study.
The patients of the ADHD study group were initially diagnosed by experienced 
psychiatrists and fulfilled the diagnostic criteria of DSM-IV according to the ADHD-DC 
(ADHD Diagnostic Checklist, Rösler et al. 2004b). Twenty-four patients were classified as 
ADHD combined type and 2 as ADHD hyperactive/impulsive subtype. Control subjects 
were recruited from the staff of different university departments. They were matched 
with ADHD patients according to their sex and age. 
Table 1 gives descriptive statistics for ADHD cases and controls with regard to age, sex 
distribution and ADHD symptoms.
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All patients displayed a sum score of at least 30 points in the Wender-Utah Rating Scale 
(WURS-k, Retz-Junginger et al. 2002, 2003), which is highly indicative for childhood 
ADHD symptoms, obtained by self assessment. Diagnostic criteria of ADHD were first 
obtained from the ADHD self rating scale (ADHD-SR) for adults according to DSM IV 
(Rösler et al. 2004b). Total scores ranged from 0 to 54 points. Maximum score for the 
attention deficit subscale is 27 and 27 for the hyperactivity/impulsivity subscale. 
Second, individuals were interviewed by expert clinicians with the authorized German 
version of the Wender Reimherr Interview (WRI, Rösler et al., submitted) to obtain Utah 
criteria for adult ADHD. The WRI is also known as TAADDS (Wender 1995). The WRI is a 
semi-standardized diagnostic interview for the assessment of adult ADHD. It comprises 
28 psychopathological items on 7 subscales which are inattention, hyperactivity, 
temper, affective lability, emotional hyperreagibility, disorganisation and impulsivity. 
Each item is quantified on a Lickert Scale ranging from 0 to 2 resulting in a maximum 
total WRI score of 56.
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Table 1   Descriptive statistics for cases and controls
ADHD (N=26)
Mean (Std)
Controls (N=26)
Mean (Std)
Z-value
p-value
Age (SD) 32.4 (9.1) 32.2 (7.9) Z= -0.2
0.857
Gender 13 male
13 female
13 male
13 female
WURS-k* 47.3 (13.6) 7.0 (9.2) Z=6.1
< 0.0001
ADHD-SR* total score 36.8 (6.3) 6.0 (5.17) Z=6.4
< 0.0001
ADHD-SR attention 
deficit subscore*
18.2 (4.6) 3.0 (2.5) Z=6.3
< 0.0001
ADHD-SR hyperactivity/ 
impulsivity subscore*
18.6 (4.1) 3.0 (3.3) Z=6.4
< 0.0001
WRI score* 43.3 (5.4) 9.3 (8.2) Z=6.4
< 0.0001
* information missing on one individual with ADHD.
WURS-k: Wender-Utah-Rating Scale, German short version (Retz-Junginger et al. 2002, 2003)
ADHD-SR: ADHD self-rating (Rösler et al. 2004b)
WRI: Wender-Reimherr Interview (Rösler et al., 2008)
82
Patients with the clinical diagnosis of ADHD were included in the study only if (1) the 
WURS-k score was at least 30 points, (2) at least 6 of 9 items of inattention and/or 
hyperactivity/impulsivity were rated as present (score ≥ 1) on the ADHD-SR and (3) 
ADHD-SR attention deficit and/or hyperactivity/impulsivity subscores were at least 12 
points.
Transcranial magnetic stimulation technique (TMS)
TMS utilizes the principle of electromagnetic induction by the discharge of very large 
currents over a short period which flow through a copper-wire coil. A rapid time-varying 
magnetic field is induced by an impulse of approximately 270µsec. When the coil is held 
to the head of a subject, the magnetic field pulse induces a small current parallel to the 
plane of the coil in the adjacent second conductor, the brain. When the induced current 
flowing parallel to the brain surface is sufficient, depolarization of neuronal membranes 
occurs, and hence an action potential is generated. Thereby preferentially interneuronal 
elements are activated, which are oriented horizontally to the surface of the brain (Day 
et al. 1989). TMS is thought to predominantly activate the pyramidal cells transsynapti-
cally through excitatory interneuronal elements (Amassian et al. 1990; Day et al. 1989; Di 
Lazzaro et al. 1998; Nakamura et al. 1996).
With this technique, two magnetic stimuli are delivered in close sequence to the same 
cortical spot through a single stimulation coil (Kujirai et al. 1993). The first, conditioning, 
pulse (CP) is a subthreshold pulse and is considered to condition the response for the 
second, the test stimulus (TS) which is a suprathreshold stimulus and follows within a 
time period of several milliseconds. The magnetically evoked potential (MEP) obtained 
depends on the intensity of the CP, the interval between the stimuli (interstimulus 
interval, ISI), and the intensity of the TS (Pascual-Leone et al. 1998). Different circuits are 
recruited by varying intensities of CP and TS. At a ISI of 1 to 20 ms ICI and ICF may be 
studied. In our study, MEP’s after an ISI of 1, 3, and 5 ms were accepted to indicate 
inhibition, and MEP’s after an ISI of 7, 9, 11, 13, and 15 ms to indicate facilitation.
TMS was applied with a Medtronic MagPro X 100 Stimulator with MagOption (Medtronic, 
Denmark). A figure of eight coil with a diameter of 65mm was placed at the skull above the 
supposed hand area of the motor cortex. Surface electromyography was recorded from 
the contralateral first dorsal interosseus muscle (FDI) with a standard electromyographic 
amplifier (Medtronic Keypoint 4; recording software Medtronic Keypoint V 5.01). The 
bandwidth of the filters was set to 1 Hz and 10 kHz, respectively. The optimal position of 
the coil was determined by moving the coil by 0.5 cm steps until an optimal MEP could be 
registered. Resting (RMT) and active motor thresholds (AMT) were determined according 
to the protocol of Kujirai et al. (1993). Briefly, RMT was the minimal stimulus intensity which 
was required to produce motor potentials of more than 50µV peak to peak amplitude in 
50% of the testpulses. AMT was determined in analogy to RMT, while the subject tonically 
distended a dynamometer with 10-20% of maximum power.
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“In-Out”-curves were determined by increasing stimulus intensity in steps of 10% 
beginning from subthreshold intensities up to maximum stimulus output at 100%. Eight 
MEP´s were averaged at each stimulus level. 
Double-pulse stimulation was performed according to the technique of Kujirai et al. 
(1993). The subthreshold conditioning pulse (CP) was set at 80% of RMT and was 
followed by a suprathreshold test stimulus (TS). The TS was adjusted to produce a mean 
MEP of 0.5 to 1.2 mV peak to peak amplitude, when unconditioned (uMEP). The 
interstimulus intervals were set between 1 and 15 ms at distances of 2 ms. At each 
interstimulus interval 8 trials were averaged. The time between two measurements was 
at least 5 seconds to avoid secondary effects, such as potentiation. Peak-to-peak 
amplitudes of these conditioned MEP´s (cMEP) were set into relation to a MEP elicited by 
the mean of 8 testpulses without any conditioning prepulse (unconditioned MEP, 
uMEP). Data are presented as relative amplitudes of the uMEP (relative amplitude = 
cMEP/uMEP). Care was taken to relax the subjects and to avoid any movements of the 
extremities during recordings. Each MEP was checked optically to ensure that first dorsal 
interosseus muscle (FDI) was completely relaxed. Recordings were discarded if any 
evidence of electromyographic activity was detected and repeated.
Statistical analysis
Descriptive statistics to compare ADHD scores and mean MEP after different ISI in cases 
and controls were performed by the non-parametric Wilcoxon rank sum test. Spearman 
correlations were calculated to assess correlation of ADHD scores with mean inhibitory 
MEP, i.e. the averaged response after an ISI of 1, 3, and 5ms.
To compare inhibition and facilitation between groups, multivariate statistical analysis 
of co-variance (MANCOVA) adjusted for age, was performed on four blocks of variables: 
log transformed MEP after the ISI 1ms, 3ms, and 5ms on the (1) right and (2) left 
(inhibition) and log transformed MEP after the ISI 7ms, 9ms, 11ms, 13ms, and 15ms on 
the (3) right and (4) left (facilitation). Due to this multivariate analysis, no further 
adjustment for multiple testing was made. To assess the influence of attention and 
hyperactivity/impulsivity on inhibition, exploratory linear regression analyses were 
performed with the log transformed mean MEP after ISI 1ms, 3ms and 5ms (inhibition) 
of the left hemisphere as the dependent, and the ADHD self assessment scores or the 
Wender-Reimherr-Interview score as the independent variables, adjusted for age. 
Residuals were normally distributed.
Statistical analyses were performed using SAS 8.2 (SAS Institute Inc., Cary, NC, USA).
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Results
In table 1, descriptive data for ADHD patients and healthy controls are shown. There was 
no age difference in ADHD patients and controls. Groups were matched for sex. ADHD 
scores of the patients were significantly elevated compared to controls. 
Mean relative amplitude of resting motor threshold (RMT) was 50.0 (SD 6.5) (left 
hemisphere - LH) and 51.9 (SD 8.9) (right hemisphere - RH) in the ADHD group and 47.7 
(SD 5.8) (LH) and 49.6 (SD 9.96) (RH) in the control group. For active motor threshold the 
mean relative amplitude was 43.6 (SD 6.2) (LH) and 42.9 (SD 7.5) (RH) in the ADHD group 
and 39.8 (SD 5.6) (LH) and 41.7 (SD 9.7) (RH) in the control group. Neither AMT nor RMT 
differed significantly between the groups on either hemisphere. There was also no 
correlation of thresholds with ADHD symptom rating scores. Means and standard 
deviations of input-output curves did not differ between patients and controls, indicating 
that excitatory mechanisms of motor systems did not differ between groups (figure 1).
Significant differences in motor excitability between ADHD patients and controls were 
found with the double pulse protocol. As shown in figure 2, the relative MEPs (cMEP/ 
uMEP) increased with longer ISIs and displayed a sigmoidal curve in both groups. 
Lowest relative amplitudes (<1) were found in short ISI (1–5ms) of paired-pulse curves, 
reflecting intracortical inhibition (ICI). Intracortical facilitation (ICF), corresponding to 
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Figure 1   Input-output eyefit curve (stimulation left hemisphere); stimulus 
intensity [%] of maximum stimulator output; mean absolute amplitudes 
of the MEP [mV]; filled diamonds represent mean (SD) MEP in ADHD; 
open diamonds represent mean (SD) MEP in controls 
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relative amplitudes >1 occurred at ISI of above 5ms and reached maximum values at 
15ms ISI. ADHD patients showed generally higher mean relative amplitudes at each ISI 
compared to controls. There was also an increasing variability of the MEPs with 
increasing ISI in ADHD patients. 
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Figure 2   Relative amplitudes (conditioned MEP (cMEP)/unconditioned MEP 
(uMEP)) after double pulse stimulation in ADHD patients and controls:  
a) left hemisphere; b) right hemisphere. 
Filled squares represent mean relative amplitudes in ADHD, filled diamonds represent standard deviation in 
ADHD; open squares represent mean relative amplitude in controls, open diamonds represent standard 
deviation in controls. ISI: interstimulus interval
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Multivariate analysis of co-variance (MANCOVA) performed on the four ISI blocks (ICI 
and ICF, left and right hemispheres) revealed significantly impaired inhibition of the left 
hemisphere in ADHD patients compared to controls (Wilk´s Lambda = 0.84; F=3.23; 3, 51 
DF; p=0.030; see table 2). A similar change was found, when the mean of the MEP after 
an ICI of 1, 3, and 5 ms was compared between groups (mean motor inhibition in ADHD 
0.53 ± 0.33 (mean ± SD); in controls 0.34 ± 0.16 (mean ± SD; F=6.85; 1 DF, p=0.012). There 
was no further statistically relevant difference concerning facilitation of the left 
hemisphere and in the inhibition or facilitation of the right hemisphere (table 2).
Mean relative MEP significantly correlated with the WRI total score (β-estimate = 0.009; 
p=0.029; ρ = 0.30) and the impulsivity/hyperactivity score of the ADHD-SR subscale 
(β-estimate = 0.019; p=0.037; ρ = 0.30), but not with the attention deficit subscore or the 
ADHD-SR total score respectively (table 3).
Discussion
In this study, we found reduced intracortical inhibition in a sample of adult ADHD 
patients compared to controls, using transcranial magnetic double pulse stimulation. 
The findings are in line with a previous study in ADHD children (Moll et al. 2000) and a 
preliminary report in adults with ADHD (Richter et al. 2006). In our adult ADHD sample 
we found no significant increase of cortical facilitation, in agreement with previously 
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Table 3   Correlation of ADHD-scores with left hemisphere inhibition in the 
combined ADHD and control sample. Results of the linear regression 
analyses on the log-transformed mean of relative MEP after ISI 1ms,  
3ms, and 5ms as dependent variable
Independent variable β-estimate S t a n d a r d 
Error
t-value P
ADHD-SR total score 0.008 0.004 1.71 0.092
ADHD-SR
attention deficit subscore 
0.010 0.009 1.17 0.248
ADHD-SR
hyperactivity/impulsivity subscore 
0.019 0.009 2.14 0.037
WRI total score 0.009 0.004 2.23 0.029
ADHD-SR:ADHD self-rating (Rösler et al. 2004b)
WRI: Wender Reimherr Interview (Rösler et al. submitted)
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reported findings in ADHD children (Moll et al. 2000). Our findings therefore suggest 
that changes of motor excitability in adults with ADHD are similar to those in children 
with ADHD. 
When the dimensional characteristics of ADHD were assessed, inhibitory deficits in our 
ADHD subjects were positively correlated with two different symptom scores, i.e. the 
less inhibition the more symptoms. Interestingly, we found a significant correlation with 
hyperactivity and impulsivity, but not with inattention scores. Similarly, Gilbert et al. 
(2005) reported an inverse correlation (r=0.53) of ICI with ADHD symptom scores in 
Tourette patients. The strength of the association in the latter study was also greater 
with the hyperactivity/impulsivity subscore than with the inattention subscore, suggesting 
that hyperactive/impulsive behaviours are linked with cortical inhibitory dysfunction in 
Tourette patients. Compared to the study of Gilbert et al. (2005) however, the correlation 
between ICI and hyperactivity/impulsivity in our study was less pronounced. This 
difference could be due to a lack of motor tics or spontaneous motor activity in our 
study population without Tourette disorder or might be based on different pathophys-
iological mechanisms underlying these disorders. 
Moreover, the WRI score that comprises not only ADHD core symptoms but also 
additional emotional components of adult ADHD according to the Utah criteria (Wender 
2005) was significantly related to inhibitory deficits. This finding suggest, that emotional 
problems in ADHD like affective lability, emotional overreagibility and hot temper might 
be related to the same neuropathological processes as impulsivity and hyperactivity, i.e. 
deficits of cortical inhibition. 
Another result of our study was the identification of inter-hemispheric asymmetry of ICI 
deficits in ADHD patients, which was not present in healthy controls. In adults with 
ADHD, ICI deficits occurred only in the left hemisphere. Brain asymmetry in ADHD has 
been reported several times in the literature. Schrimsher et al. (2002) could predict the 
cumulative severity ratings of inattentive behaviours by measuring caudate volume 
asymmetry from serial sagittal magnetic resonance images from childhood to 
adolescence. Unilateral volume reductions of the pallidum have also been shown in 
several studies in children with ADHD (Aylward et al. 1996, Castellanos et al. 1996, 2002, 
Overmeyer et al. 2001). Most studies however, describe volume reductions within the 
right hemisphere. Therefore, the hypothetic mechanisms leading to reduced inhibition 
of the left side can only be deduced from unknown and complex mechanisms leading 
to contralateral effects.
In our study we did not find differences between ADHD subjects and healthy controls 
regarding resting motor (RMT) and active motor thresholds (AMT). Also simple stimulus 
response curves did not differ between ADHD patients and controls. This agrees with 
previously reported observations in children with ADHD (Moll et al. 2000). Thus, there is 
no evidence for motor hyperexcitability within the motor system in ADHD at the 
membrane level of cortical neurons (Ziemann et al. 1996d).
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In general, our results suggest that TMS, and the paired-pulse technique in particular, is 
a useful tool for motor excitability research in ADHD. It allows the study of intracortical 
circuits (Ziemann 1999; Kujirai et al. 1993; Valls-Sol et al. 1992; Ziemann et al. 1996d) and 
displays little inter- and intraindividual variability (Maeda et al. 2002). ICI deficits have 
been shown to have reliable test-retest stability in adults with ADHD (Richter et al. 2006). 
ICI and ICF appear to be due to activation of separate circuits (Ziemann et al. 1996d), 
represented by inhibitory interneurons or inhibitory connections between cortical 
output cells (Wassermann et al. 1996) and facilitatory interactions partially in the motor 
cortex, at or upstream from corticospinal neurons (Ziemann et al. 1996d). Conditioning 
pulses in the double-pulse stimulation technique are thought to activate inhibitory 
interneurons within the motor system including projections onto corticospinal neurons 
(Kujirai 1993). Several neural transmission systems like GABAergic, dopaminergic and 
glutamatergic systems appear to play an important role in these mechanisms. 
Medications that enhance GABAergic activity have been shown to increase the degree 
of ICI and decrease ICF evoked by paired TMS stimuli (Inghilleri et al. 1996, Werhahn et 
al. 1998, Ziemann et al. 1996b, 1996c). Dopaminergic drugs have been shown to enhance 
ICI in normal subjects (Berardelli et al. 1996, Priori et al. 1994, Ridding et al. 1995, Ziemann 
et al. 1996a). Glutamatergic drugs have been shown to increase intracortical inhibition 
and decrease facilitation (Schwenkreis et al. 1999, Ziemann et al. 1998).
In conclusion, this paired-pulse magnetic stimulation study is the first to demonstrate 
that intracortical inhibition in adult ADHD is reduced compared to matched controls 
and occurs only in the left hemisphere. These deficits correlate with ADHD sympto-
matology, especially with hyperactivity and impulsivity behaviour. The findings therefore 
corroborate the hypothesis of inhibition deficits on a neuronal level. Compared to 
previous findings of double pulse TMS in ADHD children our results suggest that there 
is no fundamental difference between affected children and adults with respect to 
excitability of the frontal motor cortex. Further studies are needed to confirm and to 
further define these excitatory phenomena in ADHD to gain a greater insight into the 
etiology of ADHD and to generate useful endophenotypes of this disorder.
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Abstract 
Background: Methylphenidate improves attention deficits, hyperactivity and impulsivity 
in ADHD. Recent investigations into motor cortex excitability with paired pulse 
transcranial magnetic stimulation technique (ppTMS), have shown inhibition deficits in 
ADHD which correlate with the clinical symptomatology. Therefore, we investigated the 
neurophysiological effects of long acting methylphenidate (LA-Mph) with the ppTMS 
technique in adult patients with ADHD.
Methods: Thirteen right handed adult ADHD patients who were first diagnosed with 
ADHD were included in this ppTMS study. Measurements took place before and under 
treatment with LA-Mph (30-54mg daily dose). Statistical analyses were performed to 
investigate treatment effects and correlations with clinical symptomatology.
Results: LA-Mph significantly decreased the relative short intracortical motor inhibition 
(SICI) magnetically evoked potential (MEP) amplitude at 3ms interstimulus interval 
(conditioned/ unconditioned MEP amplitude: 0.84±0.76 drug-free vs. 0.29±0.19 with 
Long acting-methylphenidate (LA-Mph); p=0.020). The relative intracortical facilitation 
(ICF) MEP amplitude at 11ms interstimulus interval (conditioned/ unconditioned MEP 
amplitude: 1.51±0.92 drug-free vs. 1.79±0.95 with LA-Mph) was not significantly 
increased. The reduced relative SICI MEP amplitude with LA-Mph correlated significantly 
with the improvement of the psychopathological ADHD self-rating total scores 
(p=0.046).
Conclusion: These results show that in adult patients with ADHD, LA-Mph significantly 
improves motor disinhibition and might have differential stabilizing effects on motor 
hyperexcitability.
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Introduction
Methylphenidate (Mph) is a psychostimulant and is used for more than 50 years in the 
treatment of attention deficit, hyperactivity and impulsivity symptoms in ADHD. It 
increases dopaminergic and noradrenergic synaptic efflux throughout the brain and 
has a rapid onset of action without attenuation of drug effects [1]. Low doses of Mph 
have limited influences on dopamine (DA) and norepinephrine (NE) in the prefrontal 
cortex only, without inducing effects on other areas of the brain at higher dosages [2]. 
The behavioural and cognitive effects of this stimulant drug are not specific and occur 
in ADHD as well as in normal subjects. The well known clinical experiences with Mph 
contrast with the lack of detailed knowledge about the neurobiological mechanisms of 
stimulant action on motor cortex in human ADHD. Recent imaging studies converge 
mainly towards improvement of disturbed fronto-striatal activity [3,4].
With the paired pulse transcranial magnetic stimulation (ppTMS) technique, the short 
intracortical inhibition (SICI) and intracortical facilitation (ICF) can be analyzed [5]. The 
ppTMS technique is also an useful and non-invasive tool to investigate the influence of 
pharmacological modulation on intracortical motor excitability [6]. The recent literature 
is inconsistent regarding the effects of immediate release Mph on SICI and ICF in ADHD 
and their underlying mechanisms [7-12]. Indeed, immediate release Mph has 
disadvantages, in that it has to be given several times per day, whereas long acting Mph 
(LA-Mph) can be administered once or twice a day and induces less fluctuations in 
plasma concentration. Therefore, LA-Mph given once or twice per day has pharmacoki-
netic advantages for the treatment of adults with ADHD [13], although the plasma 
concentration may show interindividual variations [14]. Over the past years, a limited 
number of studies with TMS in ADHD patients has been published in which immediate 
release Mph was used with, however, unequivocal results [7-12]. Until now, no study has 
been performed with the ppTMS technique that investigated the effects of LA-Mph. 
With LA-Mph, the clinical state of the ADHD patient is more stable and allows, therefore, 
for better clinical state correlations.
In this study, it is hypothesized that LA-Mph improves disturbed ppTMS intracortical 
excitability in adult patients with ADHD and that these effects are positively correlated 
with clinical improvement of the ADHD symptoms.
Methods
Patient characteristics and medication procedures
Thirteen right handed patients were recruited by experienced board certificated 
psychiatrists (MS, GG, WR) from specialized outpatient centres for ADHD-associated 
disorders (SHG Klinik für Psychiatrie und Psychotherapie, ADHS Ambulanz, Saarbrücken; 
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Neurozentrum der Universität des Saarlandes, ADHS Ambulanz, Homburg) . They were 
diagnosed with ADHD combined type for the first time according to the diagnostic 
criteria of DSM IV (ADHD-DC: ADHD Diagnostic checklist [15]), and had used no stimulant 
medication before. The Wender Utah Self Rating Scale (WURS-k) [16,17]) was used to 
indicate childhood ADHD symptoms. Statistical test analysis indicated a sensitivity of 
85% and specificity of 76% at a cutoff of 30 points. Its inner consistency is high (Cronbach 
α= 0.91) [17]. Patients with the clinical diagnosis of ADHD were included in the study if 
the WURS-k score was at least 30, and when at least 6 of 9 items of inattention and/or 
hyperactivity/impulsivity were present. As indicator of severity of symptoms, the ADHD 
self-rating scale for adults (ADHD-SR) according to DSM IV [15] was used (total score: 0 to 
54; attention deficit and hyperactivity/impulsivity subscores: each maximal 27; test-retest 
reliability 0.80, inner consistency Cronbach α=0.90). A semistandardized expert clinical 
assessment for adult ADHD, the German validated version of the Wender Reimherr 
Interview (WRI) [18,19], was applied to quantify the Utah criteria for adult ADHD. The WRI 
is also known as WRAADDS [19] and comprises the subscales inattention, hyperactivity, 
temper, affective lability, emotional hyperreagibility, disorganization and impulsivity, 
yielding 28 psychopathological items, each being quantified on a Lickert Scale ranging 
from 0 to 2. This results in a maximum total WRI score of 56. The internal consistency of 
this interview is also high (Cronbach α=0.82) [18]. SCID-1 and 2 interviews were used to 
exclude further axis I and II DSM categorical diagnoses. 
The recruited patients had no psychoactive medication prior to the diagnosis of ADHD. 
None of them had additional DSM IV axis I or II diagnoses. As additional exclusion criteria 
served: drug abuse, relevant somatic problems, as well as any known conditions with 
metabolic or immunologic pathology. Other exclusion criteria were any kind of 
degenerative, traumatic, inflammatory or vascular brain disturbance (e.g. developmental 
disorder, meningitis, encephalitis in the anamneses, neurodegenerative brain disease), 
and low intelligence (IQ<85). Estimation of intelligence was done by the “Mehrfachwahl 
Wortschatztest (MWT-B)“, a verbal IQ test [20] .
The patients gave written informed consent to participate in the study. The TMS study 
was approved by the local ethical committee. 
In this clinical study, oral dose of LA-Mph was increased gradually to obtain both an 
optimal individual dosage and to avoid side effects. Patients were examined by a board 
certified and experienced academic psychiatrist with intervals of two weeks. The first 
clinical and electrophysiological measurement took place just before the start of the 
medication. After the patients had reached the optimal individual dose of LA-Mph 
(Medikinet ret®, Concerta®) for at least two weeks, they were re-assessed with the above 
mentioned ADHD instruments. The second electrophysiological measurement was 
performed two weeks after the ADHD scores were decreased by at least 50% (ADHD-SR) 
according to the clinical interviews (WRI, ADHD-DC). The patients had to take the 
medication at an exactly defined time point (8.00h). The medication dosage should be 
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in the range of 0,3 to 1,0 mg/kg bodyweight. An optimal dosage was defined as the 
dosage that reached optimal subjective profit for the patients in daily living without or 
with a minimum of tolerable side effects. The LA-Mph medication had to be stable for 
at least two weeks before TMS tests. A follow up TMS test was performed 4 to 6 hours 
after the last medication intake. Eleven patients were treated with Medikinet ret® (range 
of daily dosage 30-40mg), and 2 patients with Concerta® (daily dosage 36/54mg). 
Thirteen adult ADHD patients (11 male, 2 female), aged 34.3±11.8 years (mean±SD, range 
18-49 years) participated in the study. All patients fulfilled DSM IV criteria for adult ADHD 
combined type (for ADHD scores, see Table 1). The ADHD patients displayed a total 
score of more than 30 in the self-assessment WURS-k [15], which is strongly indicative 
for childhood ADHD symptoms (49.23±12.05). There was a highly significant reduction 
of ADHD clinical symptoms (see Table 1) under medication of 30-54mg LA-Mph 
(34.62±7.28). The average therapeutic daily dose of LA-Mph was 0.50±0.1 mg/kg 
bodyweight (range 0.41-0.78 mg/kg). 
TMS protocol
Patients were lying comfortably in a supine position with elevated stand of the upper 
body and head. TMS was applied with a Medtronic MagPro x100 Stimulator with 
MagOption (Medtronic, Denmark). A figure of eight coil with a diameter of 65 mm was 
placed at the left motor cortex area where the hand motor region was subjected. The 
rapid time-varying magnetic field induced an impulse of approximately 270 µsec. 
Surface electromyography was recorded from the contralateral first dorsal interosseus 
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Table 1   Basic ADHD scores and neurophysiological data (mean ± STD) in drug 
naïve and after two weeks of stable treatment with LA-Mph (30-54mg)
drug-free with LA-Mph Paired t-test 
statistic
ADHD-SR total score 38.15 ± 7.00 16.54 ± 4.37 t=16.645; p<.000
ADHD-SR subscore attention 
deficit
19.85 ± 4.1 9.08 ± 3.59 t=18.252; p<.000
ADHD-SR subscore 
hyperactivity/ impulsivity
18.31 ± 5.07 7.46 ± 2.73 t=11.223; p<.000
WRI- score 42.23 ± 6.11 19.92 ± 6.28 t=13.883; p<.000
RMT 54.00 ± 7.20 56.00 ± 6.84 n.s.
AMT 44.46 ± 6.75 45.69 ± 6.87 n.s.
SICI 3ms 0.83 ± 0.76 0.29 ± 0.19 t= 2.679; p=0.020
ICF 11 ms 1.51 ± 0.92 1.79 ± 0.95 n.s.
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muscle (FDI) with a standard electromyographic amplifier (Medtronic Keypoint 4; 
recording software Medtronic Keypoint V 5.01). The bandwidth of the filters was set to 1 
Hz and 10 kHz, respectively. The optimal position of the coil was determined by moving 
the coil by 0.5 cm steps until an optimal magnetically evoked potential (MEP) could be 
registered. When the induced current flowing parallel to the brain surface was sufficient, 
depolarization of neuronal membranes occurred, and hence an action potential was 
generated and recorded at the FDI muscle of the right hand. Care was taken to relax the 
subjects and to avoid any movements of the extremities during recordings. Each MEP 
was checked optically to ensure that the FDI was completely relaxed. Recordings were 
discarded if any evidence of electromyographic background activity was detected and 
repeated.
Resting (RMT) and active motor thresholds (AMT) were determined according to the 
protocol of Kujirai et al. [5]. Briefly, RMT was the minimal stimulus intensity which was 
required to produce motor potentials of more than 50 µV peak to peak amplitude in 
50% of the test pulses. AMT was determined in analogy to RMT, while the subject 
tonically distended a dynamometer with 20% of maximum power. 
Two magnetic stimuli were delivered in close time sequence to the same cortical spot 
through a single stimulation coil [5] to perform the paired pulse protocols. The first, 
conditioning pulse (CP), was a subthreshold pulse that was considered to condition the 
response for the second, the test stimulus (TS), which was a suprathreshold stimulus. 
The TS followed within a time period of milliseconds. Different brain circuits are recruited 
by varying intensities of CP and TS. 
Eight MEP’s were averaged at each stimulus level. Paired pulse stimulation was 
performed according to the technique of Kujirai et al. [5]. The subthreshold conditioning 
pulse (CP) was set at 80% of RMT. The TS was adjusted to produce a mean MEP of 
0.5–1.2mV peak to peak amplitude, when unconditioned (uMEP). The interstimulus 
intervals were set at 3ms and later at 11ms. At each interstimulus interval 8 trials were 
averaged. The time between two trial pulses was at least 5 sec to avoid secondary 
effects, such as potentiation. Peak-to-peak amplitudes of these conditioned MEP’s 
(cMEP) were set into relation to the uMEP. TMS data are presented as relative amplitudes 
(=cMEP/uMEP). At ISI 3ms, arelative MEP ratio of smaller than 1 is to be considered as 
short intracortical inhibition (SICI). At ISI 11ms, a ratio of more than 1 is to be considered 
as intracortical facilitation (ICF). In our study, relative MEP’s at an ISI of 3ms were accepted 
to indicate inhibition, and relative MEP’s at an ISI of 11ms to indicate facilitation [5,36].
Statistical analysis
To compare the differences of the dependent neurophysiological variables between 
the pre- and under medication with LA-Mph measurements, the Student’s t-test was 
performed. For the correlations between neurophysiological and clinical parameters, 
the Pearsons PM correlation coefficient (r) is used. An analysis of covariance (ANCOVA) 
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was applied to study the influence of the covariates ADHD-SR total and subscores 
(attention deficit, hyperactivity/ impulsivity), WRI total and subscores (inattention, 
hyperactivity, temper, affective lability, emotional hyperreagibility, disorganization and 
impulsivity), intelligence, age, medication doses as well as body weight adapted 
medication doses, on the relative MEP amplitudes before and after treatment. The level 
of significance was set at p = .05. All analyses were performed witch SPSS 15.0
Results
In this study, thirteen adult ADHD patients with an age range of 18-49 years who met 
DSM IV criteria for adult ADHD combined type were treated with LA-Mph. Paired pulse 
transcranial magnetic stimulation was performed before and after 2 weeks of stable 
individualized oral dose. 
In the drug naïve condition, the left hemisphere resting motor threshold (RMT) in ADHD 
patients was 54.0±7.2% and 56.0±6.8% during treatment with LA-Mph. There was no 
significant difference between the RMT with or without LA-Mph, or between the AMT 
with or without LA-Mph (44.5±6.7% vs. 45.7±6.9% with MPH). There was also no 
significant correlation with motor thresholds and ADHD symptom rating scores.
There was a significant difference in relative MEP amplitudes (cMEP/uMEP) between 
drug naïve conditions and medication with LA-Mph (Table 1 and Figure 1). The relative 
MEP amplitude at ISI of 3ms corresponds to SICI, whereas the ISI of 11ms corresponds to 
ICF (see also [21]). At ISI 3ms, the mean relative MEP was 0.83±0.76, and with LA-Mph it 
was lowered to 0.29±0.19. This relative amplitude reduction was significant (t=2.679; 
p=0.02). At ISI 11ms, drug naïve mean relative MEP amplitude was 1.51±0.92. With 
LA-Mph, it was 1.79±0.95. This increase in relative amplitude was not significant. The SICI 
and ICF amplitudes did not correlate with LA-MPH dosage. 
The drug naïve relative MEP amplitudes at ISI 3ms correlated significantly with the 
ADHD-SR total score (r=0.590; p=0.034/ see Figure 2) and the ADHD-SR hyperactivity/ 
impulsivity subscore (r=0.604; p=0.029). The relative MEP amplitude at ISI 3ms under 
LA-Mph medication, correlated only weakly with the difference on the ADHD-SR score 
between drug naïve and medication condition (r=0.56; p=0.046). Correlations with 
ADHD-SR inattention subscores or WRI scores with relative MEP amplitudes at ISI 3 or 11 
ms, as well as with the amplitude differences with and without LA-Mph, revealed no 
statistical significance.
Further analysis of covariance revealed that the neurophysiological data were not 
significantly influenced by medication doses, ADHD-SR and WRI subscores, age, and 
intelligence.
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Discussion
In this study, it was assessed whether LA-Mph has an influence on motor excitability in 
adult patients with ADHD. For that purpose, the ppTMS technique was used, which 
previously had already revealed a lowered SICI in adults with ADHD [21,22]. The ppTMS 
technique has been shown to provide a reliable test-retest stability of SICI and ICF in 
adults with ADHD [5,23]. 
RMT and AMT are supposed to be markers of membrane stability of cortical neurons 
[24]. In the present study, LA-Mph had no influence on RMT and AMT. These results are 
in line with those from other recent studies [7,9,10,11,25] and support the hypothesis 
that Mph does not affect membrane characteristics.
Inhibition is a cortical phenomenon which is considered to reflect the inhibitory activity 
of interneurons in the motor cortex or of connections between cortical output cells [26]. 
In contrast, facilitation occurs at the level of the corticospinal neurons, and upstream [27, 
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Figure 1   Effects of long acting methylphenidate (LA-Mph) on relative short 
intracortical inhibition (ISI 3ms) and intracortical facilitation amplitude 
(ISI 11ms) in a paired pulse TMS protocol (N= 13, MPH: 30–54mg). 
Ordinate: relative MEP amplitude (cMEP/uMEP). Squares represent mean values, bars representing SD 
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24]. SICI and ICF are supposed to reflect cortical excitability independently and to be 
modulated through complex neural transsynaptic systems (mainly GABA, dopamine, 
glutamate, serotonine). Several drugs influence the ppTMS motor inhibition as well as 
the facilitation [6]. Pharmacologic interactions with SICI and ICF are suggested to 
depend from the clinical state, since it is known that paroxetine may enhance ICF in 
healthy probands, but decreases this parameter in patients with schizophrenia [28]. In 
healthy volunteers, it has been shown that, dependent on the 5-HT transporter 
genotype, serotonergic reuptake inhibitors may, however, have differential effects on 
SICI [29]. Thus, drug effects of Mph on motor excitability may vary dependent on the 
genetic phenotype.
Mph increases the synaptic levels of dopamine via blockade of the dopamine transporter 
(DAT). In addition, Mph binds to and inhibits the neuronal norepinephrine transporter 
(NET) [30]. More neuronal transporters and receptors are affected, since Mph binds also 
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Figure 2   Scatterplot of relative SICI MEP amplitudes (ISI 3ms) in drug naïve 
condition (open squares) and under medication with LA-Mph  
(black squares). 
Abscissa: ADHD-SR scores. Linear regression fits are displayed: r= 0.589, p= 0.034 (drug naïve condition) 
and r= -0.096,  n.s. (under medication with LA-Mph) 
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to muscarinic and serotonergic receptors and to serotonin transporters in the brain [31]. 
Dopaminergic and noradrenergic agonists have been shown to increase SICI, while 
dopamine antagonists have a decreasing effect [6]. It is also suggested that the degree 
of SICI is increased by GABAergic action via cortical GABAergic interneurons, whereas 
ICF is decreased [32-35], [6],[36]. 
Whilst the clinical and pharmacological treatment effects of Mph are well described, the 
underlying basic pharmacological mechanisms in the motor cortex remain unclear as 
yet [37,38]. It is actually hypothesized that in ADHD a general deficit in the behavioural 
inhibition is present [39] and also in the inhibition of motor systems [40]. No direct 
evidence, however, is available which motor inhibition deficit is specifically involved in 
ADHD. This may be explained by the complex interactions between the motor cortex 
and the frontocortical regulatory systems (prefrontal cortex, caudate nucleus, and 
globus pallidus) and the parietal cortex which are all disturbed in ADHD [3,41]. Since 
Mph exerts effects on the total spectrum of ADHD symptoms, studying the effects of 
Mph in ADHD cannot be interpreted as an influence on motor systems only [38]. 
Although the data that support direct interactions of Mph on motor cortex are scarce, 
Lou and colleagues [42] demonstrated with PET-scan technique that Mph administration 
reduces blood flow in the primary motor and sensory cortex. These findings were 
interpreted as improvement of inhibition and consequently of motor overactivity also.
Previous studies have shown higher basic SICI MEP amplitudes in ADHD patients, not 
only in childhood [11], but also in adults [8, 21]. The latter phenomenon appeared to 
correlate also with the clinical ADHD scores and ADHD hyperactivity/impulsivity 
subscores [8,21]. The here presented results show that LA-Mph in daily dosages between 
30 and 54mg significantly reduces elevated SICI MEP amplitudes, but do not influence 
ICF MEP amplitudes. A significant correlation was found only between the difference in 
the two scores on the ADHD self rating instruments (baseline and 8 weeks treatment 
with Mph) and the second measurement of SICI MEP amplitude. This might be attributed 
to other factors than the ADHD phenotype influencing motor cortex exitability. 
Significant lowering of elevated SICI MEP amplitudes under Mph medication was 
reported by Moll and coworkers [11], as well as by Buchmann and coworkers in children 
with ADHD [7]. The latter also reported a correlation of reduced SICI MEP amplitudes 
with clinical ADHD symptomatology under treatment with Mph which is comparable to 
the here described results in adults with ADHD. The decline of hyperactivity/impulsivity 
symptoms in ADHD during lifetime [9,43] may explain why the power of the associations 
of the neurophysiological data with hyperactivity/impulsivity scores becomes less 
pronounced as observed in the present study. 
Our findings that SICI MEP amplitudes decrease during treatment with LA-Mph are 
partially in line with the observations in healthy adults by Ilic [10] and coworkers and 
also by Kirschner and coworkers [25] The latter investigators described, in addition to a 
lowering of SICI MEP amplitudes with Mph, an increase in ICF MEP amplitudes. This 
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could lead to the hypothesis that Mph exerts effects on the cortical motor system but 
not specifically in ADHD. 
It is questionable whether short time treatment with 30mg Mph is sufficient to 
investigate putative effects of Mph on ADHD neurophysiology [8]. Therefore, the 
recruited patients were kept in a stable clinical condition for at least 2 weeks prior to the 
experimental phase. Furthermore, LA-Mph was used in order to achieve the most 
consistent biological availability and TMS was performed after the most optimal clinical 
response was achieved.
The lack of correlation effects of LA-Mph and SICI with the inattention scale of ADHD-SR 
underlines our previously formulated hypothesis that the ppTMS technique reflects 
motor cortex excitability (hyperactivity/impulsivity) and not the attention dysfunction 
[21]. Furthermore, it should be mentioned that the WRI measures primarily disorganiza-
tion, attention deficit and temper regulation problems, as well as affective aspects of 
impulsivity, but not motor phenomena. Therefore, effects on motor symptoms cannot 
be evaluated with this instrument. 
A limitation of this study is the open label design without including relevant control 
groups (healthy subjects treated with immediate release and/or long acting Mph, 
unmedicated ADHD patients). Moreover, the statistical power of the data with this small 
group of ADHD patients is low. Furthermore, plasma concentrations of LA-Mph, that 
could have elucidated abnormal metabolism of the compound, were not measured 
[14]. The latter might explain why clinical symptoms as assessed with the ADHD scoring 
instruments, had no significant influence on the variability of the neurophysiological 
data. Finally, genetic factors like subtypes of DAT or noradrenaline transporter may also 
account for different motor behaviours elicitated by Mph [29] cited in the literature.
In conclusion, the results from this study demonstrate that LA-Mph decreases SICI MEP 
amplitudes in adults with ADHD, which correlated with the clinical improvement of 
ADHD symptoms. These results are in line with those from treatment studies with Mph 
in ADHD children. It can therefore be hypothesized that the pathophysiological 
mechanism, as reflected by paired pulse TMS in children with ADHD, is also present in 
adulthood. This may explain the identical response to pharmacological treatment in 
adults. Since the reports on treatment effects of Mph in adults with ADHD are so far 
equivocal, further studies are warranted especially with respect to pharmacokinetics 
and release of Mph.
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Abstract
Disturbances in corticocortical and corticosubcortical circuits in schizophrenia have 
been described by previous neuroimaging and electrophysiological studies. Transcranial 
magnetic stimulation (TMS) provides a neurophysiological technique for the measurement 
of cortical excitability, especially of the motoneural system. Previous studies using 
paired-pulse TMS to investigate short-interval cortical inhibition (SICI) and intracortical 
facilitation (ICF), mainly involving chronic patients, have been inconsistent and only one 
study in first-episode patients has been conducted so far. 
We assessed SICI (interstimulus interval, ISI, 3 milliseconds, ms) and ICF (ISI 7 ms) in 29 
first-episode schizophrenia patients (FE-SZ) with limited exposure to antipsychotic 
treatment compared to 28 healthy controls (HC). The amplitudes of the motor evoked 
potentials (MEPs) were measured in the left and right first dorsal interosseus muscle 
(FDI). The conditioning stimulus was set at 80 % intensity of resting motor threshold 
(RMT) and test stimulus (TS) was set at an intensity that produced a MEP amplitude of 
about 1 millivolt.
Patients with first-episode schizophrenia demonstrated significant higher MEP amplitudes 
on left motor cortex (right FDI) and higher amplitudes at a trend level on right motor 
cortex (left FDI) for SICI compared to healthy control subjects (FE-SZ 41 % vs. HC 21 % of 
TS, p = 0.017 for left motor cortex, and FE-SZ 59 % vs. HC 31 % of TS, p = 0.059 for right 
motor cortex; Mann-Whitney-U-Test). No significant difference in MEPs could be detected 
for ICF on both hemispheres. In addition no difference was seen in left and right RMT 
comparing patients and control subjects. 
Our result of a reduced SICI in a large sample of well characterized first-episode 
schizophrenia patients suggests that a GABAergic deficit may be involved in schizophrenic 
pathophysiology, already early in the disease course, supporting the intracortical dys-
connectivity hypothesis.
CHAPTER 6
113
1. Introduction
Transcranial magnetic stimulation (TMS) of the motor cortex has been investigated as a 
noninvasive approach for in vivo evaluation of inhibitory and excitatory cortical circuits 
(Maeda and Pascual-Leone 2003). In the primary motor cortex, TMS is thought to 
predominantly activate the pyramidal cells transsynaptically through excitatory inter -
neuronal elements (Day et al. 1989).
With paired-pulse techniques, interactions between the first and the second pulse 
occur. Typically, a subthreshold first (conditioning) stimulus induces a shortterm 
modulation of the motor evoked potential (MEP) from a suprathreshold second (test) 
stimulus (Kujirai et al. 1993). Short interstimulus intervals (ISIs) of 2–5 ms inhibit, and 
longer ISIs of 7–20 ms facilitate the MEP amplitude. This TMS-induced modulation must 
at least in part be generated cortically, presumably by intracortical interneurons 
modulating the activity of corticospinal neurons (Kujirai et al. 1993; Ziemann et al. 2000). 
It is believed that in short-interval intracortical inhibition (SICI), using ISIs of 2-5 ms, the 
sub-threshold first pulse produces an inhibitory post-synaptic potential (IPSP) at the 
corticospinal neurones through activation of a low-threshold cortical inhibitory circuit, 
which inhibits action potential generation by excitatory post-synaptic potentials (EPSPs) 
elicited by the supra-threshold second pulse (Kujirai et al. 1993, Ziemann 2004). The SICI 
is discussed to be mediated through GABAergic interneurons via GABA
A
-receptors, 
which modulate ligand-gated ion channels causing most of the fast synaptic inhibition 
in the mammalian brain (Nakamura et al. 1997). Consistent with this hypothesis GABA
A
 
agonists enhance SICI (Ziemann 2004). Intracortical facilitation (ICF), using ISIs longer 
than 7 ms, seems to be influenced by excitatory neuronal circuits in motor cortex, which 
are at least in part dissociable from the SICI network (Ziemann 2004). ICF may represent 
a net facilitation consisting of prevailing facilitation and weaker inhibition. The latency 
to onset of EPSP mediated by NMDA receptors is in the order of 10 ms, which would be 
consistent with the time course of ICF, and points towards the importance of 
glutamatergic transmission for ICF. According to this assumption, NMDA receptor 
antagonists, and in addition GABA
A
 agonists, mostly decrease ICF (Ziemann 2004). 
Post-mortem investigation demonstrated reduced numbers of cortical gabaergic 
interneurons in the brain of patients who suffered from schizophrenia (Benes 1998), 
suggesting abnormalities in interneuro-pyramidal modulation. Reduced glutamic acid 
decarboxylase (GAD67) mRNA expression in the dorsolateral prefrontal cortex, an 
enzyme that synthesizes GABA, is one of the most consistent findings in schizophrenia 
in post mortem studies (Knable et al. 2002). Furthermore, a dysfunction of subpopulations 
of gabaergic interneurons in dorsolateral prefrontal cortex with the consequence of 
alteration in perisomatic inhibition of pyramidal neurons is made responsible for deficits 
in working memory, a core syndrome in schizophrenia (Lewis et al. 2005). 
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Motor deficit is a known feature in patients with schizophrenia with or without 
medication (Chen et al. 2000, Smith et al. 1999), and cortical inhibition deficit has been 
suggested as one component of the possible pathophysiological mechanisms in 
schizophrenia (Freedman et al. 1983). In consequence, these considerations build the 
background for investigating cortical inhibition in schizophrenia by transcranial magnetic 
stimulation. 
Previous studies using the paired-pulse paradigm in schizophrenic patients revealed 
controversial results. While in one study reduced SICI in a small sample of unmedicated 
schizophrenic patients, but not in patients treated with antipsychotics compared to 
healthy controls could be observed (Daskalakis et al. 2002), in another study reduced 
SICI and increased ICF in medicated, but not in drug-naïve schizophrenic patients was 
found (Pascual-Leone et al. 2002). One research group observed reduced SICI in 
medicated schizophrenic patients compared to controls (Fitzgerald et al. 2002a) and no 
difference in facilitation, but could not replicate this finding in a larger sample of patients 
(Fitzgerald et al. 2002b). An investigation of neuroleptic-naive first-episode patients, 
mainly consisting of patients with disorganised schizophrenia, showed no difference in 
SICI or ICF compared to healthy gender and age matched control subjects (Eichhammer 
et al. 2004). However this sample seems not to be representative of first-episode 
patients, as they mostly belong to the paranoid subtype of schizophrenia. 
In addition, there is some evidence that in schizophrenia patients the development of 
cerebral lateralization is disturbed (e.g. Crow et al. 1989). Healthy subjects may have a 
lower resting motor threshold (RMT) on the dominant (left) hemisphere in correlation to 
handedness and increased use of the dominant (right) hand (Triggs et al. 1994). 
Schizophrenia patients failed to show this normal laterality in physiologic differences in 
cortical motor representation compared to healthy controls in a previous study 
(Pascual-Leone et al. 2002).  
In the present study first-episode patients (FE-SZ), representative for this patient group 
and recruited from a hospital setting with minimal exposure to antipsychotics, were 
measured by paired-pulse TMS to examine their cortical excitability in comparison to 
healthy control subjects (HC). Additionally, motor threshold in both hemispheres were 
compared within the subgroups. 
2. Methods
2.1. Subjects
The study sample consists of 57 persons recruited at the University Hospital of the 
Saarland between 2003 and 2006, 29 patients with first-episode schizophrenia, all 
paranoid subtype, and 28 healthy control subjects. Subjects suffering from dementia, 
neurological illnesses, severe brain injuries or brain tumors as lifetime diagnoses were 
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excluded from the study. The following standardized examinations were performed on 
each subject: biographic interview (Bassett et al. 1993) and test of hand preference 
(Annett 1970). Patients underwent standardized assessment of psychopathology by 
PANSS-rating (Kay et al. 1987), of disease severity by clinical global impressions (CGI) 
(Guy and Bonato 1976) and of social functioning (GAF) (Endicott et al. 1976). The 
diagnosis based on a consensus of two independent psychiatrists performing SCID I 
and II interviews (Wittchen et al. 1997. Fydrich et al. 1997). Additionally the duration of 
illness (DUI), counted from the beginning of initial prodromal symptoms, the duration of 
psychosis (DUP), starting with the first positive symptoms belonging to the criteria of 
schizophrenia, and familial risk factors (psychosis in first degree relatives) were assessed. 
After a complete description of the study, written informed consent was obtained from 
each subject. The local ethic committee approved the protocol, which is in accordance 
with the Declaration of Helsinki. 
None of the participants had a contraindication for TMS.
All 29 schizophrenic patients were treated with second generation antipsychotics 
(aripiprazole 2, olanzapine 18, quetiapine 2, risperidone 7, and two patients additionally 
treated with haloperidol) not longer than 6 weeks continuously. To compare the 
cumulative and daily doses of the different antipsychotics and to explore the influence 
of this medication on TMS parameters, chlorpromazine equivalents were calculated 
using suggestions of reviews and studies especially with regard to second generation 
antipsychotics (e.g. Woods 2003). Duration, cumulative dose and daily dose of the 
antipsychotic medication (expressed in chlorpromazine (CPZ) equivalents) are described 
in table 1. Concomitant treatment with benzodiazepines, mood stabilizers, beta-blocking 
agents and anticholinergics were not allowed during the last week before performing 
the TMS measurement.
2.2 TMS procedure
Subjects were seated in a comfortable chair with their arms supported passively. Elec-
tromyographic (EMG) recordings were made with surface electrodes from the right and 
left first dorsal interosseus muscle (FDI) using a commercial amplifier with a bandpass 
filter of 2 Hz to 10 kHz (Keypoint portable, Medtronic Co., Denmark), and each signal 
curve was analysed off-line and manually.  Focal transcranial magnetic stimulation 
(TMS) was applied to the hand area of the left and right motor cortex using a figure-of-
eight magnetic coil and a MagPro X 100 magnetic stimulator (Medtronic Co., Denmark). 
For each subject, the optimal coil position, defined as the stimulation site that produced 
the largest MEP at moderately suprathreshold stimulation intensities (i.e., intensities that 
induced MEPs of about 0.5–2.0 mV) in the resting right and left FDI muscle was 
determined by moving the coil in 0.5-cm steps over the presumed area of the left and 
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right motor cortex. The site was marked to ensure that the coil was held in the same 
position throughout the experiment. The coil was held tangentially on the head with 
the handle pointing backward and 45 degree laterally from midline that the induced 
current points forward and perpendicular to the central sulcus and is optimal for 
producing transsynaptic activation of corticospinal neurons. The resting motor 
threshold (RMT), expressed as a percentage of maximum stimulator output, was defined 
as the lowest intensity that produced a MEP of >50 µV in five out of ten trials in relaxed 
FDI (Ziemann et al. 1996a). 
Short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF) were 
obtained in accordance to previously published protocols (e.g., Maeda and Pascual-Leone 
2003, Eichhammer et al. 2004). The intensity of the first (conditioning) stimulus was 
always set at 80 % of the RMT. The second (test) stimulus was delivered at an intensity 
that produced MEPs averaging 0.5 - 1.5 mV in the resting FDI. Since it is known from 
previous studies that short ISIs (2 – 5 ms) lead to an inhibition and longer ISIs (7 – 20 ms) 
lead to a facilitation of the test stimulus (Kujirai et al. 1993), we used an ISI of 3 ms as 
inhibitory (SICI) and an ISI of 7 ms as facilitatory (ICF) paired-pulse TMS paradigm. We 
performed a minimum of 10 trials with each ISI and 10 trials with the test stimulus alone. 
The effect of the conditioning stimuli on MEP amplitude of the test stimulus was 
determined as the ratio of the average amplitude of the conditioned ppTMS MEP (cMEP) 
to the average amplitude of the unconditioned test MEP (uMEP) (Eichhammer et al. 
2004). 
The measurements were performed by an experienced investigator (T.W.), controlled by 
another experienced investigator (M.S.), and corrected for outliers and extreme values. 
The stimuli were ordered differently and randomly for each subject, and they were 
counterbalanced across groups.
2.3. Statistics
For statistical analyses SPSS for Windows 14 was used. All tests were two-tailed. Level of 
significance was set at  a = 0.05. Dependent variables were RMT, SICI (ISI 3 ms) and ICF 
(ISI 7ms) on both hemispheres. Independent variable was diagnosis (healthy controls, 
FE-SZ). Kolmogorov-Smirnov tests were applied to test the assumption of normal 
distribution for all dependent variables. As for SICI and ICF the normality assumption 
was violated, non-parametric tests were performed for these variables. 
Oneway analysis of variance (ANOVA) was used to analyze if there were significant age 
differences between the two diagnostic groups. Chi²-test on independence was 
performed to analyze if distribution of gender and hand difference was different 
between the groups.
For the control sample, correlations between age and dependent variables were 
computed (RMT: Pearson product moment correlations, SICI and ICF: Spearman rank 
correlations) and mean differences for the factor gender were analyzed (RMT: oneway 
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ANOVA, SICI and ICF: Mann-Whitney U-test). Since all controls were right-handers, mean 
differences for factor hand preference was analyzed in the FE-SZ sample (RMT: oneway 
ANOVA, SICI and ICF: Mann-Whitney U-test).
These preliminary calculations regulated the main analyses. For RMT analysis of 
covariance (ANCOVA, factor diagnosis, covariate age) was computed, since age 
correlated significantly with RMT. Furthermore, MANOVA with repeated measure design 
(within-subject factor side, between subject factor diagnosis) was performed to test the 
hypothesis, that in right-handed subjects RMT is lower on the left compared to the right 
motor cortex. For SICI and ICF variables Mann-Whitney U-test was used to analyze 
diagnosis differences. For the FE-SZ patients Spearman rank correlations between 
dependent variables and total PANSS scores, GAF, CGI, DUP and DUI were performed.
3. Results
3.1. Sociodemographic and clinical characteristics
The first-episode patients did not differ significantly in age compared to the healthy 
control subjects (mean age 29.8 ± 8.5 years versus 32.2 ± 7.9 years, p = 0.28). The 
percentage of male patients was higher at a trend level in the schizophrenic patient 
group (p = 0.082). While all healthy control subjects were right-handers, in the FE-SZ 
group 4 patients were ambidexters (p=0.042). No subject fulfilled the criteria for 
borderline or antisocial personality disorder (due to SCID II interview, DSM-IV axis II, 
personality disorders), which may include abnormal high impulsivity potentially linked 
to reduced inhibition processes. In addition no healthy control subject fulfilled the 
criteria of any axis II disorder.
The first-episode patients suffered from moderate to severe positive and negative 
symptoms according to the PANSS, accompanied by a severe degree of illness (CGI), and 
were severely impaired in their social functions (GAF) (for details see table 1).
More severely ill patients received higher dosages (expressed in CPZ-equivalents), as the 
cumulative doses correlated positively with total PANSS score (rho = -0.65, p = 0.062) at 
a trend level an even significantly with CGI (rho = 0.65, p < 0.0005). 
3.2. Influence of sociodemographic characteristics on TMS parameters
A positive correlation was found between age and RMT on both hemispheres in the 
healthy control group (r = 0.36, p = 0.04, left motor cortex; r = 0.41, p = 0.04 , right motor 
cortex). In the healthy control group a significant influence of gender on cortical 
facilitation (ISI 7 ms, right side) was observed (male controls displayed enhanced 
facilitation; p = 0.004). In FE-SZ, for all dependent variables no significant differences 
between right-handers and ambidexters were observed. 
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3.3. Resting motor threshold (RMT)
RMT was similar in first-episode patients and healthy controls on both sides (46.9 % in 
FE-SZ vs. 47.8 % in HC, p = 0.88 for left motor cortex and 48.3 % in FE-SZ vs. 49.6 % in HC; 
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Table 1   Sociodemographic and clinical parameters
HC
(N = 28)
FE-SZ
(N = 29)
m sd m sd df F p
Age (years)a 32.18 7.86 29.79 8.47 1, 55 1.21 0.28
DUP (weeks) - - 50.41 64.0 - - -
DUI (weeks) - - 183.17 157.1 - - -
PANSS total score - - 91.48 17.2 - - -
PANSS positive score - - 22.14 6.1 - - -
PANSS negative score - - 21.45 6.6 - - -
PANSS gen. psychop. score - - 47.90 9.4 - - -
CGI - - 5.96 0.6 - - -
GAF - - 28.6 10.5 - - -
Daily dose of antipsychotics  
(CPZ-equivalents)
356.2 203.7
Duration of antipsychotic 
medication (days)
21.0 14.4
Cumulative dose of antipsychotics 
(CPZ-equivalents)
7565.2 7886.8
df Chi² p
Gender (male/female)b 14 / 14 21 / 8 1 3.02 0.082
Handedness (right/left/both) b 28 / 0 / 0 25 / 0 / 4 1 4.15 0.042
Psychosis in first degree relatives, 
no. of subjects (%)
0 (0) 12 (41.3) - - -
Legend:
HC = healthy controls; FE-SZ = patients with first-episode schizophrenic; m = mean; sd = standard 
deviation; DUP = duration of psychosis; DUI = duration of illness (including initial prodrome); PANSS = 
Positive and Negative Syndrome Scale; gen, psychop. = general psychopathology; CGI = Clinical Global 
Impressions; GAF = Global Assessment of Functioning; no. = number; df = degrees of freedom; F = 
F-statistics; p = probability; CPZ = chlorpromazine.
a Analysis of variance (ANOVA); b Chi-Quadrat test
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p = 0.73 for right motor cortex) (for details see table 2). When only the right-handed 
subjects were included in the analysis, RMT was significantly lower on the left compared 
to the right motor cortex in both subgroups (p = 0.039). 
3.4.  Short-interval intracortical inhibition (SICI) and intracortical 
facilitation (ICF)
In first-episode patients (FE-SZ) significantly higher MEP ratios (cMEP/uMEP) were 
measured at the inhibitory ISI of 3 ms compared to healthy controls (HC) on left motor 
cortex (MEP ratio 41 % in FE-SZ vs. 21 % in HC; p = 0.017) (figure 1), reflecting lower SICI 
in the patient group. When only the right-handed FE-SZ (MEP ratio 40 %) were analyzed, 
the difference compared to the control group remained significant (p = 0.033). On the 
right motor cortex this reduced SICI in FE-SZ (ISI 3 ms) was seen at a trend level (MEP 
ratio 59 % in FE-SZ vs. 31 % in HC; p = 0.059).
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Figure 1   Error bars for paired-pulse inhibition in diagnostic groups 
First-episode patients showed significantly lower decreased MEP amplitudes (higher ratio: conditioned 
MEP/unconditioned MEP; mean, 95 % CI) at the inhibitory ISI of 3 ms compared to healthy controls on left 
motor cortex (Z = -2.39; p = 0.017; Mann-Whitney-U-test).
Abbreviations: CI = confidence interval; MEP = motor evoked potential; ISI = interstimulus interval; FE-SZ = 
patients with first-episode schizophrenia
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For the MEP ratio of the facilitatory ISI of 7 ms (ICF) no significant differences between 
the two groups on both hemispheres could be observed (for details see table 2).
3.5. Correlation with clinical parameters
There was a positive correlation between PANSS total score and RMT of left motor 
cortex (rho = 0.395, p = 0.034; Spearman rank correlations) and a negative correlation 
between PANSS total score and cortical inhibition (MEP ratio at 3 ms) of left motor 
cortex in first-episode schizophrenia (rho = -0.403; p = 0.030; Spearman rank correlations). 
These correlations could not be found with the PANSS positive or negative subscore, 
but between RMT of left motor cortex and PANSS general psychopathology (rho = 
0.385, p = 0.039; Spearman rank correlations). The detected correlations remained not 
significant after Bonferonni correction and have to be interpreted with caution. No 
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Table 2   TMS parameters
HC
(N = 28)
FE-SZ
(N = 29)
m sd m sd df F p
 
RMT left motor cortex (%)a
47.82 6.5 46.93 6.9 1, 54 
0.0 0.88
 
RMT right motor cortex (%)a
49.58 10,0 48.25 8.0
1, 51 0.1 0.73
df Z p
ppTMS ISI 3 ms left motor cortex 
(ratio cMEP/uMEP)b
0.20 0.1 0.41 0.3 1 -2.39 0.017
ppTMS ISI 7 ms left motor cortex  
(ratio cMEP/uMEP) b
0.96 0.5 1.12 1.0 1 -0.22 0.83
ppTMS ISI 3 ms right motor cortex 
(ratio cMEP/uMEP) b
0.31 0.2 0.59 0.9 1 -1.89 0.059
ppTMS ISI 7 ms right motor cortex 
(ratio cMEP/uMEP) b
1.14 0.7 1.48 1.4 1 -0.41 0.68
Legend:
HC = healthy controls; FE-SZ = patients with first-episode schizophrenic; m = mean; sd = standard deviation; 
ppTMS = paired-pulse transcranial magnetic stimulation; ISI = interstimulus interval; mV = millivolt; N = number; 
df = degrees of freedom; F = F-statistics; Z = Z-value; p = probability; cMEP = conditioned motor evoked 
potential; uMEP = unconditioned motor evoked potential; RMT = resting motor threshold
a Analysis of covariance (ANCOVA, factor diagnosis, covariate age ). percentage of maximum stimulator 
output
b Mann-Whitney-U-Test
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other significant correlations between clinical parameters (GAF, CGI, DUP, DUI) and TMS 
parameters could be demonstrated. 
3.6. Influence of antipsychotic medication on TMS parameters
Because the duration, cumulative dose and daily dose of the antipsychotic medication 
(expressed in chlorpromazine (CPZ) equivalents) were not normally distributed, we 
performed non-parametric correlations to assess the influence of these variables on 
TMS parameters. No significant correlations could be observed. At a trend level there 
was a positive correlation between the cumulative dosage (CPZ-equivalents) and RMT 
of left motor cortex (rho = 0.34, p = 0.068), and a negative correlation between the 
cumulative dosage (CPZ-equivalents) and the MEP ratio at ISI 7 ms (ICF) of left motor 
cortex (rho = -0.32, p = 0.085). There were no significant correlations of dosage (CPZ-
equivalents) with RMT of right motor cortex (rho = 0.17, p > 0.2), MEP ratio at ISI 7 ms of 
right motor cortex (rho = 0.20, p > 0.2) or MEP ratios at ISI 3 ms of left (rho = -0.21, p > 
0.2) and right motor cortex (rho = 0.01, p > 0.2). 
4. Discussion
The main result of the present study is that first-episode patients demonstrated increased 
MEP amplitudes evoked by paired-pulse TMS at the inhibitory interstimulus interval (ISI) 
of 3 ms compared to healthy control subjects. No significant differences at the facilitatory 
ISI of 7 ms could be detected between the diagnostic groups. These findings reflect 
reduced short interval cortical inhibition (SICI) and no difference of intracortical 
facilitation (ICF) in patients with first-episode schizophrenia compared to healthy controls. 
Following the literature, reduced cortical inhibition in schizophrenic patients demonstrated 
by paired-pulse TMS is not conclusive to date. Reduced SICI was seen in a small sample 
of unmedicated schizophrenic patients, but not in patients treated with antipsychotics 
(Daskalakis et al. 2002). In another study reduced SICI and increased ICF was shown in 
medicated, but not in drug-naïve schizophrenic patients (Pascual-Leone et al. 2002). 
One research group observed reduced SICI in medicated schizophrenic patients and no 
difference in ICF (Fitzgerald et al. 2002a), but could not replicate this finding in a larger 
sample of patients (Fitzgerald et al. 2002b). The only study investigating neuroleptic-
naive first-episode patients (mainly disorganized subtype) showed no difference in 
cortical inhibition or facilitation compared to healthy control subjects (Eichhammer et 
al. 2004). Differences between these study results may be partially explained by different 
patient populations, often consisting of multi-episode patients with chronic disease 
and the influence of different antipsychotic medication. Patients with first-episode 
schizophrenia were rarely investigated. However, although the literature is still inconsistent, 
our finding of reduced cortical inhibition in a large sample of medicated first-episode 
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patients with limited exposure to antipsychotic medication strongly supports the 
hypothesis that inhibitory intracortical deficits may be part of the schizophrenic patho-
physiology. Several other neurophysiological studies using other tools than TMS, have 
provided evidence for inhibitory deficits in schizophrenia. For instance schizophrenic 
patients showed reduced P50 wave suppression in an auditory conditioning test 
paradigm (Adler et al. 1982), potentially reflecting reduced inhibition in a cortico-sub-
cortical loop. We could not detect significant differences in ICF between medicated 
first-episode patients and comparable healthy control subjects. Besides reduced SICI 
schizophrenia patients could have presented increased ICF, but in our study this was not 
the case.
SICI is linked to the GABAergic system and the function of cortical GABAergic 
interneurons (Ziemann 2004). In healthy subjects GABA
A
 agonists and also glutamate 
antagonists enhance SICI; the latter effect may be best explained through a decrease of 
facilitatory effects (Ziemann 2004). Recent investigations were able to segregate 
different GABAergic inhibitory circuits in human motor cortex and to show that SICI is 
probably mediated via a2- or a3-subunit rather than the a1-subunit of the GABA
A 
receptor (Di Lazzaro et al. 2007). The a2-subunit is found only in about 15 % of cortical 
GABA receptors but at above 95 % of inhibitory synapses onto pyramidal neuron axon 
initial segments, especially in the superficial layers of the human cerebral cortex and 
seems to be related to higher affinity for GABA, which results in faster activation and 
slower deactivation times than the more common a1-subunit of the GABA
A 
receptor 
(Lewis et al. 2005). On the other hand there are pharmacological studies suggesting that 
GABAergic activation (e.g. through benzodiazepines) mainly influence ICF rather than 
SICI in healthy controls (Ziemann et al. 1996b). Dopamine and noradrenaline agonists 
increase SICI, while dopamine antagonists like haloperidol decrease SICI (Ziemann 
2004). Interestingly, the selective serotonine re-uptake inhibitor citalopram increased 
SICI in subjects, who were homozygotic for the long variant of the 5-HT transporter 
gene (Eichhammer et al. 2003). This finding suggests also an involvement of serotonine, 
dependent on genetic polymorphism, on cortical inhibition. On the other hand neither 
single nor chronic administration of paroxetine resulted in changes of SICI, but single 
dose of paroxetine decreased ICF, while chronic paroxetine administration enhances ICF 
in healthy volunteers (Gerdelat-Mas et al. 2005). This contrary effect on ICF emphasizes 
the different pharmacological action of a drug at cortical level depending on its acute 
or long-term administration. For ICF the majority of pharmacological studies on healthy 
subjects demonstrated a decrease of ICF by NMDA antagonists (Ziemann 2004). In 
contrast another study found an increase of ICF after ketamine application, a NMDA 
antagonist, potentially mediated by activating non-NMDA glutamatergic transmission 
via AMPA and kainate receptors (Di Lazzaro et al. 2003). In conclusion, our results of 
decreased SICI and unchanged ICF compared to healthy controls fits best to the 
hypothesis of GABAergic dysfunction in schizophrenia, although the dysbalance of 
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other neurotransmitters like glutamate, dopamine and serotonine involved in SICI 
reduction could not be ruled out. Nevertheless, the cited findings in healthy subjects 
are not necessarily comparable to the results and conditions in schizophrenia patients, 
and neuronal networks in schizophrenia including adaptive processes during disease 
course and long-term medication may be responsible for differences.
We found no significant differences in resting motor threshold (RMT) between 
schizophrenic patients and healthy controls. This is in line with the literature. Summing 
up the results of previous studies investigating RMT in schizophrenic patients, more 
than half of the studies (8 of 15) demonstrated no significant differences between 
patients and control subjects (Wobrock et al. 2007). In 3 studies a decreased RMT in 
schizophrenic patients was observed, as it has to be expected if reduced cortical 
inhibition and increased excitability of motor neurons is assumed (Abarbanel et al. 1996, 
Daskalakis et al 2002, Eichhammer 2004). In an other study a significant increased RMT in 
patients treated with antipsychotics compared to medication- free patients and normal 
controls was detected (Pascual-Leone et al. 2002), and in addition, a higher RMT on the 
left dominant hemisphere compared to the right side in medicated and unmedicated 
patients could be observed. This is remarkable concerning the observation that in some 
investigations healthy controls display a lower RMT on the left dominant side in inter-
hemispheric comparison (Triggs et al. 1994). In our study we found no difference in 
laterality between controls and first-episode patients. In two studies investigating the 
effect of low frequency rTMS on RMT, in schizophrenic patients no increase of RMT was 
seen after rTMS compared to healthy controls (Oxley et al. 2004, Fitzgerald et al. 2004). 
This was discussed as reduced cortical neuroplasticity or missing cortical inhibition in 
schizophrenia. 
In addition, we found evidence for a correlation between total symptom severity, 
expressed by PANSS total score and increased RMT, as well as decreased cortical 
inhibition. This means that reduced cortical inhibition is inversely associated with 
symptom severity, which seems rather contraintuitive. An explanation may be that 
more severely ill patients receive higher dosages of antispsychotics (CPZ-equivalents), as 
they did in our study, and therefore the cortical inhibition deficits could be 
“overcorrected”. However the above mentioned negative correlation between SICI only 
on left motor cortex and PANSS total score could not be replicated with the PANSS 
positive and negative subscore. This may indicate that there is no stable correlation 
between symptom severity and cortical inhibition deficits at all. Furthermore, our 
findings of decreased cortical inhibition in schizophrenia may reflect a more general 
vulnerability factor (e.g. as a trait marker) than a characterization of psychopathology 
(e.g. as a state marker). 
Our study has several limitations. First of all, antipsychotic medication could be a 
considerable confounding factor using TMS paradigms (Davey et al. 1997). For instance, 
one study found a difference in RMT between patient treated with risperidone (increased 
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RMT) and olanzapine (decreased RMT) (Fitzgerald et al. 2002c). We did not find a 
differential influence of the used antipsychotics in our patient sample. This contributes 
to the result of another study with healthy control subjects, where an effect on resting 
motor threshold (RMT) after olanzapine or haloperidol administration could not be 
detected (Daskalakis et al. 2003). This was explained by the fact that RMT is conventionally 
regarded as a measure of the membrane excitability of corticospinal neurons and 
interneurons in the motor cortex, increased by drugs that block voltage-gated sodium 
channels and not affected by drugs that alter GABA, glutamate or dopamine transmission 
(Di Lazarro et al. 2003, Liepert et al. 1997, Werhahn et al. 1999, Ziemann et al.1996a, 
Ziemann et al. 1996b, Ziemann et al. 1997, Ziemann et al. 1998) like olanzapine or haloperidol.
For paired-pulse measurements, medication influencing GABA, glutamate, serotonine 
or dopamine transmission should be potentially relevant, because the interneuronal-
pyramidal circuits are mediated via these pathways. However, according to the literature, 
one would expect that antipsychotics should compensate the reduced inhibition and 
not produce it, because there are no studies available showing increased cortical inhibition 
in unmedicated or medicated schizophrenia and only one study demonstrating reduced 
cortical inhibition exclusively in medicated patients (Pascual-Leone et al. 2002). Studies 
of the medication effect on cortical inhibition performed on healthy people (mostly 
given as single dose) do not necessarily reflect the effect of the same psychopharmaco-
logical drugs administered chronically to schizophrenic patients with a potentially 
different neuronal network. For future studies in schizophrenia patients it may be 
helpful to include other comparison groups e.g. patients with bipolar disorder treated 
with atypical antipsychotic drugs to control for effects of these drugs and to compare 
these effects with disease specific alterations.
The strength of our study is that we were able to investigate a well characterized 
relatively large sample of first-episode patients which seems representative for this 
patient group in a clinical setting. Due to disease severity and the clinical necessity for 
medication it was not possible to measure these patients neuroleptic-naïve.
The origin of reduced cortical inhibition measured by TMS in schizophrenia is still 
speculative. In one model reduced cortical inhibition in schizophrenia is explained by 
the assumption of a disorder of altered dopaminergic inputs from pyramidal to 
nonpyramidal neurons in the cortex (Benes 2000, Benes 1998). To support this hypothesis 
it was demonstrated that in schizophrenia dopaminergic projections to the cortex 
erroneously terminate on non-pyramidal cells (i.e. interneurons) to inhibit their function. 
Such connectivity would result in decreased activity of inhibitory interneurons and 
increased excitatory output in the cortex. Another explanation may be the finding of 
decreased numbers of (inhibitory, gabaergic) interneurons in the postmortem brains of 
schizophrenic patients, which could lead to reduced cortical inhibition (Benes 1991). 
There is an increasing literature pointing towards a GABAergic dysfunction in schizophrenia 
(Lewis et al. 2005). In individuals with schizophrenia an increased density of GABA
A
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receptors was found in ligand binding studies, probably indicating a local upregulation 
in response to a reduction in perisomatic inhibitory input from chandelier and wide 
arbor neurons (Lewis et al. 2005). In post mortem studies there is convincing evidence 
for decreased GABA synthesis in schizophrenia with the finding of reduced glutamic 
acid decarboxylase (GAD67) mRNA expression in dorsolateral prefrontal cortex (Knable 
et al. 2002). This reduced synthesis of GABA in a parvalbumin-containing subpopulation 
of inhibitory GABA neurons may be caused by deficiency in signalling through tyrosine 
kinase receptor B, the receptor for brain-derived neurotrophic factor (BDNF) (Lewis et al. 
2005). One of the consequences of reduced GABAergic transmission may be a deficit in 
synchronisation of pyramidal cells resulting in e.g. working memory deficits, a core 
syndrome of schizophrenia (Lewis et al. 2005). Our finding of reduced SICI contributes to 
the hypothesis of GABAergic dysfunction in schizophrenia. However, it has to be kept in 
mind that histopathological studies demonstrating a reduced number of GABAergic 
interneurons in the primary motor cortex of schizophrenia patients are not available.
A reduced SICI detected by TMS has been found in other neuropsychiatric disorders, i.e. 
unipolar depression (Bajbouj et al. 2006), attention-deficit/hyperactivity disorder (ADHD) 
(Richter et al. 2007) or obsessive-compulsive disorder (OCD) (Greenberg et al. 2000). 
With regard to these findings intracortical inhibition deficits seem not specifically restricted 
to schizophrenia. 
Future studies combining different modalities and investigational tools (e.g. TMS, event 
related potentials, magnetencephalography, structural and functional magnetic 
resonance imaging) may gain new insights in neuronal networks and either intracortical 
or cortico-subcortical connectivity. 
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Abstract
Background: First-episode-schizophrenia (FE-SZ) and attention deficit hyperactivity 
disorder (ADHD) are both neuropsychiatric disorders associated with an impaired 
dopaminergic transmission. Though displaying different clinical phenotypes, a common 
pathophysiological pathway is discussed controversially. Several studies using transcranial 
magnetic stimulation (TMS) revealed abnormalities in human motor cortex excitability 
in both schizophrenia and ADHD patients. Studies on cortical excitability comparing 
these two diseases directly are lacking. 
Method: In this study, a total of 94 subjects were analyzed. 25 FE-SZ patients were 
directly compared with 28 ADHD patients and 41 healthy controls (HC). We investigated 
cortical excitability (inhibitory and facilitatory networks) with single- and paired-pulse-
TMS to the left and right motor cortex. 
Results: Compared to healthy controls, FE-SZ/ADHD displayed an impaired cortical 
inhibition over the left hemisphere. Apart from an enhanced intracortical facilitation, 
FE-SZ did not differ compared to ADHD patients in the main outcome measures. Both 
patient groups presented a dysfunctional hemispheric pattern of cortical inhibition and 
facilitation in comparison with HC. 
Conclusion: The results of this study indicate a pattern of cortical disinhibition and 
abnormal hemispheric balance of intracortical excitability networks in two different 
psychiatric diseases. These effects might be associated with an imbalance in GABAergic 
and dopaminergic transmission and might provide evidence for a common patho-
physiological pathway of both diseases. 
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Introduction
Attention deficit hyperactivity disorder (ADHD) and schizophrenia are both heterogeneous 
disorders sharing a psychopathological profile of attention deficits and difficulties in 
social interaction. However, very perspicacious distinguishing features between these 
diseases are delusions, hallucinations and negative symptoms as a clinical manifestation 
in schizophrenia patients [1]. There is comorbidity between these diseases and retrospective 
studies of individuals with schizophrenia have shown a history of premorbid or concomitant 
ADHD [2].
With regard to the pathophysiology, both conditions are associated with a dysfunctional 
dopaminergic transmission of the limbic-frontal network and other midbrain structures 
[3,4]. An enhanced dopaminergic transmission in mesolimbic structures is associated 
with positive symptoms, whereas a dopaminergic underactivity in these brain structures 
has been linked to negative symptoms and cognitive dysfunction in schizophrenia 
patients. In ADHD, the pathophysiological role of the dopamine system remains elusive. 
Both, high midbrain dopamine activity or reduced dopamine activity are discussed to 
be involved in the appearance of ADHD symptoms and the discussion about hypo- or 
hyperdopaminergic transmission imbalance remains contradictory [4,5]. In some 
studies, a dopaminergic hyperfunction in the mesolimbic structures was correlated 
with hyperactivity and impulsivity and a dopaminergic hypofunction was found to 
underlie different cognitive symptoms [3,4,6-8]. Apart from dopamine, other neu-
rotransmitter systems, especially GABAergic interneurons, are involved in the patho-
physiology of these diseases [9,10]. 
Using paired-pulse transcranial magnetic stimulation (TMS) a reduced cortical inhibition 
as another common pathophysiological state was found in both diseases [11,12]. 
Paired-pulse TMS offers the possibility to investigate different mechanisms of cortical 
inhibition (short interval intracortical inhibition, SICI) and of cortical facilitation 
(intracortical facilitation, ICF) in the human brain [13]. SICI is discussed to be mediated by 
GABAergic interneurons via GABA
A
-receptors and ICF might result from primarily 
glutamatergic neurotransmission [14]. Furthermore, dopaminergic neurotransmission 
has an impact on SICI and ICF, because dopamine agonists lead to an enhancement of 
SICI and ICF and dopamine antagonists reduce SICI and ICF  in healthy subjects [14]. The 
contralateral silent period (CSP), a single-pulse TMS measure, is at least in part the result 
of GABA
B
 mediated inhibitory mechanisms [15,16].
In schizophrenia patients, several TMS studies revealed abnormalities in motor-cortical 
excitability which have been linked to GABAergic and dopaminergic dysfunction [17-20]. 
Our research group has recently demonstrated a reduced SICI and a prolonged CSP in 
first-episode schizophrenia (FE-SZ). We hypothesized that reduced SICI points towards a 
GABA
A
 deficit and the prolonged CSP may reflect compensatory increased GABA
B
 
transmission induced by hyperactivity of the dopaminergic system [11,21]. 
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Studies with child and adult ADHD patients displayed controversial results. Three 
different studies found abnormal SICI and ICF in children with ADHD, which normalized 
after administration of a psychostimulant [22-24]. Furthermore, a reduced duration of 
the CSP and the ipsilateral silent period (iSP), a measure of interhemispheric connectivity, 
is a common finding in children with ADHD [23,24]. In adults with ADHD, two studies 
revealed a reduced SICI [12,25] and in another study the reduced SICI did not reach 
statistical significance [26]. Methodological differences in measuring and analyzing 
cortical excitability in adults with ADHD might be related to the negative finding of the 
latter study. The shift of ADHD symptoms during lifetime might be accompanied by 
adaptations in motor cortex excitability in some ADHD phenotypes. Furthermore, the 
higher variability of MEPs in ADHD might be the reason for the weak statistical 
significances of differences in cortical excitability between some ADHD adults and 
healthy controls [26]. As shown for ADHD in childhood, one study found a shortened iSP 
in adult ADHD, but there were no differences in CSP [27]. 
The present study was designed to directly compare measures of cortical excitability 
between ADHD and FE-SZ. To shed more light on the impact of cortical excitability on 
the underlying pathophysiology, 25 FE-SZ with minimal exposure to antipsychotics 
were compared with 28 adult ADHD patients with no psychotic or other axis I or II history 
and 41 healthy controls (HC). Therefore, previously and independently published samples 
(see materials and methods) were merged and newly analyzed towards excitability 
differences between schizophrenia and ADHD patients. TMS over both hemispheres was 
used to test parameters of cortical excitability and functional hemispheric balance (SICI, 
ICF, CSP and motor thresholds). 
Our aim was to focus on TMS measures on transmission mechanisms related to GABA
A
, 
GABA
B
 and glutamatergic systems in order to test the hypotheses of common patho-
physiological motor networks in schizophrenia and ADHD.  From the background 
outlined above, we hypothesized that schizophrenia patients would show the most 
pronounced abnormality in excitability that is less evident in ADHD. Another aim was to 
investigate functional hemispheric asymmetry and connectivity based on measures of 
cortical excitability. We hypothesized that especially schizophrenia patients would 
show pronounced impairments in hemispheric asymmetry.
Material and Methods
Subjects
The study sample consists of 94 subjects. 28 patients with ADHD and 25 patients with 
FE-SZ (all paranoid subtype) from the same geographical area were recruited from 
inpatient and outpatient units and were compared with 41 healthy subjects. Parts of this 
sample have been previously published independently [11,21,25], but this study provides 
new data for on direct comparison of disorders, CSP in ADHD and late-ICF in first-episode 
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schizophrenia. Subjects with a history of dementia, neurological illnesses and severe 
brain injuries were excluded from the study. All subjects were right handed according 
to a standardized test of hand preference [28].
A clinical psychiatrist, blinded to the aims of the study, and a member of the study 
group (TW or MS) made a consensus diagnosis according to the German version of the 
Structural Clinical Interview for DSM IV [29]. Each subject underwent an assessment of 
disease severity (Clinical Global Impressions) [30] and an assessment of social functioning 
(Global Assessment of Functioning) [31]. 
In schizophrenia patients an assessment of psychopathology (Positive and Negative 
Syndrome Scale) [32], the duration of illness (DUI), counted from the beginning of initial 
prodromal symptoms and the duration of psychosis (DUP), counted from the onset of 
diagnostic/characteristic positive symptoms were evaluated according to the foregoing 
publication [11]. All schizophrenia patients were treated with second generation 
antipsychotics, but at the time of TMS measurements no patient had been treated 
longer than 6 weeks continuously. We calculated chlorpromazine equivalents [33] for 
the cumulative and daily doses of the different antipsychotics to explore the influence 
of this medication on the study results.
The ADHD patients (combined type) were diagnosed according to the diagnostic 
criteria of DSM IV (ADHD-DC: ADHD Diagnostic checklist [34]), and had used no stimulant 
medication before. The Wender Utah Self Rating Scale – short version (WURS-k) [35]) 
was used to assess childhood ADHD symptoms. Patients with the clinical diagnosis of 
ADHD were included in the study if the WURS-k score was at least 30, and when at least 
6 of 9 items of inattention and hyperactivity/impulsivity were present. As indicators of 
severity of symptoms, the ADHD self-rating scale for adults (ADHD-SR) according to 
DSM IV [34] was used (total score: 0 to 54; attention deficit and hyperactivity/impulsivity 
subscores: each maximal 27). SCID-1 and 2 interviews were used to exclude further axis 
I and II DSM categorical diagnoses. 
After a complete description of the study, written informed consent was obtained from 
each subject. The local ethics committee approved the protocol, which is in accordance 
with the Declaration of Helsinki.
TMS procedure
As described previously [11], subjects were seated in a comfortable reclining chair with 
their arms supported passively. Electromyographic (EMG) recordings from the right and 
left first dorsal interosseus muscle (FDI) were made with surface electrodes. Raw signals 
were amplified, bandpass filtered (2 Hz–10 kHz) and digitized using a commercial 
amplifier (Keypoint portable, Medtronic Co., Denmark). Each EMG recording was 
manually analyzed off-line. TMS was performed by using a MagPro X 100 magnetic 
stimulator (Medtronic Co., Denmark) and focal transcranial magnetic stimulation (TMS) 
was applied to the hand area of the left and right motor cortex with a standard figure-
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of-eight magnetic coil. The optimal coil position was defined as the stimulation site that 
produced the largest motor evoked potential (MEP) at moderately suprathreshold 
stimulation intensities (i.e. intensities that induce MEPs of about 0.5–1.5 mV, SI1mV) in 
the resting right and left FDI muscle. The optimal position was marked to ensure that 
the coil was held in the correct position throughout the experiment. The coil was held 
tangentially to the head, with the handle pointing backwards and in an angle of 45 
degrees lateral to the midline. This ensured that the induced current pointed forwards 
and perpendicular to the central sulcus, which is optimal for producing transsynaptic 
activation of corticospinal neurons. The resting motor threshold (RMT), expressed as a 
percentage of maximum stimulator output, was defined as the lowest intensity that 
produced an MEP of >50 µV in five out of ten trials in the relaxed FDI.
In accordance with standard TMS publications, SICI and ICF were obtained [13,18], 
setting the intensity of the conditioning stimulus at 80 % of the RMT and the test 
stimulus at an intensity that produced MEPs averaging 0.5 - 1.5 mV in the resting FDI. 
SICI/ICF were measured with interstimulus intervals (ISIs) of 3, 5, 7 and 15 ms and we 
performed a minimum of 8 trials with each ISI and 10 trials with the test stimulus alone. 
The effect of the conditioning stimulus on MEP amplitude of the test stimulus was 
determined as the ratio of the average amplitude of the conditioned MEP (cMEP) to the 
average amplitude of the unconditioned test MEP (uMEP).
CSP duration was obtained in moderately tonically active FDI (25 – 30 % of maximal 
contraction) by stimulating the contralateral motor cortex with intensities of 120 % and 
140 % of RMT. For each intensity, 8 trials were performed and the mean CSP duration 
calculated. The CSP duration was defined as the time from the motor evoked potential 
(MEP) onset to the return of any voluntary EMG activity (absolute CSP) [36].
All measurements and clinical characterizations were performed by an experienced 
investigator (FE-SZ: T.W.; ADHD: M.S.), controlled by another experienced investigator 
FE-SZ: M.S.; ADHD: T.W.), and corrected for outliers and extreme values. The data analysis 
was performed by A.H., T.W., M.S. and one statistician (T.SA.). 
Statistical analyses
For statistical analyses, SPSS for Windows 17.0 was used. All tests were two-tailed. Level 
of significance was set at α = 0.05. Data are presented as mean ± standard deviation 
unless otherwise indicated. Kolmogorov-Smirnov tests were applied to test normal 
distribution and logarithmic transformation was used if normality assumption was 
violated (SICI and ICF). Independent factor was group (FE-SZ, ADHD, HC) and dependent 
variables were RMT, ISI (3, 5, 7, 15 ms) and CSP (intensities 120% and 140% of RMT) on 
both hemispheres. As initial analyses, Pearson correlations between age and dependent 
variables were calculated and One-way-ANOVA was performed to analyze if the factor 
gender influenced the dependent variables. If a significant influence of these intervening 
variables was found, the main analyses were adjusted for these variables.
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A repeated measures multivariate analysis of variance (RM-MANOVA) with the within- 
subject factor “side” (left and right hemisphere) and the between-subject factor “group” 
(Healthy control, ADHD, FE-SZ) was initially performed. Only if this RM-MANOVA revealed 
a significant effect or a trend of factor “group” or “side x group” interaction , separate 
ANOVA’s for the left and right hemisphere were performed. If appropriate, corrected 
Tukey´s post-hoc tests were performed to determine the differences between groups.
Pearson’s product moment correlations between CPZ equivalents and dependent 
variables were calculated for the FE-SZ.
Results
Sociodemographic and clinical characteristics, influence of intervening 
variables age and sex on dependent variables
There were no significant age and sex differences between groups. Schizophrenia 
patients presented a severe degree of illness and severe impairment of social functioning 
according to CGI and GAF and moderate to severe positive and negative symptoms 
(PANSS). ADHD patients suffered from at least moderate symptoms according to the 
ADHD rating score. 
All schizophrenia patients received an antipsychotic medication (but no other 
concomitant medication, like benzodiazepines) and the dosages of daily and cumulative 
antipsychotic medication (expressed as CPZ equivalents) were 356.21 ± 203.65 (daily 
dosage) and 7565.17 ±7886.79 (cumulative dosage). ADHD patients and healthy controls 
were unmedicated. For details of the sociodemographic and clinical characteristics see 
table 1. 
Except of significant correlations between age and RMT (left: r = 0.32, df = 92, p = 0.002; 
right: r = 0.31, df = 92, p = 0.003) there was no significant influence of age on dependent 
variables. From One-way-ANOVA there was no significant difference between female 
and male subjects for any dependent variable. 
Resting motor threshold (RMT)
After adjustment for age, no statistical significant differences of RMT between groups 
were revealed (see table 2). 
Intensity to evoke MEPs of 1mV (SI1mV)
There were no significant differences between groups (see table 2).
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Short-interval intracortical inhibition (SICI) and intracortical  
facilitation (ICF)
The RM-MANOVA showed a significant “side x group” interaction for ICF at 7ms (F (2, 86) 
= 6.08, p = 0.003) and ICF at 15ms (F (2, 85) = 5.20, p = 0.007) and a trend for the factor 
“group” for SICI at 3ms (F(2, 86) = 3.04, p = 0.053). 
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Table 1   Demographic and Clinical Data of Study Subjects: Interval scaled data are 
presented as mean ± standard deviation. Values are expressed as c² 
statistics for categorical variables and F statistics for continuous variables
Variable FE-SZ ADHD HC Statistic P
N 25 28 41
Gender 18 M, 7 F 15 M, 13 F 20 M, 21 F c²(2)=3.522 0.17
Age (years) 29.96 ± 8.5 32.36 ± 9.1 33.37 ± 9.1 F(2, 91)=1.140 0.32
Schizophrenia patients
PANSS positive
PANSS negative
PANSS general
PANSS total
21.96 ± 5.7
21.76 ± 6.4
48.28 ± 8.3
92.00± 14.5
---
---
---
---
---
---
---
---
CGI
GAF
CPZ1
CPZ2
5.88 ± 0.6
30.0 ± 10.5
356 ± 204
7565 ± 7887
---
---
---
---
ADHD Patients
ADHD-SR total score
Attention deficit subscore
Subscore Impulsivity
Subscore Hyperactivity
----
----
----
----
36.78 ± 6.3
18.22 ± 4.6
10.63 ± 2.1
7.93 ± 2.6
FE-SZ: first-episode schizophrenia, ADHD: attention deficit hyperactivity disorder; HC: healthy controls; P: 
error probability of first kind; N, number; F, female; M, male; CGI: Clinical Global impression; GAF: Global 
Assessment of Functioning; CPZ1: chlorpromazine equivalents, daily dosage; CPZ2: chlorpromazine 
equivalents, cumulative dosage; Total and subscores ADHD-SR.
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Table 2   Main outcome parameters
Variable FE-SZ ADHD HC Statistics 
Factor
“Group” (P)
RMT left 47.68 ± 6.55 50.04 ± 6.50 47.49 ± 5.93  ~
RMT right 49.00 ± 7.43 51.92 ± 8.86 48.29 ± 8.92   ~
S1mV left 57.08 ± 9.31 64.79 ± 10.57 61.88 ± 10.70  ~
S1mV right 59.50 ± 10.33 64.56 ± 13.35 63.65 ± 14.48  ~
CSP120 left 160.82 ± 41.59 164.72 ± 33.78 133.64 ± 40.88 0.013
CSP120 right 165.04 ± 55.03 162.81 ± 43.89 166.48 ± 37.38 0.974 
CSP140 left 203.89 ± 42.63 192.45 ± 46.53 172.36 ± 38.29 0.037
CSP140 right 210.38 ± 53.60 197.40 ± 57.13 186.34 ± 44.19 0.303
SICI 3ms left 39.61 ± 29.97 39.68 ± 36.95 23.90 ± 17.63 0.051
SICI 3ms right 51.11 ± 57.97 35.70 ± 32.54 32.00 ± 22.99 0.183
SICI 5ms left 82.88 ± 83.18 90.86 ± 51.28 63.86 ± 35.86  ~
SICI 5ms right 86.87 ± 74.57 74.69 ± 50.88 81.48 ± 55.73  ~
ICF 7ms left 110.68 ± 110.01 143.54 ± 79.73 94.35 ± 49.14 0.011
ICF 7ms right 148.23 ± 142.51 101.88 ± 58.60 113.56 ± 67.02 0.400
ICF 15ms left 162.95 ± 131.20 163.57 ± 130.08 119.18 ± 61.01 0.160
ICF 15ms right 190.86 ± 173.20 107.03 ± 67.72 146.68 ± 92.61 0.060
FE-SZ: first-episode schizophrenia, ADHD: attention deficit hyperactivity disorder; HC: healthy controls; P: 
error probability of first kind; RMT: resting motor threshold; S1mV: Intensity to evoke a MEP of 1 mV (peak to 
peak); CSP120: cortical contralateral silent period at 120% RMT; CSP140: cortical contralateral silent period 
at 140% RMT; SICI: Short-interval intracortical inhibition at one certain interstimulus interval (3ms, 5ms); ICF: 
Intracortical facilitation at a defined interstimulus interval (7ms, 15ms). Data are presented as mean ± 
standard deviation. Please notice that statistical analyses on SICI and ICF values were performed on log-
transformed values (raw values are presented in this table). Statistics present results separately for the right 
and left hemisphere. ~ = RM – MANOVA did not show a side x group interaction or a group effect at least 
on trend level for this dependent variables, therefore no further ANOVAs were performed separately for 
the left and right hemisphere.
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The subsequent ANOVA showed separately for the left hemisphere a trend  for the 
factor group for SICI at 3ms (F (2, 90) = 3.08, p = 0.051, Tukey´s post-hoc test: trend for 
FE-SZ < HC (p = 0.080)) and a significant effect for ICF at 7ms (F(2, 90) = 4.76, p = 0.011, 
Tukey´s post-hoc test: ADHD > HC (p = 0.013), ADHD > FE-SZ (p = 0.044).  ANOVA for the 
right hemisphere revealed a trend for ICF at 15ms (F(2, 85) = 2,92, p = 0.060, post-hoc 
Tukey´s test: trend for ADHD < FE-SZ (p = 0.051) (see figure 1 and 2 and table 2).
Cortical Silent Period (CSP)
For CSP120, RM-MANOVA revealed a significant effect for the factor “group” (F(2, 47) = 
3.84, p = 0.028) and a significant “side x group” interaction (F(2, 47) = 6.22, p = 0.004). For 
CSP140, RM-MANOVA showed only a significant effect for “group” (F(2, 46) = 3.36, p = 
0.043), but no significant “side x group” interaction (F(2, 46) = 0.17, p = 0.84). 
ANOVA separately for the left and right hemisphere showed a significant effect for the 
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Figure 1   Relative values for paired-pulse (SICI, ICF) measures on the left 
hemisphere expressed as percentage change compared to the testpulse 
in all groups 
*p < 0.05 (RM-MANOVA), #0.05 ≤ p ≤ 0.060. At 3ms FE-SZ (p = 0.080) had a trend towards a reduced SICI 
compared to HC. ADHD patients displayed an enhanced ICF at 7ms compared to HC (p = 0.013) and to 
FE-SZ (p = 0.044). The numeric differences for ISI 5ms and ISI 15ms did not reach significance. Data are 
presented as mean ± standard error of the mean. P – values are corrected in accordance to Tukey´s test. 
Analyses were performed on logarithmic transformed data (see methods). 
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factor “group” on the left hemisphere for CSP120 (F(2, 67) = 4.61, p = 0.013 (Tukey´s 
post-hoc tests: ADHD > HC (p = 0.028), FE-SZ > HC (p = 0.042)) (see figure 3) and CSP140 
(F(2, 63) = 3.47, p = 0.037 (Tukey´s post-hoc tests: FE-SZ > HC (p = 0.032)), but no difference 
on the right hemisphere for CSP120  (F(2, 57) = 0.03, p = 0.97) and CSP 140(F(2, 55) = 1.22, 
p = 0.30). For details see table 2.
Influence of antipsychotic medication on TMS parameters
In the group of FE-SZ we did not find a significant correlation between antipsychotic 
medication and TMS parameters.
Discussion
Our main results are that both, FE-SZ patients and ADHD patients demonstrate a 
prolonged CSP and a cortical disinhibition measured by TMS-protocols compared to 
healthy controls (HC). Direct statistical comparison showed that both patient groups 
have a similarly prolonged CSP compared to HC. Furthermore, FE-SZ and ADHD patients 
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Figure 2   Hemispheric differences of ICF at 7ms and 15ms in the FE-SZ and ADHD 
groups 
At 7ms on the left hemisphere FE-SZ had a reduced ICF compared to ADHD (p = 0.044). At 15ms on the 
right hemisphere FE-SZ had an enhanced ICF compared to ADHD (p = 0.051). Analyses were performed on 
logarithmic transformed data (see methods). *p < 0.05 (RM-MANOVA), #0.050 ≤ p ≤ 0.060
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displayed a trend towards a reduced SICI in comparison to HC. A generally enhanced ICF 
was found in ADHD in the left hemisphere when compared to HC. Apart from an 
enhanced ICF at 15 ms over the right hemisphere and reduced ICF at 7 ms over the left 
hemisphere, TMS measures in FE-SZ did not significantly differ from ADHD patients. 
Analysis of hemispheric effects revealed significant differences between groups.  Both 
patient groups had a significantly different pattern of the hemispheric distribution of 
the inhibitory CSP and facilitatory ICF compared to healthy controls. Interestingly, despite 
having a largely similar pattern of cortical disinhibition (CSP), a distinct hemispheric 
distribution of some facilitatory parameters could be detected between FE-SZ and ADHD 
(see figure 2). 
The modified cortical excitability in both ADHD and FE-SZ compared to healthy controls 
and the divergent hemispheric excitability pattern in both diseases are to our knowledge 
new and important findings that support the idea of a common pathological pathway 
in brain transmission in these diseases and raise questions about functional brain asymmetry 
in these diseases. In order to better understand the pattern of our result some hypothetical 
and mechanistic explanation are provided below.
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Figure 3   CSP120 duration on the left hemisphere in all groups 
ADHD (p = 0.028) and FE-SZ (p = 0.042) present longer CSP120 duration compared to HC. ADHD and FE-SZ 
do not differ concerning the CSP120 duration on the left hemisphere (p = 0.950). Data are presented as 
mean ± standard error of the mean. P – values are corrected in accordance to Tukey´s test
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General remarks
The role of SICI and CSP in schizophrenia remains controversial. Different studies pointed 
towards a reduced SICI in medicated chronic schizophrenia patients [20,37,38] and FE-SZ [11], 
whereas other studies failed to show this difference [18,19]. CSP in medicated patients 
was found to be shortened [20] or prolonged [19,21,39] compared to healthy subjects. 
The situation for ADHD is clearer laid out. Two studies revealed a reduced SICI in adult 
ADHD patients [12,25], whereas in another study this could not reach statistical 
significance [26]. In contrast to schizophrenia patients, ADHD patients did not show a 
prolonged CSP compared to healthy controls in previous studies [27]. 
The reduced SICI and the enhanced ICF in FE-SZ and ADHD patients in our study can be 
considered as parameters of cortical disinhibition and might be linked to a dysfunction 
of the GABA
A
 neurotransmission. The prolonged CSP in both patient groups can be best 
explained by an enhanced GABA
B
 transmission [14]. To understand the relationship of 
different inhibitory and facilitatory pathways, the two following aspects are important. 
Possible mode of action with regard to intrahemispheric and  
interhemispheric networks
First, it was shown that CSP and SICI have an inverse relationship and that SICI is 
suppressed and ICF is facilitated during CSP. SICI seems to be controlled by presynaptic 
GABA
B
-receptor mediated autoinhibition on inhibitory GABA
A
-interneurons, similar to a 
presynaptic autoinhibition revealed by paired intracellular recordings in slices of rat and 
human motor cortex [40,41]. Therefore, one explanation of our results might be that the 
enhanced GABA
B
-related inhibition (CSP) and the reduced GABA
A
-related inhibition 
(SICI)/enhanced glutamate-related facilitation (ICF) on the left hemisphere are 
interdependent and might reflect a compensatory circuit within this hemisphere [21]. 
However, we are not able to determine which network is dysfunctional and which 
network might compensate for this dysfunctionality.  
Second, ADHD patients and FE-SZ presented a modified hemispheric pattern for CSP 
and ICF compared to healthy controls. This is of particular importance, because 
abnormal brain laterality is a well known finding in these diseases. Especially an atypical 
lateralization to the right hemisphere explored in EEG and structural MRI studies is an 
important finding in ADHD and schizophrenia [42-44]. It could be hypothesized that this 
relationship is linked to an impaired interhemispheric connectivity/inhibition (IHI). We did 
not investigate this in our sample. However, one study found an impaired IHI in adult 
ADHD patients [27] and a reduced IHI was observed in schizophrenia patients [45]. 
But why do FE-SZ patients differ from ADHD concerning the hemispheric distribution of 
ICF? We know from other studies that a cortical disinhibition of the left hemisphere 
(hyperexciatbility) can result in a reduced facilitation (hypoexcitability) over the contralateral 
right hemisphere [46-48]. To understand our findings, the cortical disinhibition in both 
diseases on the left hemisphere (enhanced ICF in ADHD, reduced SICI in FE-SZ compared 
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to HC) should be primarily taken into consideration. Therefore, we would like to 
hypothesize that the relatively reduced ICF in ADHD patients on the right hemisphere 
might compensate for the enhanced ICF on the left hemisphere. In FE-SZ this 
compensatory mechanisms might be impaired and this might be reflected by the 
relatively facilitated ICF on the right hemisphere. 
In general, we would like to discuss an intrahemispheric compensatory mechanisms 
(reflected by CSP enhancement), which is unaffected in both patient groups and an 
inter- hemispheric compensatory circuit (reflected by a reduction of ICF), which seems 
to be exclusively active in the ADHD group.
Is there a hypothetical link to dopaminergic transmission?   
It is a remarkable finding that FE-SZ and ADHD did not differ in our outcome measures, 
except for the aforementioned difference in ICF in both hemispheres. As hypothesized 
in the introduction, these diseases might share in parts a common pathophysiological 
pathway and one possible pathway could be associated with dysfunctional dopaminergic 
transmission. Drug studies in healthy subjects and research on a hypodopaminergic 
disease (Parkinson's disease) revealed interesting findings about the effect of dopamine 
on TMS parameters. The CSP was prolonged after administration of dopamine agonists 
(L-Dopa, Pergolide) and shortened in patients with Parkinson's disease [14,49]. Hence, 
the prolonged duration of the CSP over the left hemisphere might be linked with the 
theory of dopaminergic hyperactivity in schizophrenia and ADHD. Here, the enhanced 
dopaminergic input would lead to a compensatory increase of GABAergic transmission 
and probably cause the CSP prolongation [50]. In ADHD there is a discussion over the 
possibility of dopaminergic dysbalance in frontal subcortical regions. Recently, we 
demonstrated an improvement of SICI in ADHD with long acting methylphenidate [51]. 
This was interpreted as a dopamine-related response to the stimulants, possibly 
reflecting a complex dopaminergic-GABAergic interaction. However, with the TMS 
technique we are not able to determine the localization of the affected brain regions 
involved in dopaminergic transmission nor directly probe dopaminergic functions. 
Therefore, currently this theory remains speculative.
Limitations
Our comparative study has several limitations. First of all, all schizophrenia patients 
received antipsychotic medication, which might have an impact on the results of TMS 
paradigms. We did not find a correlation between CPZ equivalents on the results of the 
TMS measures and an influence of antipsychotic drugs on TMS measurements is 
discussed controversially. One recent study showed that unmedicated schizophrenia 
patients and patients treated with second generation antipsychotics (risperidone, 
olanzapine, quetiapine) had a reduced CSP and that patients treated with clozapine had 
significant less SICI and a longer CSP compared to healthy controls [37]. All of our 
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patients received second generation antipsychotic medication but, in contrast to Liu 
and colleagues [37] none of our patients received clozapine. Also, it is important to 
recognize that the schizophrenia patients in our study were at their first episode with a 
relatively short treatment history whereas Liu and co-authors investigated chronically ill 
schizophrenia patients and patients with a schizoaffective disorder. However, reviewing 
the literature, we would expect that antipsychotics should compensate for the reduced 
inhibition and not enhance it [11,14,21]. Furthermore it should be considered, that the 
drug naïve adult ADHD patients showed a motor disinhibition which was not present in 
healthy controls. Finally, there were no significant differences between ADHD and FE-SZ 
patients with regard to inhibitory TMS parameters. This might support the hypothesis 
that diminished cortical inhibition is genuine to these diseases. Nevertheless, our results 
in adult ADHD patients are partially in contrast with the results of two previous studies, 
where significant differences in SICI and CSP could not be found [26,27]. This could be 
due to different methodical procedures in TMS techniques as well as to divergent 
recruitment strategies. However, our results stay well in line with the diminished SICI 
seen in children and adolescents with ADHD [22,52]. 
Although FE-SZ and ADHD patients present a similar cortical disinhibition, we cannot 
rule out that different mechanisms may underlie these effects and that these are not 
specifically restricted to these diseases [53]. Cortical disinhibition, as revealed by TMS 
might reflect a general characteristic of psychiatric conditions, because different other 
psychiatric diseases, like depression or OCD, are known to show a cortical disinhibition 
[54,55].  
ADHD is a dimensional diagnosis, but diagnosis of schizophrenia is based on the 
qualitative dimensions of symptoms. But, they still share some common executive 
dysfunctions (working memory, impulsivity etc.) and attention deficits, whereas the 
motor symptoms usually are opposite.  Despite of the different subsumed pathophysi-
ology and phenotypes, a common dopaminergic pathway has been discussed in both 
diseases [3,4]. However, it should be considered, that dopamine has a neuromodulatory 
function. The dopamine effect depends on spontaneous neuronal activity, dopamine 
concentration and dopaminergic sub-receptors [53]. Therefore, the transfer of our 
TMS-findings to the complex aspects of dopaminergic transmission mechanisms to 
both diseases can be done only in a limited manner. Therefore, the interpretation of our 
TMS results should be mainly focused on the discussed primary GABAergic transmission 
pathways. 
Finally, it should be noted that overlapping parts of this study have been published 
before (see method section). However, this is the first study which directly compares 
cortical excitability in first-episode schizophrenia and ADHD. Furthermore, we provide 
new CSP data for ADHD and new late-ICF data (15 ms) for first-episode schizophrenia 
and we show for the first time elaborate data for functional hemispheric asymmetry 
measured by TMS for both diagnostic groups. A detailed discussion specific for each 
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diagnostic groups and focusing on effects of one hemisphere can be found in our other 
publications [11,21,25].
Conclusions
In conclusion, the results of our study provide evidence for a cortical disinhibition in 
ADHD and FE-SZ and for a common pathophysiological pathway, which might involve 
GABAergic, glutamatergic and dopaminergic transmission. Furthermore, we were able 
to present a functional hemispheric asymmetry in both diseases. This comparative work 
supports the idea of common pathophysiological pathways in motor excitability in 
schizophrenia and ADHD.
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8. General discussion and conclusions
Attention Deficit/ Hyperactivity Disorder (ADHD) is characterized by shifting of sympto-
matology from childhood to adulthood. Especially hyperactivity and impulsivity seem 
to become less prominent, and disorganization dominates the symptomatic expression 
of attention problems (15). 
To investigate the specific mechanisms leading to adult ADHD symptoms, this thesis 
provides evidence about the functional aspects of attention, executive and motor 
functions in this disorder. We assessed by functional magnetic resonance imaging (fMRI) 
the attention and executive brain networks in drug naive adult ADHD patients and 
implemented the data to the clinical phenotype (chapter 3). The motor cortex excitability 
and its clinical impact in adult ADHD patients was compared with healthy controls by 
means of the paired pulse transcranial magnetic stimulation (ppTMS) technique (chapter 
4). The influence of long acting methylphenidate (LA-Mph), the standard medication for 
this disorder, on the motor system was assessed with this technique (chapter 5) to 
elucidate the underlying pathomechanisms. Motor excitability was studied in patients 
with schizophrenia in chapter 6 and subsequently ppTMS in ADHD and schizophrenia 
was compared to clarify common pathophysiological pathways and their specific 
components in diseases with dopaminergic dysbalances (chapter 7). 
As previously delineated in chapter 1, in terms of specific aims, the main results of the 
thesis will be discussed. The interpretation of the studies, the clinical implications, as 
well as the methodological strengths and limitations including the recommendations 
for future research are presented, and, finally, the conclusions of the thesis are formulated.
8.1 fMRI in adult patients with ADHD
Our fMRI study with a continuous performance task paradigm showed altered activation 
patterns of a selective attention brain network in the fronto-striatal and parietal brain 
regions in adult patients with ADHD. These findings are in agreement with the existing 
hypotheses about the pathophysiology of ADHD. More explicitly, prefrontal cortex, 
anterior cingulated cortex (ACC) and striatum were implicated, that all can be considered 
as belonging to the frontal attentional system. In addition, the parietal lobule as part of 
the posterior attentional system appeared to be also hypofunctional (see overview 
from 89). 
From the dimensional perspective, these results demonstrated that lowered activation 
of these distinct attention networks correlates not only with the clinical phenotype of 
combined type ADHD, but also with ADHD symptomatology in partially remitted 
patients. This leads to the hypothesis that in patients with partially remitted ADHD 
similar brain networks are impaired as in those with adult ADHD, combined type. 
Furthermore, a functional hypoactivity of several brain networks was established that 
could be positively related to specific ADHD symptoms: ACC to impulsivity, caudate 
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nuclei to attention deficits, and parietal lobule to the complete symptom profile. In 
contrast, the left insula was associated with hyperactivation, as reflected in clinically 
observed increased hyperactivity and impulsivity. The latter can be considered as a 
compensatory overactivation of brain regions counterbalancing the impaired networks 
(22,24). 
Thus, the results of this study support the hypothesis that adult ADHD has to be 
considered as a dimensional disorder of which the severity of symptoms correlates with 
the degree of dysfunction in various brain networks, even in patients in whom ADHD 
symptoms were partially remitted after childhood. These observations in adults with 
ADHD are in line with those reported in younger patients and reflect pathophysiologi-
cal trait characteristics of ADHD (caudate nucleus: 17, 37. ACC: 17, 38,39. Parietal lobe: 17). 
8.2 ppTMS in drug naïve adult patients with ADHD versus healthy controls
No differences were found between ADHD patients and healthy controls with respect 
to resting motor threshold (RMT) and active motor threshold (AMT). The same holds for 
the stimulus response curves. Thus, no evidence could be obtained for the presence of 
hyperexcitability within the motor systems at the membrane level of cortical neurons in 
adult patients with ADHD versus healthy controls (123). 
With the ppTMS technique, we found a reduced short intracortical inhibition (SICI) in 
adult ADHD patients as compared to controls. In the present study, no significant 
increase of cortical facilitation could be demonstrated. These findings are in line with a 
previous preliminary report on adults with ADHD (93). 
With respect to the dimensional characteristics of ADHD, a positive correlation was 
found between inhibitory deficits (SICI) and severity of symptoms scores (Wender-Re-
imherr-Interview (WRI) total score and ADHD-self rating (ADHD-SR) hyperactivity and 
impulsivity subscores). Comparable findings were reported by Gilbert et al. (52) in 
Tourette patients with comorbid ADHD symptoms. In sum, the hyperactive/impulsive 
behaviours in adult ADHD patients are most probably linked to cortical inhibitory 
dysfunction.
As presented in chapter 4, SICI deficits in ADHD patients appeared to have an inter-
hemispheric asymmetry to the left side. Comparable findings have been reported with 
brain imaging techniques that described hemispheric asymmetries either globally or in 
distinct brain areas, specifically the caudate nucleus and pallidum (8,26,27,83,109). 
With respect to the SICI, several GABAergic and dopaminergic intracortical neural 
transmission systems have been reported to be involved (120,72,110,123). Deficits in SICI 
have been shown to have reliable test-retest stability in adults with ADHD (93) and little 
inter- and intraindividual variability (74). These observations lead to the hypothesis that 
attenuation of SICI results from GABAergic, glutamatergic and/or dopaminergic changes 
in transmission and reflects a trait marker of ADHD.
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Summarizing, this is the first study with ppTMS demonstrating reduced SICI, primarily in 
the left hemisphere, in adult patients with ADHD. Moreover, this lowered SICI correlated 
with the ADHD symptom profile, in particular with disinhibited behaviours. These 
findings are in line with the hypothesis of neuronal motor inhibition deficits in adult 
ADHD. TMS, more specifically ppTMS, appeared to be an appropriate technique to 
investigate motor excitability in ADHD. 
8.3 ppTMS effects of LA-Mph in adults with ADHD
This study (chapter 5) was performed to investigate the effects of LA-Mph – the current 
pharmacological treatment of ADHD - on motor excitability in adults with ADHD. 
Previous findings of lowered SICI in ADHD, as indicator of elevated brain motor 
excitability, were the rationale for this study (93,94).
Treatment with stimulants like LA-Mph should lead to normalization of elevated 
(lowered amplitude of) SICI. In contrast to a study with adult ADHD patients which 
showed no significant differences in ppTMS parameters under medication with Mph 
(62), Gilbert and colleagues (51,52) found an increase of amplitude of the SICI in adult 
patients with Tourette disorder comorbid with ADHD. Therefore, we studied the effects 
on ppTMS parameters in adult ADHD patients without comorbidity under stable 
medication with LA-Mph.
The results demonstrated no effect of LA-Mph on RMT and AMT and support the 
hypothesis that the compound does not directly affect membrane characteristics. 
These observations are in line with those reported by other investigators (ADHD 
children: 78,79,19; adults with ADHD: 62).
With LA-Mph in an individualized stable dose varying between 30 and 54 mg per day, a 
significantly reducing effect on SICI magnetically evoked potential (MEP) amplitudes 
was found, but not on ICF MEP amplitudes. SICI MEP amplitude appeared to be 
correlated with ADHD self rating scores at baseline, but not after 2 weeks of treatment. 
In children with ADHD, however, treatment with Mph induced significant decreases in 
SICI MEP amplitudes (78,19). It can, therefore, be hypothesized that the pathophysiolog-
ical mechanisms, as reflected by ppTMS parameters, are present in children as well as in 
adults with ADHD.
In summary, the results from this study demonstrate that, like in studies with children, 
LA-Mph decreases SICI MEP amplitudes in adults with ADHD. A direct clinical correlation 
of the neurophysiological parameters with the clinical improvement of ADHD symptoms 
could, however, not be established.
8.4 ppTMS in adult patients with first episode schizophrenia or ADHD
ADHD and other psychiatric disorders, like schizophrenia, share attention deficits, executive 
dysfunctions and motor disturbances. Since the pathophysiology of schizophrenia is 
supposed to be related to dysbalances in dopaminergic transmission, studies with ppTMS 
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were performed in patients with first episode schizophrenia and adult patients with 
ADHD (chapters 6 and 7). 
With respect to RMT in patients with first episode schizophrenia, a positive correlation 
was found with symptom severity as measured with the Positive and Negative Syndrome 
Scale (PANSS) total score, but not with the PANSS subscores. No differences in RMT 
could be established between patients with first episode schizophrenia and healthy 
controls. These results support the idea that membrane excitability is not primarily 
disturbed in schizophrenia.
Concerning ppTMS, increased SICI MEP amplitudes were found in patients with first 
episode schizophrenia. With respect to ICF, no significant differences were observed 
between patients and healthy controls. These findings indicate a reduced SICI, without 
changes in ICF in patients with first-episode schizophrenia. It can, therefore, be 
hypothesized that inhibitory intracortical deficits may either be involved in the patho-
physiology of this disorder or serve as a vulnerability factor. 
Since deficits in SICI have been demonstrated in a variety of neuropsychiatric disorders 
(e.g. unipolar depression: 9; ADHD: 94; obsessive compulsive disorder: 53), the ppTMS 
results in patients with adult ADHD were compared to those obtained in adult patients 
with first episode schizophrenia in order to delineate putative common psychopatho-
logical pathways. 
From this comparative study using ppTMS, it appeared that patients with either first 
episode schizophrenia or adult ADHD patients displayed deficits in SICI and a prolonged 
cortical silent period (CSP) over the dominant left hemisphere. Enhancement of ICF, 
however, was only found in ADHD. This observation is not in line with those as reported in 
chapter 4, in which elevation of ICF did not reach the level of significance and may be 
explained from variations in the number of controls (26 vs 41). It has to be stressed, 
however, that elevated SICI and ICF MEP amplitudes both reflect a generally increased 
cortical excitability. Because SICI and ICF are thought to be primarily related to GABAergic 
neurotransmission (see also chapter 1.4.3), the observations in patients with first episode 
schizophrenia or ADHD of reduced and enhanced values for SICI and ICF, respectively, may 
indicate enhanced cortical disinhibition via GABAergic involvement. The prolonged CSP in 
both patient groups points in the same direction (121). It can, however, not be excluded 
that the increase of GABAergic transmission results from an enhanced compensatory 
dopaminergic activation in subcortical brain regions (101,104). In this respect, is could be 
postulated that the cortical-striatal-pallidal-thalamical-cortical loop is affected in both 
schizophrenia and ADHD (33,49,61,72,80). Although in patients with first episode 
schizophrenia and in patients with ADHD cortical disinhibition of the left hemisphere (hy-
perexcitability) was found, it can not be excluded that this phenomenon results from 
reduced facilitation (hypoexcitability) over the contralateral right hemisphere (58,108,116). 
Most probably, in schizophrenia, intrahemispheric and interhemispheric compensatory 
mechanisms are involved as reflected by CSP enhancement and ICF modulation. 
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In conclusion, the results of these studies support the ideas of cortical disinhibition in 
both ADHD and first episode schizophrenia and suggest common pathophysiological 
pathways related to GABAergic and dopaminergic neurotransmitter functionality. 
8.5 Limitations and strengths of the studies
The fMRI technique has several techniqual limitations which are mainly related to the 
slow time courses of the signals which hampers stable representation of rapidly 
changing executive and motor functions in human beings. In addition, repeated 
measurements in a group of patients are warranted to get a reliable outcome. 
Moreover, patients must lie in a resting state without significant motor activity for 
about 15 minutes. These factors partly explain the inconsistency of the results in 
patients with psychiatric disorders, particular in whom motor disinhibition is a key 
symptom such as ADHD. Thus, fMRI data have to be controlled for movement artifacts 
which have led to a significant number of drop-outs (ca. 15%) in the data as presented 
in this thesis.
The main technical problem in applying TMS is the highly variable amplitude of the 
elicited motor signal. Therefore, averaging of the magnetically evoked potentials has to 
be performed in order to obtain reliable data. This specific technical limitation is 
particularly relevant in patients with highly increased motor activity (like in ADHD). 
Given this, the results of measurements in very hyperactive or restless patients had to 
be excluded from the data analyses.
As mentioned in the discussion sections of the papers included in this thesis, the results 
have to be interpreted cautiously since several confounding factors were present. Apart 
from the technical difficulties as described above, the study groups comprised a limited 
number of patients only, which influenced the statistical power. Furthermore, in the 
study with ppTMS in patients with schizophrenia, the results may have been influenced 
by the use of antipsychotic medication. Finally, but relevant for all research in psychiatry, 
stability over time of the diagnosis and scoring instruments to assess intensity of 
symptoms cannot be clearly validated (e.g. the German validation of the adult ADHD 
scoring instruments is still going on). In this respect, it has to be stressed that the 
Diagnostic and Statistical Manual (DSM) is a categorical classification system and its 
symptom validity to establish psychiatric diagnoses is still a matter of debate. The latter 
has already resulted in several relevant adaptations in the subsequent issues of the DSM. 
Apart from the more general remarks on the limitations of these studies, their 
methodical strength has also to be underlined. All but the one study with LA-Mph 
followed a controlled design. The age of the included patients ranged from 18 to 49 
years and neither age nor intelligence influenced the stability of the neurophysiological 
parameters. Moreover, no relevant gender effect of the ‘pure’ and drug-naïve ADHD 
patients could be demonstrated so that ‘real’ ADHD pathophysiology could be studied 
indeed. Finally, functionality of brain mechanisms in ADHD was compared with that in 
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another diagnostic group, first episode schizophrenia, a disease with parallels regarding 
cognitive psychopathology and brain transmission mechanisms. 
8.6 Clinical relevance and future outlines
As demonstrated in this thesis, the fMRI technique can be used to elegantly investigate 
brain networks involved in processing attention and executive brain functions. The 
results of the here presented studies demonstrate that the symptomatology of ADHD 
may persist over decades, but not always in a similar intensity and constellation. 
Interestingly, data from the literature indicate that alterations in the neurophysiological 
parameters as measured with fMRI are qualitatively rather stable over time. In other 
words, this functional disturbance in subcortical-cortical neuronal pathways originates 
from childhood and persists into adulthood irrespective the psychopathological 
presentation of the disorder. ADHD in adulthood can be described as an impairment of 
attention and executive functioning as well as motor inhibition, that may be considered 
as trait characteristics of the disorder. Therefore, this technique may be used in future 
studies to investigate putative genotype-phenotype relationships and associations 
between phenotypical presentations and sex and/or age. In addition, since the fMRI 
technique is non-invasive and can be performed repeatedly, it can be used to perform 
longitudinal studies aimed to detect compensatory or restorating mechanisms and 
effects of pharmacological interventions in individual patients with ADHD. This may 
ultimately lead to an endophenotypically orientated individualized diagnosis and 
treatment of adult patients with ADHD. 
PpTMS is a non-invasive technique too by which motor functionality, related to neu-
rotransmitter systems, can be investigated in humans. Since the magnetically evoked 
potential (MEP) is the result of all excitatory and inhibitory postsynaptic potentials on 
the motor neuroaxons, ppTMS is one of the most appropriate techniques to study 
overall activity of pyramidal neurons including their dynamic compensatory 
capacities. Given its sensitivity to pharmacological influence and its correlation with 
clinical phenotypes, ppTMS can be applied in follow-up treatment studies with the 
emphasis on the long-term effects on motor systems in adults with ADHD. As 
compared to the data obtained by other investigators in children with ADHD, the 
results of the neurophysiological parameters in the here presented studies with adult 
ADHD patients suggest that treatment with LA-Mph induces similar effects. This 
method may eventually lead to the development of “therapeutic drug monitoring” 
and to a better understanding of motor cortex transmission in psychiatric disorders in 
general. 
An additional aspect to be considered is that age and gender are not of major significance 
in attention or motor brain network activation patterns in adults with ADHD, albeit that 
shifting of symptomatology occurs from childhood into adulthood (see chapter 1). 
Since the studies presented here were performed with drug naïve ADHD patients, the 
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neurophysiological parameters can be considered to reflect trait factors in ADHD patients 
without drug-induced variations in neuroplasticity. 
Finally, in the study comparing patients with first episode schizophrenia and adults 
with ADHD, overlapping changes in MEP amplitudes were found which points towards 
a common neurobiological pathway including GABAergic and dopaminergic neuro-
transmitter systems and may ultimately lead to more endophenotypically orientated 
treatment strategies. 
Future longitudinal studies are warranted to further elucidate the postulated 
endophenotypic trait stability of ADHD. These investigations may eventually disclose a 
clear genotype-phenotype relationship of ADHD and consequently a more targeted 
pharmacological treatment approach for this and other dopamine-related disorders or 
symptoms.
8.7 Conclusions
Four main conclusions can be formulated on the basis of this thesis.
The fMRI data from the controlled study demonstrated impairments of attentional and 
executive brain networks in adult ADHD in comparison to healthy controls. The hypo-
activation in fronto-striatal and parietal brain networks correlated with the clinical 
ADHD symptom scores. Thus, ADHD patients used deviant brain networks via the left 
insula to compensate for the hypoactivation of the above mentioned attention 
networks. 
PpTMS was used to investigate motor cortex excitability in adult patients with ADHD. 
The results of this controlled study showed that motor inhibition deficits localized in the 
left hemisphere were present in ADHD. The observed increases in inhibitory MEP 
amplitudes could be associated with the symptom profile. 
The amplitude of the inhibitory MEP decreased during treatment with the dopamine 
agonistic compound LA-Mph, which suggested that dopaminergic dysfunctions are of 
significance in the pathophysiology of ADHD indeed.
In the controlled studies, results of ppTMS in patients with first episode schizophrenia 
were compared to those obtained in adult patients with ADHD. In patients from both 
diagnostic categories a diminished intracortical inhibition was demonstrated, especially 
in the left dominant hemisphere. In the right hemisphere, however, the intracortical 
facilitation appeared to be increased in patients with schizophrenia but not in those 
with ADHD. In addition, a prolonged CSP was found in both schizophrenic and ADHD 
patients suggesting that imbalances in GABAergic neurotransmission are also involved 
in the pathophysiology of motor inhibition. As a consequence, the equilibrium between 
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GABAergic and dopaminergic neurotransmission might be disturbed which indicates 
that schizophrenia and ADHD share common neurotransmitter deficits.
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Summary
Attention Deficit/ Hyperactivity Disorder (ADHD) is characterized by a shifting of 
symptomatology from childhood to adulthood. Especially hyperactivity and impulsivity 
seem to become less prominent, and disorganization dominates the symptomatic 
expression of attention problems. Therefore, there is a need to investigate the patho-
physiological brain mechanisms leading to ADHD symptomatology in adults and their 
links to the clinical phenotype. In this thesis, the functional magnetic resonance imaging 
(fMRI) technique was used to delineate the attention and executive impairments in 
ADHD. With the paired pulse transcranial magnetic stimulation (ppTMS) technique the 
brain motor excitability was analysed in ADHD and its modulation with the long acting 
stimulant methylphenidate. The comparison with patients with schizophrenia, a 
disorder which also includes attention deficits and motor phenomena, was included to 
delineate the common or distinguishing pathophysiological pathways.
First, in chapter 3 the attention network in adult ADHD patients was investigated as it 
still remains unclear whether ADHD psychopathology shows distinct deficits in 
adulthood. A total of 11 adult patients with ADHD, 8 probands with ADHD associated 
symptoms in childhood, and 17 controls were recruited for this event related fMRI study. 
With a continuous performance test (CPT) inhibitory functions were tested in the NoGo 
condition. It turned out that in ADHD patients not only the fronto-striatal network could 
be activated less, but also the posterior parietal attention system, reflecting hypofunc-
tionality of a more broad attention network. These reduced activation patterns were 
similar to the patterns observed in studies with children and adolescents with ADHD. 
Linear regression analysis showed a correlation of reduced activities of caudate nuclei, 
anterior cingulate cortex as well parietal cortical structures with ADHD self-rating 
symptomatology. It is concluded that impairment of an array of brain regions involved 
in cognitive processing is present in adult patients with ADHD.
Second, motor inhibition and facilitation in adult ADHD patients was studied in chapter 
4 using ppTMS. A group of 26 right handed adult ADHD patients (according to DSM-IV 
criteria) was investigated and compared to 26 age and sex-matched controls. In the left 
hemisphere, mean motor inhibition was decreased in ADHD patients as compared to 
controls. There were no significant differences in motor excitability concerning 
facilitation. Decreased motor inhibition correlated with a higher symptom score derived 
from the Wender Reimherr Interview and also with self rated hyperactivity/impulsivity 
symptoms. It was concluded that decreased motor inhibition in adult ADHD corroborates 
similar findings in children with ADHD and reflects disturbed impulsivity and 
hyperactivity on a neurophysiological level.
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Third, the neurophysiological effects of long acting Methylphenidate (LA-Mph) were 
investigated in chapter 5 in adult patients with ADHD using ppTMS technique. Thirteen 
right handed adult ADHD patients were included. Measurements took place before and 
under treatment with LA-Mph in a stable individualized daily dose. LA-Mph significantly 
decreased the relative short intracortical motor inhibition (SICI) magnetically evoked 
potential (MEP) amplitude. The relative intracortical facilitation (ICF) MEP amplitude was 
not increased. The reduced relative SICI MEP amplitude with LA-Mph correlated with 
the improvement of the psychopathological ADHD self-rating total scores. These results 
demonstrate that LA-Mph significantly improves motor disinhibition in adult patients 
with ADHD and might have differential stabilizing effects on motor hyperexcitability. 
Fourth, SICI and ICF were assessed in 29 first-episode schizophrenia patients with limited 
exposure to antipsychotic treatment and in 28 healthy controls in chapter 6. For SICI 
conditions, in patients with schizophrenia significantly higher MEP amplitudes were 
found from left motor cortex and, for MEPs from right motor cortex, a similar trend was 
observable. No difference in MEPs could be detected for ICF on either hemisphere. In 
addition, there was no difference in left and right resting motor threshold (RMT) 
comparing patients and controls. Finally, cortical excitability (inhibitory and facilitatory 
networks) was investigated in ADHD and schizophrenia with single- and paired-pulse-
TMS to the left and right motor cortex in chapter 7. Compared to healthy controls, 
patients with either schizophrenia or ADHD displayed impaired cortical inhibition over 
the left hemisphere. Both patient groups presented a dysfunctional hemispheric 
pattern of cortical inhibition and facilitation in comparison with controls. These results 
indicate a pattern of cortical disinhibition and abnormal hemispheric balance of 
intracortical excitability networks in both dopamine-related diseases. These effects 
might be associated with an imbalance in GABAergic and dopaminergic transmission 
and might provide evidence for a common pathophysiological pathway of both 
diseases.
In chapter 8, the most important results in relation to the aims of this thesis were 
discussed and the conclusions were presented. 
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Samenvatting
Attention Deficit/ Hyperactivity Disorder (ADHD) wordt gekenmerkt door een 
verschuiving in de klinische symptomatologie van de kindertijd naar volwassenheid. 
Vooral hyperactiviteit en impulsiviteit lijken minder prominent, terwijl desorganisatie 
de symptomatologie van de aandachtsproblemen domineert. De onderliggende 
 pathofysiologie is echter niet bekend. Daarom is het noodzakelijk de pathofysiologische 
processen in het centrale zenuwstelsel die ten grondslag liggen aan ADHD symptomen 
bij volwassenen te onderzoeken, alsmede de verbanden met het klinische fenotype. 
In dit proefschrift werd de functionele magnetische resonantie imaging (fMRI) techniek 
gebruikt om de aandachts- en executieve functiestoornissen in ADHD te onderzoeken. 
Met de gepaarde puls transcraniële magnetische stimulatie (ppTMS) techniek werden 
de motorische excitabiliteit van de hersenen en de modulatie door de langwerkende 
afgiftevorm van methylfenidaat bij volwassen patiënten met ADHD geanalyseerd. E 
en vergelijkende analyse met ppTMS bij patiënten met schizofrenie, een aandoening 
die ook gepaard gaat met aandachtsstoornissen en psychomotorische verschijnselen, 
zou vervolgens de gemeenschappelijke of de te onderscheiden pathofysiologische 
mechanismen inzichtelijk kunnen maken.
Allereerst werden in hoofdstuk 3 de aandachtsnetwerken bij volwassen ADHD patiënten 
onderzocht om de mechanismen van ADHD psychopathologie in de volwassenheid 
aan te tonen. Een totaal van 11 volwassen patiënten met ADHD, 8 personen met aan 
ADHD geassocieerde symptomen in de kindertijd, en 17 controles werden gerekruteerd 
voor deze ‘event-related’ fMRI studie. Met een continue performance test (CPT) werden 
de inhibirende functies in de NoGo conditie getest. Bij ADHD patiënten bleek niet alleen 
het fronto-striatale-netwerk minder geactiveerd te worden, maar ook het posterieure 
pariëtale attentie systeem, ten gevolge van hypofunctionaliteit van een groter attentie 
netwerk. Deze verminderde activatie patronen waren vergelijkbaar met die zoals eerder 
gevonden in kinderen en adolescenten met ADHD. Lineaire regressie-analyses toonden 
een correlatie tussen verminderde activiteiten in de caudate nuclei, de anteriore 
cingulaire cortex en pariëtale corticale structuren en de ADHD symptomatologie op de 
zelfbeoordelingslijsten. Geconcludeerd wordt dat een reeks van hersengebieden die bij 
cognitieve verwerkingen betrokken zijn, bij volwassen patiënten met ADHD een 
veranderde functionele activiteit hebben. 
Vervolgens werd in hoofdstuk 4 motorische inhibitie en facilitatie bij volwassen ADHD 
patiënten onderzocht met behulp van ppTMS. Een groep van 26 rechtshandige 
volwassen ADHD patiënten (volgens DSM-IV criteria) werd onderzocht en vergeleken 
met 26 leeftijd en geslacht gematchte controles. In de linker hersenhelft bleek de 
gemiddelde motorische inhibitie te zijn verminderd bij ADHD patiënten in vergelijking 
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met controles. Er waren geen significante verschillen in motorische excitabiliteit met 
betrekking tot de facilitering. Verminderde motorische inhibitie correleerde met een 
hogere symptoom score, zoals afgeleid van het Wender Reimherr Interview en ook met 
de hyperactiviteit/impulsiviteitsscores van de ADHD zelfbeoordelingslijsten.
Geconcludeerd werd dat, evenals  bij kinderen met ADHD, bij volwassenen met ADHD 
verminderde motorische inhibitie aanwezig is. De klinische symptomatologie van de 
impulsiviteit en hyperactiviteit sluit bij volwassenen met ADHD aan op de neurofysiolo-
gisch meetbare disinhibite.
Daarna werden in hoofdstuk 5 de neurofysiologische effecten van langwerkend 
methylfenidaat (LA-Mph) bij volwassen patiënten met ADHD onderzocht met behulp 
van de ppTMS techniek. Dertien rechtshandige volwassen ADHD-patiënten werden 
gerecruteerd. Metingen vonden plaats vóór en tijdens de behandeling met LA-Mph in 
een stabiele individuele dagelijkse dosering. LA-Mph verminderde significant de relatieve 
korte intracorticale motorische inhibitorische (SICI) magnetisch evoked potential (MEP) 
amplitude. De relatieve intracorticale faciliterende (ICF) MEP amplitudes waren niet 
verhoogd. De verminderde relatieve SICI MEP amplitude met LA-Mph correleerde met 
een verbetering van de ADHD symptomen, zoals vastgelegd met de totaal scores op 
zelfbeoordelingslijsten. Deze resultaten tonen aan dat LA-Mph de motorische disinhibitie 
bij volwassen patiënten met ADHD significant verbetert en een gedifferentieerd stabiliserend 
effect heeft op de motorische hyperexcitabiliteit.
In hoofdstuk 6 werden SICI en ICF geanalyseerd in 29 eerste episode schizofrenie 
patiënten met een beperkte blootstelling aan antipsychotische behandeling en bij 28 
gezonde controlepersonen. Voor de conditie SICI werden bij patiënten met schizofrenie 
significant hogere MEP amplitudes gevonden van de linker motorische cortex. Een 
soortgelijke trend werd ook voor de rechter motorische cortex gevonden. Geen verschil 
van MEP kon worden gedetecteerd in de ICF van beide hemisferen. Daarnaast was er 
geen verschil in de motorische drempel in rust (RMT) tussen patiënten en controles. 
Tot slot werd in hoofdstuk 7 met behulp van single- en gepaarde puls-TMS de corticale 
excitabiliteit (inhiberende en faciliterende netwerken) over de linker en rechter 
motorische cortex onderzocht bij patienten met ADHD of schizofrenie. In vergelijking 
met gezonde controles vertoonden de patiënten met schizofrenie of ADHD een 
verminderde corticale inhibitie over de linker hemisfeer. In vergelijking met controles 
toonden beide groepen patiënten een disfunctioneel hemisferisch patroon van 
corticale inhibitie en facilitatie. Deze resultaten wijzen op een patroon van corticale 
desinhibitie en abnormale hemisferische balans van intracorticale excitabiliteit van 
neuronale netwerken in deze dopamine-gerelateerde ziekten. Deze effecten zijn 
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waarschijnlijk gerelateerd aan een disbalans in GABA-erge en dopaminerge neurotrans-
missie en wijzen op een gemeenschappelijke pathofysiologische factor.
In hoofdstuk 8 worden de belangrijkste resultaten met betrekking tot de doelstellingen 
van dit proefschrift besproken en de conclusies gepresenteerd. 
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Zusammenfassung
Die Aufmerksamkeits-Defizit/ Hyperaktivitätsstörung (ADHS) ist durch eine klinische 
Symptomverlagerung von der Kindheit zum Erwachsenenalter charakterisiert.
Besonders Hyperaktivität und Impulsivität scheinen im Laufe der Zeit weniger 
prominent zu werden, währenddessen die Desorganisation symptomatisch für die 
 Aufmerksamkeitsprobleme wird. Diese Aspekte unterstreichen die Notwendigkeit, 
die pathophysiologischen Mechanismen des Gehirns zu untersuchen, die zur ADHS 
Symptomatik bei Erwachsenen führen und die Zusammenhänge zum klinischen 
Phänotyp zu verdeutlichen. In dieser Arbeit wurde die funktionelle Magnetresonanzto-
mographie (fMRI) angewandt, um die Aufmerksamkeits- und exekutiven Störungen bei 
ADHS darzustellen. Mit der transkraniellen Doppelpuls-Magnetstimulation (ppTMS) 
wurde die motorische Erregbarkeit des Gehirns bei ADHS inklusive deren Modulation 
mit der lang wirksamen Applikationsform des Stimulans Methylphenidat untersucht. 
Der Vergleich mittels ppTMS mit Patienten mit Schizophrenie, einer Krankheit, die 
auch Aufmerksamkeitsstörungen und psychomotorische Phänomene aufweist, könnte 
die Abgrenzung von gemeinsamen oder unterschiedlichen pathophysiologischen 
Vorgängen ermöglichen.
Zunächst wurden in Kapitel 3 die Aufmerksamkeitsnetzwerke bei erwachsenen ADHS- 
Patienten untersucht, zumal unklar war, ob die ADHS-Psychopathologie relevante 
funktionelle Defizite im Erwachsenenalter aufzeigt. Insgesamt 11 erwachsene Patienten 
mit ADHS, 8 Probanden mit ADHS-assoziierten Symptomen in der Kindheit, und 17 Kon-
trollprobanden wurden für diese ereigniskorrelierte fMRI-Studie rekrutiert. Mit einem 
Continuous Performance-Test (CPT) wurden die inhibitorischen Funktionen in der NoGo 
Bedingung untersucht. Es stellte sich heraus, dass bei ADHS-Patienten nicht nur die 
fronto-striatalen Netzwerke weniger aktiviert wurden, sondern auch die posterioren 
Aufmerksamkeitssysteme, was auf Hypofunktionalität breiter Aufmerksamkeitsnetz-
werke hindeutet. Diese reduzierten Aktivierungsmuster ähnelten den Mustern aus 
Studien mit Kindern und Jugendlichen mit ADHS. Die lineare Regressionsanalyse zeigte 
eine Korrelation von reduzierter Aktivität des Nucleus caudatus, anterioren cingulären 
Cortex als auch parietaler kortikaler Strukturen mit der Symptomatologie der ADHS-
Selbstbeurteilungsskalen. Es wurde daraus gefolgert, dass Beeinträchtigungen einer 
Reihe von Hirnregionen bestehen, die mit der kognitiven Verarbeitung, bei erwachsenen 
Patienten mit ADHS vergesellschaftet sind.
Zweitens, motorische Inhibition und Fazilitation wurden bei erwachsenen ADHS- 
Patienten in Kapitel 4 mit Hilfe der ppTMS untersucht. Die physiologischen Parameter 
von 26 rechtshändigen erwachsenen ADHS-Patienten (nach DSM-IV) wurden mit denen 
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von 26 Alters- und Geschlechts-gematchten Kontrollen verglichen. In der linken 
Hemisphäre, war die gemittelte motorische Inhibition bei den ADHS-Patienten im 
Vergleich zu den Kontrollen vermindert. Es gab keine signifikanten Unterschiede in der 
motorischen Erregbarkeit im Bezug auf die Fazilitation. Die verminderte motorische 
Inhibition korrelierte mit einem höheren Symptom-Score aus dem Wender Reimherr 
Interview und auch mit den Hyperaktivitäts-/ Impulsivitätsscores der ADHS-Selbstein-
schätzungsskalen. Es konnte festgestellt werden, dass die verminderte motorische 
Inhibition bei erwachsenen ADHS-Patienten ähnliche Befunde erbrachte, die bei 
Kindern mit ADHS beschrieben wurden. Störungen der Impulsivität und Hyperaktivität 
spiegeln sich somit auf neurophysiologischer Ebene wider.
Drittens, wurden die neurophysiologischen Auswirkungen von lang wirksamem 
Methylphenidat (LA-Mph) in Kapitel 5 bei erwachsenen Patienten mit ADHS mit der 
ppTMS Technik untersucht. Dreizehn rechtshändige erwachsene ADHS-Patienten 
wurden in diese Studie eingeschlossen. Die Messungen fanden vor und während der 
Behandlung mit einer stabilen individuellen Tagesdosis LA-Mph statt. LA-Mph 
verringerte signifikant die relative, kurze intrakortikale motorische inhibitorische (SICI) 
magnetisch evozierte Potential-(MEP) Amplitude. Die relative intrakortikale Fazilitations 
(ICF)- MEP Amplitude wurde nicht erhöht. Die Verringerung der relativen SICI MEP 
Amplitude mit LA-MPH korrelierte mit der Verbesserung des psychopathologischen 
ADHD-Self-Rating-Gesamtscores. Diese Ergebnisse zeigen, dass LA-Mph deutlich die 
motorische Dysinhibition bei erwachsenen Patienten mit ADHS verbessert und eine 
differentielle stabilisierende Wirkung auf die motorische Übererregbarkeit haben 
könnte.
Viertens, SICI und ICF wurden in Kapitel 6 bei 29 ersterkrankten Schizophrenie-Patienten 
mit begrenzter Exposition mit antipsychotischer Behandlung und bei 28 gesunden 
Kontrollpersonen untersucht. Für die SICI-Bedingungen wurden bei den Patienten mit 
Schizophrenie deutlich höhere MEP-Amplituden im linken motorischen Kortex 
gefunden. Ein ähnlicher Trend war bei den Patienten im rechtshemispärischen 
motorischen Kortex zu beobachten. Kein Unterschied in den MEPs konnte für die ICF auf 
beiden Hemisphären nachgewiesen werden. Darüber hinaus ergaben sich im links- und 
rechtshemisphärischen Vergleich der motorischen Schwellen in Ruhe (RMT) von 
Patienten und Kontrollen keine Abweichungen. Schließlich wurde in Kapitel 7 die 
kortikale Erregbarkeit (inhibitorische und fazilitatorische Kreisläufe) bei ADHS und 
Schizophrenie mit single- und paired-pulse-TMS am linken und rechten motorischen 
Kortex untersucht. Im Vergleich zu gesunden Kontrollpersonen, wiesen Patienten mit 
Schizophrenie oder ADHS Verminderungen der kortikalen Inhibition über der linken 
Hemisphäre auf. Beide Patientengruppen präsentierten ein dysfunktionales Hemisphä-
renmuster der kortikalen Inhibition und Fazilitation im Vergleich zu Kontrollen. Diese 
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Ergebnisse zeigen ein Muster der kortikalen Enthemmung und abnormen hemisphäri-
schen Balance der Erregbarkeit intrakortikaler Netzwerke in beiden dopaminergen 
Erkrankungen auf. Solche Effekte könnten mit einem Ungleichgewicht der GABAergen 
und dopaminergen Transmission in Verbindung gebracht werden und könnten auf 
einen gemeinsamen pathophysiologischen Weg der beiden Erkrankungen deuten.
In Kapitel 8 wurden die wichtigsten Ergebnisse in Bezug auf die Fragestellungen dieser 
Arbeit diskutiert und die Schlussfolgerungen präsentiert. 
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Behorende bij het proefschrift van Marc Schneider 
 1.  Bij ADHD bij volwassenen vinden zich stoornissen bij hersenen attentie netwerken 
die betrokken zijn bij de verwerking van eenvoudige signalen en ook van signal 
conflicten. (Dit proefschrift)
 2.  Aandachtstekort en hyperactiviteit/impulsiviteit zijn geassocieerd met verminderde 
activatie van de neuronale circuits behorende bij attentie en motoriek.  
(Dit proefschrift) 
 3.  Volwassenen met ADHD vertonen verminderde activatie van fronto-striatale en  
parietale hersengebieden in vergelijking met gezonde controles; deze verminderde 
activatie correleert met de klinische symptomatologie. (Dit proefschrift)
 4.  Verhoogde motorische excitabiliteit van de hersenen bij patiënten met ADHD is 
zichtbaar in de linker hemisfeer en correleert met het klinische fenotype.  
(Dit proefschrift)
 5.  Een behandeling met Methylfenidaat vermindert de symptomen van ADHD en 
normaliseert de verlaagde inhibitie van het motorische neurotransmissie systeem. 
(Dit proefschrift)
 6.  Bij patiënten met ADHD en schizofrenie wordt een hemisferische disbalans 
in de motorische excitabiliteit gevonden, hetgeen duidt op een mogelijke 
gemeenschappelijke pathofysiologische betrokkenheid van dopaminerge en 
GABAerge neurotransmissie systemen bij deze beide ziektebeelden.  
(Dit proefschrift)
 7.  There are no such things as applied sciences, only applications of science.   
(Louis Pasteur 1822-1895)
 8.  Human affairs are so obscure and various that nothing can be clearly known. 
(Desiderius Erasmus 1469-1536)
 9.  Auf dem Wege in die Irre ist der Rückschritt Fortschritt. (Josef Viktor Stummer  
1910-1981)
 10.  Soms kan het zeer handig zijn, tijdens het eten van een kogelvis in een Japaans 
restaurant een pijlgif kikker in de buurt te hebben.
 11.  Essence of science. You first think of something that might be true - then you look  
to see if it is, and generally it isn’t. (Bertrand Russell 1872-1970)
